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Oligosaccharides are important biomolecules that are targets and also components 
of many medical treatments, including treatments for cancer, HIV, and inflammation. 
While the demand for medically-relevant oligosaccharides is increasing, these 
compounds have proven difficult to synthesize. Whole-cell oligosaccharide synthesis is a 
promising method that requires relatively inexpensive substrates and can complete the 
synthesis in just one step. However, whole-cell oligosaccharide synthesis employing 
common microorganisms like E. coli have been plagued by low yields. This dissertation 
investigates an alternative microorganism for oligosaccharide production: Agrobacterium 
sp. ATCC 31749. This Agrobacterium strain produces high levels of curdlan 
polysaccharide, demonstrating its natural ability to produce the sugar nucleotide 
precursor for oligosaccharide production. The two main objectives of this dissertation are 
1) to develop biocatalysts for oligosaccharide synthesis by engineering ATCC 31749 and 
2) to determine what factors affect poly- and oligosaccharide production in this 
Agrobacterium strain. 
ATCC 31749 was engineered to produce two oligosaccharides of medical 
importance: N-acetyllactosamine and galactose-α1,3-lactose. Oligosaccharide production 
in the biocatalyst was further improved with additional metabolic engineering. Substrate 
uptake was increased through expression of a lactose permease, and availability of the 
sugar nucleotide substrate improved with gene knockout of the curdlan synthase gene. 
Both of these engineering efforts led to increased oligosaccharide synthesis in the 
Agrobacterium biocatalyst. Overall, the engineered Agrobacterium strains synthesized 
 xxvii
gram-scale quantities of the oligosaccharide products in just one step and requiring only a 
few inexpensive substrates and cofactors.   
 Additional improvement of the oligosaccharide-producing biocatalysts required 
further investigation of the factors influencing poly- and oligosaccharide production in 
ATCC 31749. In this dissertation, several environmental and intracellular factors are 
identified that affect both oligosaccharide and curdlan production. Sucrose was the 
preferred carbon source for oligosaccharide synthesis, and the addition of citrate to the 
synthesis reaction led to significant improvement in oligosaccharide production. To 
identify the genetic factors and possible mechanisms regulating curdlan production, the 
genome of ATCC 31749 was sequenced. The genome sequence was utilized for 
transcriptome analysis of ATCC 31749. In the transcriptome analysis, genes significantly 
up- and down-regulated during curdlan production were identified. Subsequent gene 
knockout experiments showed several factors to be important for curdlan synthesis, 
namely the nitrogen signaling cascade, polyphosphate, and the GTP-derived second 
messengers (p)ppGpp and c-di-GMP. In addition to the development of biocatalysts for 
oligosaccharide production, this investigation provides insight into the complex 




The work contained in this dissertation was written either with intent to publish, 
in submission currently, or already published in scientific journals. Previously published 
or accepted manuscripts were modified to include additional data and to adhere to the 
formatting requirements. This dissertation includes an introduction containing 
background information on oligosaccharides and Agrobacterium sp. ATCC 31749 
(Chapter 1), the experimental findings of this research project along with discussion 
(Chapters 2-6), and a summary of the conclusions of this dissertation along with 






1.1  Oligosaccharides 
 The term ‘oligosaccharide’ comes from the Greek word for ‘few’ (oligos) and the 
term for sugar (saccharide). As suggested by its etymology, oligosaccharides are 
comprised of a few sugar residues, generally two to ten, linked by glycosidic bonds. 
Sugar residues have a general molecular formula of (C·H2O)n, allowing oligosaccharides 
to also be classified as carbohydrates. Carbohydrates are one of the four main 
components of a cell, with lipids, nucleic acids, and amino acids as the other three. 
Despite its abundance in nature, the biological significance of carbohydrates and of 
oligosaccharides in particular has remained a mystery until the emergence of 
glycobiology in the late 1980’s [1]. 
1.1.1 Oligosaccharide structure 
Oligosaccharides typically consist of a combination of the nine common 
monosaccharides: glucose, N-acetylglucosamine, galactose, N-acetylgalactosamine, 
xylose, glucuronic acid, mannose, fucose, and N-acetylneuraminic acid or sialic acid [2]. 
Despite this limited selection of monosaccharides, oligosaccharides display great 
structural diversity. The sugar residues of oligosaccharides can be linked at different 
positions around the sugar ring, and each glycosidic linkage can be either α or β with 
respect to its geometry (Figure 1.1). Furthermore, oligosaccharides are classified based 
on their linkage to a main scaffold [3]. O-linked glycosylation involves an 
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oligosaccharide attached to a serine or threonine residue of a protein (Figure 1.1a). In N-
linked glycosylation, an oligosaccharide is attached to the asparagine residue of an Asn-
X-Ser/Thr sequence in a protein, where X is any amino acid except for proline (Figure 
1.1b). Oligosaccharides can be attached to lipids, forming glycolipids (Figure 1.1c), and 
glycosylphosphatidylinositol(GPI)-anchored proteins utilize glycolipids to anchor the 
protein to the cell membrane (Figure 1.1d). In addition to variations in the linkage and 
attachment to a main scaffold, oligosaccharide structure can also be modified by the 
addition of side groups to the monosaccharide components. With this great structural 
diversity, oligosaccharides also display a great range of functional diversity. 
 
 
Figure 1.1 Examples of oligosaccharides linked to a main scaffold. a) O-linked 



















































Figure 1.1  Continued. 
 
1.1.2 Biological function 
Carbohydrates have long been recognized for their roles as energy sources and 
carbon storage compounds. Carbohydrates are common nutrients in the human diet, and 
polysaccharides such as glycogen and starch provide a carbon storage mechanism for 
animal and plant cells respectively. Other polysaccharides contribute to cell structure. For 
example, cellulose is found in the cell walls of plants and other organisms, and chitin 
contributes to arthropod exoskeletons and some fungal cell walls. While these energy, 
storage, and structural functions are biologically important, a new role for carbohydrates 






responsible for many interactions between the cell and its environment, contributing to 
cell-cell interactions, antibody attachment, hormone and toxin binding, and viral and 
bacterial infection [3]. Cell surface carbohydrates are also important in immune response. 
In fact, some bacteria and viruses can avoid detection by the immune system through 
coating their surface with exopolysaccharides. In addition, oligosaccharides can promote 
proper protein folding, and glycosylation can be essential for activating protein function. 
With these various biological roles, it is not surprising that many poly- and oligo-
saccharides are involved in several disease states of the cell. 
1.1.3 Medical applications 
With recent discoveries in oligosaccharide function, medical researchers have a 
new class of candidates to consider for medical treatments. In fact, many oligosaccharide-
based medical treatments are currently under development. Just as the structure and 
function of oligosaccharides vary, so do the types of diseases with potential for 
oligosaccharide-based treatment. Oligosaccharide-based treatments are under 
investigation for diseases ranging from cancer to infection to inflammation. The oldest 
and most well known carbohydrate-based drug is heparin. Heparin is a sulfated 
glycosaminoglycan which has used as an anticoagulant since 1937 [4].  Following the 
discovery of heparin, other carbohydrate-based medical treatments proved difficult to 
develop. In 1980, a carbohydrate-based vaccine was developed to fight against 
Haemophilus influenza type B (Hib), the causative agent of bacterial meningitis (group 
C) [5]. With the advent of this vaccine, Hib has been virtually eliminated from the U.S., 
most European countries, and other developing nations, saving thousands, if not millions 
of lives worldwide [1]. 
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1.1.3.1 Oligosaccharide-based treatments for bacterial, parasitic, and viral infections 
Since the advent of the Hib vaccine, carbohydrate-based treatments have been 
under investigation for many other bacterial and parasitic infections. A potential malaria 
vaccine is in development which contains a hexasaccharide found on the cell surface of 
the malaria-causing parasite Plasmodium falciparum [6]. Other notable carbohydrate-
based vaccines under development stimulate immune defense against Bacillus anthracis, 
the causative agent of anthrax [7-9]. With the promise of these oligosaccharide vaccines, 
the threat of B. anthracis as a deadly bioweapon may soon be eliminated. In addition to 
the malaria and anthrax vaccines, numerous other bacterial and parasitic infections are 
being targeted by carbohydrate-based vaccines, including opportunistic staphylococcal 
infections, Shigella, cholera, typhoid, Candida albicans, leprosy, and leishmaniasis [5]. 
Carbohydrates are also important components of treatments for several viruses. 
Viral coats commonly contain glycoproteins which help the virus to evade the immune 
system of the host; the carbohydrate components of glycoproteins offer new targets for 
treatment of viral infections [1]. Numerous research efforts are underway to develop an 
HIV vaccine by targeting the gp120 viral envelope glycoprotein. Previous research has 
shown that infected individuals who generate antibodies against the gp120 glycoprotein 
can survive longer than those who lack the antibody [10]. HIV vaccines which promote 
gp120 antibody production may be able to extend the lifetime of the estimated 36 million 
people currently infected with HIV. Carbohydrate targets may also lead to the 
development of an antiviral treatment for influenza. The influenza virus enters 
mammalian cells when glycoproteins on the viral coat bind to N-acetylneuraminic acid 
(sialic acid) residues on the host cell [2]. A sugar that mimics N-acetylneuraminic acid 
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may inhibit the binding of the influenza virus and the subsequent infection of the host 
cell. As knowledge grows regarding the mechanisms of viral infection, carbohydrates 
have emerged as attractive targets for preventing virus transmission and dissemination. 
1.1.3.2 Oligosaccharide-based treatments for cancer 
One disease has proven difficult to treat due to the fact that the diseased cells are 
nearly identical to healthy cells; this disease is cancer. Fortunately, cancerous cells are 
nearly identical to healthy cells, not exactly. One differentiating feature is the cell surface 
oligosaccharides. Cancerous cells may over- or under-express certain natural 
oligosaccharides or they may express oligosaccharides which are typically expressed only 
in embryonic tissues [11]. The change in oligosaccharide expression is not universal for 
all cancers; instead, it is specific for each type of cancer. Table 1.1 lists the known 
changes in oligosaccharide expression for various types of malignant tissue. These 
differences in carbohydrate expression allow for differentiation of cancerous cells from 
healthy cells and thus provide an avenue for targeted treatment of malignant tissue. 
Vaccines under development for breast cancer and small cell lung cancer link the cancer-
associated oligosaccharide, Globo-H and Fucosyl GM1, with a highly immunogenic 
protein to recruit the immune system to attack malignant cells [1]. Other carbohydrate-
based cancer vaccines under development include treatments for malignant melanoma, 
prostate cancer, non-small-cell lung carcinoma, small-cell lung carcinoma, and ovarian 
cancer [5]. Additional research and improvements are required before oligosaccharide-
based cancer vaccines can be used in clinical application, yet these vaccines may become 
important weapons in the fight against cancer.  
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Table 1.1  Changes in oligosaccharide expression in malignant tissues [11] 
 
Oligosaccharide    Malignant Tissue  
     Ovary     Pancreas     Breast     Colon     Brain     Prostate     Skin     Lung 
 
sLex              X      X            X           X 
sLea              X      X         X           X 
sTn        X            X      X         X     X        X 
TF        X        X         X     X 
Ley        X            X      X         X     X        X 
Globo H       X            X      X         X     X        X 
PSA              X      X           X         X 
GD2                X      X 
GD3                X      X 
Fucosyl GM1                X 
GM2       X           X     X        X          X  X     X       X  
 
 
 With the promising research efforts on carbohydrates described above, companies 
have invested in carbohydrate ventures to capitalize on this new pharmaceutical tool. 
Large pharmaceutical companies like Amgen, Merck, and Wyeth have developed 
carbohydrate-based products that are now commercially available, and many new start-up 
companies have focused on carbohydrate science, including Oxford Glycosciences, 
GlycoTech, Oncothyreon (formerly Biomira), TheraCarb, and Synsorb Biotech [1, 5]. 
Unfortunately, several carbohydrate-based treatments, including Biomira’s Theratope for 
breast cancer treatment and Oxford Glycosciences’ Vevesca for treatment of Gaucher’s 
disease, have fallen short of expectations during final stages of clinical testing. Despite 
these setbacks, several carbohydrate-based treatments are currently in market, including 
those listed in Table 1.2. Before the 1980’s, very little was known about carbohydrate 
function, yet in just a few decades, carbohydrate-based medical treatments have advanced 
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for diseases including malaria, anthrax, HIV, cancer, and inflammation. As we continue 
to learn more about how carbohydrates contribute to biological processses, additional 
medical treatments and diagnostics will undoubtedly emerge as novel solutions to these 
complex medical problems. 
Table 1.2 Commercially available carbohydrate-based treatments 
 
Treatment  Function      Company 
 
EPOGEN®  Stimulates red blood cell production   Amgen 
 
Prevnar®  Treats bacteremia and meningitis   Wyeth 
 
Menjugate®  Treats meningitis C     Chiron 
 
NeisVac-C  Treats meningitis C     Baxter 
 
Hib vaccine  Treats meningitis and  pneumonia caused by H.  Merck 
    influenza type B 
 
 
1.2 Oligosaccharide Synthesis 
1.2.1 Chemical synthesis 
 Oligosaccharides have been synthesized via chemical mechanisms since the 
development of the Koenigs-Knorr glycosylation in 1901 [12]. The Koenigs-Knorr 
reaction utilizes substituted sugars with a good leaving group at the C1 position and 
suitable protection groups added to the remaining hydroxyl groups. This sugar derivative 
is reacted with another sugar containing a free hydroxyl group to form a glycosidic bond 
(Figure 1.2). The leaving group is typically a halide, with bromide being the most 
preferred. The protecting groups can vary, yet acetate, benzoate, ester, and ether groups 
are commonly used [13]. Although it has been more than century since the advent of the 





Figure 1.2 Koenigs-Knorr glycosylation reaction. X: leaving group; R: protection group. 
 
There are many challenges in the chemical synthesis of oligosaccharides. Four 
main challenges are (1) numerous reactive hydroxyl groups (2) reactivity of the 
nucleophilic hydroxyl group (3) stereochemistry of glycosidic linkage and (4) yield [13]. 
From the chemical structure, it is clear that sugars have multiple hydroxyl groups with 
similar reactivity. This complicates the formation of a specific glycosidic bond, 
generating many byproducts. To dictate the regiochemistry of the glycosidic bond, 
protection groups are added to the hydroxyl groups that do not participate in the desired 
bond formation. To address the second challenge, a leaving group must be added to the 
substrate sugar to promote good reactivity. The Koenigs-Knorr reaction illustrates these 
solutions to the first two challenges. When glycosidic bonds are formed, there are two 
possible sterochemistries: α and β. To control stereochemistry, different protection 
groups are added, producing steric hindrance which favors either the α or β conformation 
[12]. As with any reaction, one important factor is the product yield. The individual steps 
for glycosidic bond formation often have high yields (50-90%), yet the additional steps of 
adding and removing the protecting and leaving groups leads to low overall yields. For 
example, chemical synthesis of an α-Gal epitope is shown in Figure 1.3. While this 
process reduces the number of steps by using substrates with protection groups already 
added, it still requires 12 steps to produce one α1,3-glycosidic linkage. Furthermore, the 
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overall yield of the product is less than 10%. The complex synthesis steps and low overall 
yields contribute to the high cost of the oligosaccharide product, and these issues remain 
as major challenges in chemical oligosaccharide synthesis. Furthermore, if multiple 
glycosidic bonds are required for producing larger oligosaccharides, these problems are 
compounded. 
 
Figure 1.3 Reaction scheme for α-Gal epitope synthesis. Adapted from [14]. Yields: (a) 
80%; (b,c) 86%; (d) 80%; (e) 53%; (f, g) 80%; (h) 60%; (i, j) 70%; (k, l) >99%. 
  
1.2.2 Biological synthesis 
1.2.2.1 Enzymatic synthesis 
The challenges of chemical oligosaccharide synthesis have prompted scientists to 
turn towards another catalyst source: Mother Nature. To synthesize cell surface 
carbohydrates, why not use the same mechanism that naturally produces these 
compounds, enzymes. Enzymatic synthesis of oligosaccharides has many distinct 
advantages over chemical synthesis. Enzymes form glycosidic bonds in only one step. 
Hence, synthesis of the α-Gal epitope requires only one enzymatic step, compared to the 
twelve steps shown for chemical synthesis (Figure 1.3). This greatly improves the 
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possibility for industrial-scale synthesis. Enzymes can also form glycosidic bonds that are 
difficult or impossible to form chemically. For example, synthesis of α-sialyl and β-
mannosyl linkages is kinetically unfavorable, complicating chemical synthesis [15]. 
Oligosaccharides containing these glycosyl linkages are biologically important and are 
needed for biological studies and applications. The natural enzymes, α2,3-sialyltranserase 
and β1,4-mannosyltransferase, can easily form these unfavorable bonds and produce the 
oligosaccharides required for advancing biological and medical applications.  
The first challenge facing enzymatic oligosaccharide synthesis was obtaining a 
significant amount of enzyme. From the 1930’s to 1970’s, chemical synthesis was greatly 
favored over enzymatic synthesis. During this time, the enzymes for oligosaccharide 
synthesis were acquired by large-scale purification from their natural sources [16]. The 
cellular production of a particular cell surface oligosaccharide is relatively low, and 
consequently, there is a naturally low abundance of the requisite enzyme. This translates 
into low enzyme quantity after purification. The development of recombinant DNA 
technology in the 1980’s allowed for large-quantity enzyme production. As a result, the 
interest in enzymatic methods for oligosaccharide synthesis drastically increased. Two 
types of enzymes have been studied and utilized for oligosaccharide synthesis: 
glycosidases and glycosyltransferases. 
1.2.2.1.1 Glycosidases 
Glycosidases have long been studied for their ability to break down oligo- and 
polysaccharides [17], yet application of glycosidases for oligosaccharide synthesis was 
not common until the 1950’s when glycosidases such as levansucrase were used to 
produce carbohydrates like α-lactosyl-β-fructofuranoside and α-galactopyranosyl-β-
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fructofuranoside [18, 19]. Since then, glycosidases from various sources have been 
employed to synthesize numerous oligosaccharides. Recently, a β-galactosidase from 
Bacillus circulans enabled synthesis of the medically-relevant diasaccharide, N-
acetyllactosamine, with a 42% yield [20]. Other glycosidases used for oligosaccharide 
synthesis include β-glucosidase, α-galactosidase, α-fucosidase, β-mannosidase, and β-N-
hexosaminidase [15, 21].  
Glycosidases are enzymes that naturally catalyze oligosaccharide hydrolysis, but 
by altering conditions to shift the equilibrium to favor the reverse reaction, glycosidases 
can form glycosidic bonds [22]. A typical glycosidase-catalyzed reaction is shown in 
Figure 1.4. Several techniques are employed to shift the equilibrium in favor of the 
reverse reaction. Adding excess substrate, i.e. excess galactose or glucose in the 
glycosidase reaction in Figure 1.4, will push the equilibrium towards formation of the 
oligosaccharide. This is the most common approach; however, removal of the 
oligosaccharide product will also favor glycosidic bond formation [22]. Moreover, many 
glycosidases are solvent tolerant, allowing the enzymatic reaction to occur in a solvent 
instead of water. Eliminating or reducing the amount of water also shifts the equilibrium 
of the reaction towards oligosaccharide formation [15].  
 
 
Figure 1.4 Glycosidase-catalyzed reaction. 
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Glycosidases have several advantages over other enzymes capable of producing 
glycosidic bonds, namely glycosyltransferases. Glycosidases are abundant in nature and 
are therefore readily available for oligosaccharide synthesis. The glycosyl donors for 
glycosidases are simple sugars which are inexpensive and do not require extensive 
modification, reducing the cost of synthesis [15, 23]. Furthermore, many glycosidases are 
thermally stable, allowing for higher synthesis temperatures [22]. While these advantages 
are appealing, there are also many drawbacks to glycosidase-catalyzed oligosaccharide 
synthesis. An inherent disadvantage of glycosidases is that the enzymes naturally favor 
oligosaccharide hydrolysis. This requires additional expense such as excess substrate or 
product removal to shift the equilibrium towards oligosaccharide synthesis, and despite 
these extra efforts, overall yields for glycosidase-catalyzed synthesis range from 20-60%, 
significantly lower than the yields achieved with glycosyltransferases [21]. The low 
yields are also caused by the lack of glycosidase regiospecificity. While glycosidases 
have high stereospecificity, the glycosidic bond is often formed at several different 
carbons on the acceptor, leading not only to lower yields but also a mixture of products 
[15, 23]. Thus, the lack of regiospecificity also complicates downstream oligosaccharide 
purification. Despite these disadvantages, glycosidases remain a viable enzymatic method 
for synthesizing oligosaccharides. 
1.2.2.1.2 Glycosyltransferases 
 Glycosyltransferases are enzymes that naturally catalyze cellular glycosidic bond 
formation in vivo. A typical glycosyltransferase-catalyzed reaction is shown in Figure 
1.5. Glycosyltransferases require sugar nucleotides as substrates for oligosaccharide 
synthesis. In 1950, Luis Leloir and colleagues discovered the first sugar nucleotide, UDP-
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glucose [24]. Based on this discovery, glycosyltransferases requiring sugar nucleotide 
substrates are known as Leloir glycosyltransferases. Non-Leloir glycosyltransferases 
require sugar-1-phosphates as glycosyl donors, and these glycosyltransferases suffer from 
low yields and poor regioselectivity. Consequently, non-Leloir glycoysltransferases are 
not frequently used for oligosaccharide synthesis [25]. Therefore, this section will focus 
only on Leloir glycosyltransferases and any subsequent mention of a glycosyltransferase 
refers to the Leloir type.  
 
 
Figure 1.5 Glycosyltransferase-catalyzed reaction. 
 
 Although Leloir first discovered sugar nucleotides in 1950, the role of sugar 
nucleotides as glycosyl donors was not demonstrated until 1953 with the identification of 
UDP-glucuronic acid as donor for phenyl-β-D-glucopyranosiduronic acid synthesis and 
UDP-glucose as substrate for biosynthesis of trehalose phosphate [26, 27]. A few years 
later, Glaser and Brown provided evidence for the use of sugar nucleotide donors in the 
biosynthesis of polysaccharides such as hyaluronic acid [28]. Since the 1950’s, 
glycosyltransferases have been pursued for their synthesis capabilities, yet their use in 
oligosaccharide synthesis has been limited by their availability. The pioneering studies on 
glycosyltransferases focused on enzymes from mammalian sources [29]. With the 
development of recombinant DNA technology, however, it soon became apparent that 
mammalian glycosyltransferases were not optimal for large-scale production. 
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Mammalian glycosyltransferases often require detergents for solubilization and retention 
of activity in vitro. They can also be difficult to purify and are often glycoproteins 
themselves, requiring a eukaryotic host organism for production [30]. Eukaryotic 
production of a glycosyltransferase typically has lower yields and higher cost compared 
to production in a prokaryotic host. Due to these complications, bacterial sources of 
glycosyltransferases were investigated. A major challenge in identifying bacterial 
glycosyltransferases arises from the fact that most oligosaccharides of interest are those 
related to human health. Therefore, one must identify bacterial glycosyltransferases that 
can synthesize the glycosidic linkages found in human oligosaccharides. This led many 
scientists to consider pathogenic bacteria as sources of glycosyltransferases. Many 
bacterial pathogens coat their cell surfaces with oligosaccharides that mimic those of their 
host in order to avoid detection by the immune system, and as a result, 
glycosyltransferases from pathogenic bacteria are often capable of producing the 
oligosaccharides found on human cell surfaces [30]. These bacterial glycosyltransferases 
are optimal for large-scale synthesis, as they can be produced in large quantities using 
fast growing bacterial hosts like Escherichia coli. A list of bacterial glycosyltransferases 
used for oligosaccharide production can be found in Table 1.3. All of the bacterial 
glycosyltransferases in Table 1.3 are derived from human pathogens or invasive bacteria 
with the exception of the β1,4-N-acetylglucosaminyltransferase from R. leguminosarum, 








Table 1.3 Bacterial glycosyltransferases. Adapted from [25].  
 
Glycosyltransferase      Stereo- Gene  Source* 
   chemistry    
 
Galactosyltransferase         
           β1,4 lgtB      N. meningitidis, N. gonorrhoeae 
           β1,4 cps14J       S. pneumoniae 
           β1,4 hpgalT       H. pylori  
           β1,3 cgtB  C. jejuni 
           α1,4 lgtC  N. meningitidis, N. gonorrhoeae 
 
N-acetylglucosaminyltransferase 
          β1,3 lgtA  N. meningitidis, N. gonorrhoeae 
          β1,4 nodC  R. leguminosarum 
 
N-acetylgalactosaminyltransferase 
         β1,3 lgtD  N. meningitidis, N. gonorrhoeae 
         β1,4 cgtA  C. jejuni 
 
Fucosyltransferase 
         α1,3 HpfucT H. pylori 
         α1,3 fucT  H. pylori 
         α1,2 fucT2  H. pylori 
         α1,3/4 fucT  H. pylori 
 
Sialyltransferase 
         α2,3 lst  N. meningitidis, N. gonorrhoeae 
         α2,3 cst-I  C. jejuni 
         α2,3 cst-II  C. jejuni 
         α2,6 bst  P. damsel 
         α2,8/9 neuS  E. coli 
 
* C. – Campylobacter; E. – Escherichia; H. – Helicobacter; N.- Neisseria; P. – 
Photobacterium; R. – Rhizobium; S. – Streptococcus. 
 
  
As nature’s chosen catalyst for oligosaccharide synthesis, glycosyltransferases 
have high stereo- and regio-selectivity, generating very few byproducts, if any. 
Glycosyltransferases also exhibit high yields generally ranging from 70-100% [23]. 
Moreover, unnatural oligosaccharides can be synthesized using glycosyltransferases. 
Mammalian glycosyltransferases, for example, have been shown to tolerate a range of 
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glycosyl acceptors and donors, with corresponding yields ranging from 30 to 99% [31]. 
Bacterial glycosyltransferases have demonstrated even greater flexibility, utilizing a 
broad range of acceptors, sometimes with only a slight decrease in reaction rate [30]. One 
main problem deters the application of glycosyltransferases for industrial production: the 
high cost associated with the sugar nucleotide substrate. Sugar nucleotides themselves are 
difficult to synthesize. Chemical synthesis of the requisite sugar nucleotides is a laborious 
process and one that is not feasible for industrial production. Enzymatic sugar nucleotide 
synthesis is also difficult, in that it requires additional purified enzymes and other 
compounds such as sugar phosphates, phosphoenolpyruvate, and nucleoside 
5’triphosphates which are not readily available [25]. The high cost of substrates and 
cofactors required for enzymatic oligosaccharide synthesis often prevent large-scale 
oligosaccharide production utilizing this method. 
1.2.2.2 Whole-cell synthesis 
Both enzymatic and whole-cell biocatalysts have been employed to synthesize 
oligosaccharide structures. However, whole-cell strategies offer several advantages. They 
avoid the difficulties of enzyme isolation and purification and do not require extensive 
downstream separation processes to isolate the desired product, as whole-cells can be 
easily removed by centrifugation. Additionally, enzymatic synthesis requires expensive 
sugar nucleotides as substrate while whole-cell techniques generate the sugar nucleotide 
in vivo from a less expensive carbon source [32]. With these advantages, whole-cell 




1.2.2.2.1 Metabolic Engineering 
 Whole-cell oligosaccharide synthesis is made feasible through the application of 
metabolic engineering. Metabolic engineering is a relatively new method of strain 
improvement, emerging from the development of recombinant DNA technology in the 
1970’s and 1980’s. The term ‘metabolic engineering’ was first coined by James Bailey, 
Gregory Stephanopoulos, and Joseph Vallino in the June publication of Science in 1991 
[33, 34]. Metabolic engineering is the application of recombinant DNA technology to 
rationally alter cellular genetics for targeted improvement of cell function(s). Metabolic 
engineering strategies rely on previously acquired knowledge of an organism’s genetics, 
metabolism, and gene-function relationships. With this knowledge, the cell’s metabolism 
can be genetically engineered to bring about a desired phenotype, typically the improved 
production of a target metabolite. 
 There are two main resources which must be supplied for whole-cell 
oligosaccharide synthesis: carbon and energy. Oligosaccharides are composed of 
monosaccharide subunits, and as a result, the production of these carbohydrates is 
carbon-intensive, competing with the cell’s metabolism for available carbon sources. 
Therefore, any metabolic engineering effort must find a balance between the cell’s 
metabolic needs and the carbon requirement for oligosaccharide synthesis. Moreover, 
oligosaccharide synthesis requires sugar nucleotides as precursor. These sugar 
nucleotides are also major components in cell wall biosynthesis, and so, carbohydrate 
production directly competes with cell growth [35]. When a cell is forced to choose 
between carbohydrate production and cell growth, oligosaccharide synthesis is often 
minimized, producing only the quantities necessary for cell survival and growth. As a 
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result, there remains significant potential for improving oligosaccharide synthesis through 
the application of metabolic engineering. 
Production of the sugar nucleotide precursors required for oligosaccharide 
synthesis interfaces with the cell’s primary metabolism. Figure 1.6 depicts the metabolic 
pathway in E. coli for production of two sugar nucleotides, UDP-glucose and UDP-
galactose. Sugar nucleotide biosynthesis clearly effects the glycolysis pathway, which 
generates energy for the cell and provides precursors for other metabolites produced by 
the cell. An optimal flux distribution must be determined to find a balance between the 
carbon supply for glycolysis and carbohydrate synthesis. Through natural evolution, the 
carbon flux distribution has been optimized with the objective of promoting cell growth 
and survival. The flux distribution for maximum oligosaccharide synthesis, however, 
may be significantly different from the naturally evolved fluxes. Metabolic engineering 
provides the tools necessary for manipulating the carbon flux distribution to optimize 
oligosaccharide and polysaccharide production. 
 
 
Figure 1.6 UDP-glucose and UDP-galactose synthesis pathway in E. coli. 
 
Oligosaccharide synthesis is not only carbon-intensive; it is also an energy-
intensive process. As shown in Figure 1.6, two high-energy compounds are consumed for 
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phosphoenolpyruvate (PEP) depending upon the sugar transport system, is used to 
activate the sugar component. This step is illustrated by the conversion of glucose to 
glucose-6-phosphate in Figure 1.6. A second high-energy compound, UTP or another 
nucleoside triphosphate, is required for synthesis of the sugar nucleotide precursor. This 
energy requirement makes oligosaccharide and polysaccharide synthesis particularly 
costly for the cell. Additionally, the sugar component of the sugar nucleotide represents 
an unutilized carbon source, which has the potential to yield up to 38 ATP molecules 
through glycolysis, the TCA cycle, and oxidative phosphorylation [36]. Taking into 
account both the energy requirement of sugar nucleotide biosynthesis and the potential 
energy loss from an unutilized carbon source, a cell will lose up to 40 high-energy 
compounds for each sugar nucleotide synthesized in oligosaccharide production. This 
energy loss impacts many metabolic reactions throughout the cell’s metabolism. Just as 
the carbon flux distribution must be optimized, the cell’s energy production may also 
need modification for optimal oligosaccharide synthesis. Again, metabolic engineering 
offers a means of achieving this goal. 
1.2.2.2.2 Single-cell synthesis 
Single-cell synthesis of oligosaccharides requires the use of glycosyltransferases 
for glycosidic bond synthesis as glycosidases display hydrolytic activity in vivo. As a 
result, the main concerns in whole cell oligosaccharide synthesis are similar to those of 
glycosyltransferase-catalyzed synthesis, namely provision of the sugar nucleotide donor 
and acceptor.  
 An important consideration in single-cell oligosaccharide production is the 
selection of the host strain. The most common microorganism employed for single-cell 
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oligosaccharide synthesis is Escherichia coli. E. coli is a fast-growing organism 
commonly which is commonly used for the industrial production of many compounds. 
Furthermore, the tools for genetic manipulation of E. coli are well-established and 
commercially available. E. coli has been successfully engineered to produce a variety of 
oligosaccharides including N-acetllactosamine (LacNAc), globotriose, α-Gal epitope, the 
carbohydrate moieties of gangliosides GM1 and GM2, and several other higher order 
oligosaccharides [32, 37-40]. While recombinant E. coli have been successful in 
synthesizing the desired oligosaccharide, the product concentrations are quite low, 
typically less than 1 g/L. Due to the low yields in E. coli, others have chosen to engineer 
microorganisms that naturally produce the oligosaccharide product. For example, 
Corynebacterium glutamicum has been metabolically engineered to improve production 
of the trisaccharide, trehalose. Trehalose synthesis in C. glutamicum was increased nearly 
10-fold using metabolic engineering, resulting in nearly 10 g/L of trehalose [41]. While 
trehalose synthesis was successfully enhanced by engineering its natural host, many other 
oligosaccharides cannot be synthesized in significant quantities from their natural hosts. 
Many microorganisms cannot be grown in the laboratory using available growth media, 
and many also have slow growth rates. In addition, the tools available for genetic 
manipulation may not be applicable to the natural host strain. The difficulty of finding a 
host strain for efficient oligosaccharide synthesis remains a major obstacle in single-cell 
oligosaccharide production. 
1.2.2.2.3 Bacterial coupling 
Despite successful oligosaccharide synthesis with single-cell engineered strains, a 
multiple-strain approach was developed to meet the industrial demand for high product 
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concentrations. This approach recognizes the need for an abundant supply of high-energy 
compounds, in particular nucleoside triphosphates, for production of sugar nucleotide 
precursors. A bacterial strain with efficient nucleoside triphosphate synthesis is employed 
to maximize the energy supply. Pairing this strain with recombinant strains possessing 
the enzymes for sugar nucleotide synthesis and a glycosyltransferase allows for efficient 
oligosaccharide production. This strategy of combining bacterial strains of specialized 
function is known as bacterial coupling. Bacterial coupling is analogous to an assembly 
line, where each bacterial strain is selected and engineered to perform one task to the best 
of its ability, and the product of this task is transferred to the next strain which then 
performs its specific task. With this strategy, bacterial coupling maximizes each step of 
oligosaccharide synthesis by engineering each strain for optimal production of an 
essential component. It also reduces the metabolic burden imposed by metabolic 
engineering through using several strains for recombinant protein expression. 
 Bacterial coupling was first applied to oligosaccharide synthesis in 1998 for 
production of the trisaccharide, globotriose [42]. This application uses three bacterial 
strains: Corynebacterium ammoniagenes for production of UTP from orotic acid, 
recombinant E. coli containing genes for UDP-galactose synthesis, and another 
recombinant E. coli strain possessing an α1,4-galactosyltransferase (Figure 1.7). 
Coupling of these three strains enabled production of 266 mM (134 g/L) of globotriose 
with lactose supplied as the acceptor. Similar strategies was used to produce the 
disaccharide, N-acetyllactosamine, sialylated oligosaccharides, and a Lewis x 
trisaccharide [43-45]. Overall product concentrations with bacterial coupling were high, 
ranging from 20 to 140 g/L.  
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Figure 1.7 Bacterial coupling system for globotriose production. Genes named in this 
figure represent recombinant enzymes while all unidentified genes are native enzymes. 
 
 
 While bacterial coupling yields high concentrations of the oligosaccharide 
product, there are several drawbacks to this approach. Cell permeability is a major issue. 
In bacterial coupling, the product of one strain must be transported out of the producing 
cell and into the next strain where it will be used as substrate. With three to five bacterial 
strains involved in each system, cell membrane permeability posses a significant 
limitation, particularly when large, highly charged molecules such as nucleoside 
triphosphates must be transported. To address this problem, a surfactant, polyoxyethylene 
octadecylamine, and xylene were added to the reaction mixture [42-45]. Chemically-
induced cell membrane permeability is accompanied by a dissipation of the membrane 
potential which will likely reduce the energy capacity of the cell. Surprisingly, 
permeabilization in the reported bacterial coupling examples did not seem to significantly 
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inherently expensive from an industrial perspective. Each system requires three to five 
bacterial strains which must be grown in separate fermentations prior to use in 
oligosaccharide synthesis. So for each glycosidic linkage, at least four fermentations are 
required: one for growth of each microorganism and one for oligosaccharide production. 
Another aspect that may prevent the industrial application of bacterial coupling is the 
high cost of raw materials. Expensive cofactors such as orotic acid, GMP, and sialic acid 
as well as multiple carbon sources are required for the reported bacterial coupling 
strategies. These disadvantages make bacterial coupling less than ideal, yet the high 
levels of oligosaccharide synthesis are unmatched by any other whole-cell synthesis 
technique. 
1.3 Agrobacterium sp. ATCC 31749 
1.3.1 Phylogeny of the Agrobacterium genus 
 Members of the genus Agrobacterium are α-proteobacteria of the Rhizobiales 
order and Rhizobiaceae family. Rhizobiaceae are a diverse group of aerobic, rod-shaped 
bacteria classified based on their 16S rRNA gene sequence. Genera of the Rhizobiaceae 
family include Rhizobium, Carbophilus, Chelatobacter, Ensifer, and Sinorhizobium in 
addition to Agrobacterium [46]. Of these genra, Rhizobium and Sinorhizobium appear to 
be the most closely related to Agrobacterium. Rhizobium, Sinorhizobium, and 
Agrobacterium include microorganisms commonly found in soil which are known for 
their association with plants, although not all species are plant-associated. Rhizobium and 
Sinorhizobium have similar phenotypes and are known to invade the root hairs of 
leguminous plants, forming root nodules. This relationship is symbiotic, where the plant 
provides the Rhizobium or Sinorhizobium with nutrients and the bacterium fixes nitrogen 
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for the plant. On the other hand, Agrobacterium species are well-known as plant 
pathogens. Some Agrobacterium species infect plants, causing the formation of tumors 
known as gall. While famous for their plant interactions, it has long been known that the 
genes responsible for Rhizobium symbiosis and Agrobacterium pathogenesis reside on 
transferrable megaplasmids, not chromosomal DNA [47, 48]. This has sparked a great 
debate over the classification of Rhizobium, Sinorhizobium, and Agrobacterium based on 
their relation to plants [49-51]. 
 Within the Agrobacterium genus, there is also confusion regarding the taxonomy 
and phylogeny of species. There are five species of Agrobacterium dictated by the 
disease phenotype of the organism. A. tumefaciens is the most well-known species, and it 
causes crown gall in over 140 species of dicotyledonous plants. A. rubi causes crown gall 
in raspberries, while A. vitis causes gall in grapevines. A. rhizogenes is the only 
phytopathogenic species that does not cause gall, but instead, causes a condition known 
as hairy root. A. radiobacter is the only non-phytopathogenic species of Agrobacterium 
[52]. An alternative classification for Agrobacteria was proposed based on physiological 
and biochemical properties, with no influence from the disease phenotype. This 
classification segregates Agrobacteria into three biovars [53]. Both the species and biovar 
classifications are employed throughout the literature, yet with the increase in sequenced 
genomes from Agrobacterium, there have been recent efforts to reorganize the species 
classifications of this genus. 
 Perhaps the most well known Agrobacterium is A. tumefaciens. A. tumefaciens 
has agricultural significance as the causative agent for crown gall disease in 
dicotyledonous plants. This species is also exploited for the genetic engineering of plants. 
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On the tumor inducing (Ti) plasmid of A. tumefaciens, there are genes known as T-DNA 
which allow the transfer of genetic material from A. tumefaciens to the infected plant. By 
replacing the transferred genes of the T-DNA with a chosen gene sequence, A. 
tumefaciens will transfer the chosen gene to the plant, allowing for the generation of 
transgenic crops. With its significance as a plant pathogen and tool for gene transfer, A. 
tumefaciens was the first species sequenced from the Agrobacterium genus [54, 55]. 
 As the Agrobacterium genus is primarily known for its phytopathogenicity, very 
few studies have focused on the metabolism of this genus. Radiorespirometric and 
enzymatic activity studies performed in the 1970’s revealed that Agrobacteria primarily 
use the Entner-Doudoroff (ED) pathway for glucose metabolism, not the energetically 
favorable Embden Meyerhof Parnas (EMP) pathway [56, 57]. Two enzymes in the EMP 
pathway were found to have very low activity, phosphofructokinase and fructose-1,6-
diphosphate aldolase. In addition to the ED pathway, the pentose phosphate pathway 
(PPP) was found to be important in glucose catabolism. The percentage of glucose flux 
through the ED pathway ranged from 55-88% while the remaining 45-12% was diverted 
through the PPP [57]. Furthermore, A. tumefaciens was shown to have functional 
tricarboxylic acid (TCA) and glyoxylate cycles [56]. The primary metabolism of 
microorganisms in the Agrobacterium genus consists of the following pathways: ED, 
PPP, TCA cycle, and glyoxylate cycle. 
1.3.2 History of ATCC 31749 
  The natural parent strain of Agrobacterium sp. ATCC 31749 was first isolated 
from soil in 1964 by Harada and Yoshimura [58]. This bacterium was classified as 
Alcaligenes faecalis var. myxogenes 10C3, and it was initially of interest for its 
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production of a polysaccharide containing succinic acid, which was subsequently named 
succinoglycan. A spontaneous mutant derived from Alcaligenes faecalis var. myxogenes 
10C3 was found to produce a β1,3-glucan polysaccharide which forms a gel when heated 
in an aqueous suspension [59]. This polysaccharide was called curdlan [59, 60]. In 1977, 
another spontaneous mutant was obtained which produced only curdlan and no 
succinoglycan. This strain was named 10C3K, and it appeared to be genetically stable 
[61]. Shortly thereafter, a uracil auxotroph was derived from strain 10C3K and 
designated as Alcaligenes faecalis var. myxogenes IFO 13140 (ATCC 21680). In 1983, 
Phillips, Lawford, and coworkers isolated a mutant from ATCC 21680 which is not a 
uracil auxotroph, is unable to hydrolyze starch, and can grow using citric acid as the sole 
carbon source; this strain was submitted as ATCC 31749 [62, 63]. ATCC 31750, a 
spontaneous mutant of ATCC 31749, produces only water-insoluble curdlan as opposed 
to ATCC 31749 which produces both water-soluble and water-insoluble curdlan. 
Lawford obtained a patent for a continuous process for the production of curdlan from 
ATCC 31749 and ATCC 31750 in 1982 [64]. In 1991, all of these strains, originally 
classified as Alcaligenes, were reclassified as Agrobacterium based on 16S rRNA 
sequence [63]. Prior to the work detailed in this dissertation, ATCC 31749 has only been 
utilized for curdlan production. 
1.3.2.1 Curdlan polysaccharide 
 In addition to ATCC 31749 and its parent strains, other microorganisms have 
been shown to produce curdlan. Detectable amounts of curdlan were purified from other 
Rhizobia, including A. radiobacter (IFO 12607, 12665, 13127, and 13256), A. rhizogenes 
(IFO 13259), Rhizobium trifolii J60, and Rhizobium sp. TISTR 64B. In addition to these 
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Gram-negative bacteria, several Gram-positive strains are also capable of producing 
curdlan, namely Cellumonas spp. and C. flavigena KU [65]. Of all the curdlan-producing 
strains identified so far, ATCC 31749 is the most studied and has been shown to produce 
the highest amount of curdlan. 
As mentioned above, curdlan is a linear β1,3-glucose polymer containing up to 
12,000 glucose monomers. Curdlan and other β1,3-glucans can be detected using an 
Aniline Blue staining which produces a blue color when the dye binds to the β1,3-glucan 
[66]. Most forms of curdlan are insoluble in water but readily dissolve in basic solutions. 
This property is commonly used to isolate and purify curdlan. Curdlan is well-known for 
its ability to form gels upon heating. By controlling the temperature of the heating 
process, two different types of gel can be formed from aqueous curdlan suspensions. 
High-set, thermo-irreversible gels are formed by heating above 80°C and then cooling, 
while low-set, thermo-reversible gels are produced by heating to 55°C, followed by 
cooling. High-set gels differ structurally from low-set gels in that they contain triple-
stranded helices of curdlan. Low-set gels primarily contain single-stranded helices [65]. 
This unique gel-forming ability distinguishes curdlan from other glucan polysaccharides. 
Initial applications of curdlan focused on this gel-forming ability. Curdlan is 
extensively employed in the food industry as a gelling agent, thickener, extender, binding 
agent, aroma masker, water-holding agent, and coating agent. With these functions, 
curdlan has been used as an additive in many foods including jelly, pudding, tofu, 
noodles, hamburger, sausage, frozen egg products, boiled rice, and salad dressings. 
Curdlan is not easily degraded by human digestive enzymes, allowing for applications in 
calorie-reduced and diabetic food products. Moreover, curdlan gels resist degradation due 
 29
to freeze and thaw cycles, suggesting potential for frozen food applications. Curdlan also 
has applications in the agricultural industry. Curdlan has been introduced to animal and 
fish feed to inhibit intestinal putrefying bacteria that cause animals to age and to improve 
immune activity [63]. In addition, curdlan has many medical applications. As a gel, 
curdlan can serve as a drug release vehicle and coating. In fact, a patent was filed for the 
use of curdlan as a sustained release suppository for drugs such as indomethacin, 
diclofenac sodium, and ibuprofen [67]. Additional patents were also filed using curdlan 
as an inhibitor of blood coagulation and as a treatment for dementia [68, 69]. Extensive 
research has been conducted to investigate curdlan sulfate as an anti-HIV treatment, and 
in 1994, phase I clinical trials suggested that curdlan sulfate may have therapeutic effects 
[70]. Additionally, sulfoalkyl derivatives of curdlan have been shown to have antitumor 
activity [71]. There are many more applications for curdlan; in fact, 171 patents have 
been filed involving the use of curdlan. These numerous applications have led to a high 
demand for curdlan, and consequently, Takeda Chemical Industries Ltd. produces 600 to 
700 tons of curdlan each year [63]. 
1.3.2.2 Curdlan production in ATCC 31749 
 ATCC 31749 has been studied exclusively for its natural production of curdlan 
polysaccharide. In the 1980s, initial studies determined that curdlan production was 
triggered by nitrogen limitation in ATCC 31749 [72]. Since then, many parameters have 
been determined to influence curdlan production in this strain. Numerous carbon sources 
were utilized by ATCC 31749, with overall results indicating that sucrose and maltose 
yield the highest curdlan production [73]. As with many fermentations, the pH and level 
of dissolved oxygen were important factors for the production of curdlan by 
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Agrobacterium sp. The optimum pH for growth was determined to be pH 7 while pH 5.5 
led to higher amounts of curdlan during nitrogen-limited conditions [74]. High levels of 
dissolved oxygen resulted in high curdlan production [75]. This result is not surprising as 
high levels of dissolved oxygen allow for increased energy production through the TCA 
cycle. In turn, the additional energy is used for the energy-intensive process of 
polysaccharide synthesis. The concentration of residual phosphate also influences curdlan 
production. Both high and very low phosphate concentrations yielded low curdlan 
production, but a residual phosphate concentration of 0.5g/L led to curdlan production as 
high as 65g/L [76]. The analysis of intracellular nucleotides during curdlan production 
showed high concentrations of UMP, and UMP or uracil supplementation of curdlan 
fermentations showed increased curdlan production [77, 78]. Again, this is not surprising 
as both uracil and UMP are precursors for the production of UDP-glucose, the sugar 
nucleotide required for curdlan production. Overall, these studies show that curdlan 
production is regulated by nitrogen limitation, pH, and phosphate concentration, and 
curdlan synthesis in ATCC 31749 is limited by energy and nucleotide availability, not the 
carbon flux or sugar moiety. 
 Since most studies have focused on the optimization of conditions for the 
industrial production of curdlan, little is known regarding the genetics and molecular 
regulation of curdlan production. Four genes have been identified as being essential for 
curdlan production in ATCC 31749. A curdlan synthase gene (crdS) was characterized as 
the enzyme responsible for transferring glucose from the sugar nucleotide, UDP-glucose, 
to the growing β1,3-glucan polymer chain [79]. In the same putative operon, there are 
two other genes believed to contribute to curdlan synthesis; these were designated as 
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crdA and crdC. These genes have no significant homology to known protein sequences, 
and their role in curdlan production is still unknown [80]. A phosphatidylserine synthase 
gene (pssAG) was shown to be required for the production of high molecular weight 
curdlan, indicating the importance of membrane composition in curdlan synthesis [81]. A 
putative regulatory gene, crdR, was also necessary for curdlan production, yet this gene 
still remains to be characterized. In addition to identifying the genes involved in curdlan 
production, there is also an effort to uncover the regulatory mechanisms controlling 
curdlan production. As nitrogen limitation is necessary for curdlan production, the genes 
involved in nitrogen regulatory systems were investigated. Mutants of ntrBC failed to 
produce curdlan, suggesting that the nitrogen signaling cascade may regulate 
transcription of the curdlan synthesis operon. However, no RpoN-dependent promoter 
has been found for the crd operon [65]. The mechanism for enhanced curdlan production 
at pH 5.5 is also an area of interest. A proteomic study of Agrobacterium sp. comparing 
protein levels at pH 7 and pH 5.5 showed higher amounts of the proteins involved in the 
curdlan synthesis pathway, including curdlan synthase, UTP-glucose-1-phosphate 
uridylyltransferase, and phosphoglucomutase [82]. While these recent genetic and 
proteomic studies have identified genes important for curdlan production, much work still 
remains in characterizing these genes and elucidating the regulation of curdlan synthesis 
in Agrobacterium sp. 
1.4 Project Objectives 
 The work described in this dissertation focuses on two main objectives: 1) to 
develop a whole-cell biocatalyst for oligosaccharide synthesis utilizing ATCC 31749 as 
host and 2) to determine the factors influencing curdlan production in ATCC 31749. 
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1.4.1 Metabolic engineering of ATCC 31749 for oligosaccharide synthesis 
 The production of large amounts of curdlan polysaccharide make Agrobacterium 
sp. strain ATCC 31749 an ideal host for oligosaccharide synthesis. ATCC 31749 has 
been shown to produce up to 93 g/L of curdlan [78]; this requires the microorganism to 
produce 292 g/L of the sugar nucleotide substrate, UDP-glucose. UDP-glucose is easily 
converted into other sugar nucleotides, such as UDP-galactose, with the introduction of 
just one additional enzyme. In turn, a glycosyltransferase can use UDP-galactose to 
produce galactose-containing oligosaccharides. Thus, by introducing only two additional 
enzymes into ATCC 31749, the microorganism can be transformed into a whole-cell 
biocatalyst for oligosaccharide synthesis. With the high amount of sugar nucleotide 
available in the Agrobacterium host, there is potential for producing oligosaccharides at 
concentrations greater than 100 g/L. Since ATCC 31749 utilizes a cheap carbon source 
like sucrose, the cost of producing oligosaccharides can be greatly reduced compared to 
the current chemical and enzymatic methods of synthesis. Furthermore, the engineered 
ATCC 31749 would only require one fermentation as opposed to the 3 to 5 fermentations 
required by bacterial coupling, making the Agrobacterium biocatalyst ideal for industrial 
production. By increasing oligosaccharide availability and reducing the cost associated 
with oligosaccharide synthesis, the Agrobacterium biocatalyst will advance the 
development of oligosaccharide-based medical treatments and make current 
oligosaccharide treatments more affordable. 
1.4.2 What factors affect production of the curdlan polysaccharide in ATCC 31749? 
Oligosaccharide synthesis in the Agrobacterium biocatalyst will employ the same 
metabolic pathways as curdlan production, and therefore, the pathways and 
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corresponding regulatory systems of curdlan production will also influence 
oligosaccharide synthesis. Information regarding curdlan production can thereby be 
exploited to enhance oligosaccharide synthesis. As discussed in section 1.3.2.2, very little 
information is available about how ATCC 31749 produces such large quantities of 
curdlan polysaccharide. By identifying the factors which allow for high polysaccharide 
production, I will also identify metabolic engineering targets for improving 
oligosaccharide synthesis in ATCC 31749. For example, if a transcriptional activator 
governs curdlan production under nitrogen-limited conditions, this activator can be 
overexpressed during nitrogen-rich conditions, allowing for curdlan and oligosaccharide 
production during the growth phase. Unique energy-generating genes or pathways may 
also contribute to curdlan production, and once identified, the corresponding genes can be 
manipulated to enhance oligosaccharide synthesis in the engineered Agrobacterium 
biocatalyst. In addition to these potential benefits for oligosaccharide production, this 
investigation will contribute to the fundamental knowledge and understanding of 
exopolysaccharide production and regulation, an area that is not well understood. 
 
1.5 References 
1. Alper, J., R.F. Service, and M. Balter, Searching for medicine's sweet spot. 
Science, 2001. 291(5512): p. 2338-2343. 
 
2. Weiss, A.A. and S.S. Lyer, Glycomics aims to interpret the third molecular 
language of cells. Microbe, 2007. 2(10): p. 489-497. 
 
3. Saxon, E. and C.R. Bertozzi, Chemical and biological strategies for engineering 
cell surface glycosylation. Annual Review of Cell and Developmental Biology, 
2001. 17: p. 1-23. 
 
4. Linhardt, R.J., Heparin: An important drug enters its seventh decade. Chemistry 
& Industry, 1991. 2: p. 45-50. 
 34
 
5. Borman, S., Carbohydrate vaccines: Novel chemical and enzymatic 
oligosaccharide synthesis techniques could lead to a new generation of 
carbohydrate-based vaccine agents. Chemical and Engineering News, 2004. 
August, 9: p. 31-35. 
 
6. Seeberger, P.H. and D.B. Werz, Synthesis and medical applications of 
oligosaccharides. Nature, 2007. 446: p. 1046-1051. 
 
7. Daubenspeck, J.M., et al., Novel oligosaccharide side chains of the collagen-like 
region of BclA, the major glycoprotein of the Bacillus anthracis exosporium. 
Jounral of Biological Chemistry, 2004. 279(30): p. 30945-30953. 
 
8. Tarasenko, O., et al., Polymeric glycoconjugates protect and activate 
macrophages to promote killing of Bacillus cereus spores during phagocytosis. 
Glycoconjugate Journal, 2008. 25: p. 473-480. 
 
9. Werz, D.B. and P.H. Seeberger, Total synthesis of antigen Bacillus anthracis 
tetrasaccharide - Creation of an anthrax vaccine candidate. Angewandte Chemie 
(International ed.), 2005. 44(39): p. 6315-6318. 
 
10. Scanlan, C.N., et al., Exploiting the defensive sugars of HIV-1 for drug and 
vaccine design. Nature, 2007. 446: p. 1038-1045. 
 
11. Dube, D.H. and C.R. Bertozzi, Glycans in cancer and inflammation - potential for 
therapeutics and diagnostics. Nature Reviews, 2005. 4: p. 477-488. 
 
12. Bertozzi, C.R. and L.L. Kiessling, Chemical glycobiology. Science, 2001. 291: p. 
2357-2364. 
 
13. Flowers, H.M., Chemical synthesis of oligosaccharides. Methods in Enzymology, 
1978. 50: p. 93-121. 
 
14. Janczuk, A.J., et al., The synthesis of deoxy-α-Gal epitope derivatives for the 
evolution of an anti-α-Gal antibody binding. Carbohydrate Research, 2002. 337: 
p. 1247-1259. 
 
15. Palcic, M.M., Biocatalytic synthesis of oligosaccharides. Current Opinion in 
Biotechnology, 1999. 10: p. 616-624. 
 
16. Ichikawa, Y., G.C. Look, and C.H. Wong, Enzyme-catalyzed oligosaccharide 
synthesis. Analytical Biochemistry, 1992. 202(2): p. 215-238. 
 
17. Coley, N.G. and M. Keynes, History of Biochemistry, in Encyclopedia of Life 
Sciences. 2002, John Wiley & Sons. 
 
 35
18. Avigad, G., Enzymatic synthesis and characterization of a new trisaccharide, α-
lactosyl-β-fructofuranoside The Journal of Biological Chemistry, 1957. 1: p. 121-
129. 
 
19. Feingold, D.S., G. Avigad, and S. Hestrin, Enzymatic synthesis and reactions of a 
sucrose isomer α-D-galactopyranosyl-β-D-fructofuranoside The Journal of 
Biological Chemistry, 1957. 1: p. 295-307. 
 
20. Vetere, A. and S. Paoletti, High-yield synthesis of N-aceytllactosamine by 
regioselective transglycosylation. Biochemical and Biophysical Research 
Communications, 1996. 219: p. 6-13. 
 
21. Crout, D.H. and G. Vic, Glycosidases and glycosyl transferases in glycoside and 
oligosaccharide synthesis. Current Opinion in Chemical Biology, 1998. 2(1): p. 
98-111. 
 
22. Monsan, P. and F. Paul, Enzymatic synthesis of oligosaccharides. FEMS 
Microbiology Reviews, 1995. 16: p. 187-192. 
 
23. Watt, G.M., P.A.S. Lowden, and S.L. Flitsch, Enzyme-catalyzed formation of 
glycosidic linkages. Current Opinion in Structural Biology, 1997. 7: p. 652-660. 
 
24. Caputto, R., et al., Isolation of the coenzyme of the galactose phosphate-glucose 
phosphate transformation. The Journal of Biological Chemistry, 1950. 184: p. 
333-350. 
 
25. Endo, T. and S. Koizumi, Large-scale production of oligosaccharides using 
engineered bacteria. Current Opinion in Structural Biology, 2000. 10: p. 536-541. 
 
26. Dutton, G.J. and I.D.E. Storey, The isolation of a compound of uridine 
diphopshate and glucuronic acid from liver. Biochemical Journal, 1953. 53: p. 
xxxvii-xxxviii. 
 
27. Leloir, L.F. and E. Cabib, The enzymatic synthesis of trehalos phosphate. Journal 
of American Chemical Society, 1953. 75(21): p. 5445-5446. 
 
28. Glaser, L. and D.H. Brown, The enzymatic synthesis in vitro of hyaluronic acid 
chains. Proceedings of the National Academy of Sciences of the United States of 
America, 1955. 41: p. 253-260. 
 
29. Spiro, R.G., Glycoproteins. Annual Review of Biochemistry, 1970. 39: p. 599-
638. 
 
30. Johnson, K.F., Synthesis of oligosaccharides by bacterial enzymes. 
Glycoconjugate Journal, 1999. 16: p. 141-146. 
 
 36
31. Ernst, B. and R. Oehrlein, Substrate and donor specificity of glycosyl 
transferases. Glycoconjugate Journal, 1999. 16: p. 161-170. 
 
32. Bettler, E., et al., The living factory: In vivo production of N-acetyllactosamine 
containing carbohydrates in E. coli. Glycoconjugate Journal, 1999. 16: p. 205-
212. 
 
33. Bailey, J.E., Toward a science of metabolic engineering. Science, 1991. 252: p. 
1668-1675. 
 
34. Stephanopoulos, G. and J.J. Vallino, Network rigidity and metabolic engineering 
in metabolite overproduction. Science, 1991. 252: p. 1675-1681. 
 
35. Ramos, A., et al., Relationship between glycolysis and exopolysaccharide 
biosynthesis in Lactococcus lactis. Applied and Environmental Microbiology, 
2001. 67(1): p. 33-41. 
 
36. Voet, D. and J.G. Voet, Biochemistry. 3rd ed. Vol. 1. 2004: John Wiley & Sons, 
Inc. 1137. 
 
37. Antoine, T., et al., Large-Scale in vivo synthesis of the carbohydrate moieties of 
gangliosides GM1 and GM2 by metabolically engineered Escherichia coli. 
ChemBioChem, 2003. 4: p. 406-412. 
 
38. Bettler, E., et al., Production of recombinant xenotransplantation antigen in 
Escherichia coli. Biochemical and Biophysical Research Communications, 2003. 
302: p. 620-624. 
 
39. Dumon, C., et al., In vivo fucosylation of lacto-N-neotetraose and lacto-N-
neohexaose by heterologous expression of Helicobacter pylori α-1,3 
fucosyltransferase in engineered Escherichia coli. Glycoconjugate Journal, 2001. 
18: p. 465-474. 
 
40. Zhang, J., et al., Large-scale synthesis of globotriose derivatives through 
recombinant E. coli. Org. Biomol. Chem., 2003. 1: p. 3048-3053. 
 
41. Carpinelli, J., R. Kramer, and E. Agosin, Metabolic engineering of 
Corynebacterium glutamicum for trehalose overproduction: Role of the TreYZ 
trehalose biosynthetic pathway. Applied and Environmental Microbiology, 2006. 
72(3): p. 1949-1955. 
 
42. Koizumi, S., et al., Large-scale production of UDP-galactose and globotriose by 




43. Endo, T., et al., Large-scale production of N-acetyllactosamine through bacterial 
coupling. Carbohydrate Research, 1999. 316: p. 179-183. 
 
44. Endo, T., et al., Large-scale production of CMP-NeuAc and sialylated 
oligosaccharides through bacterial coupling. Applied Microbiology & 
Biotechnology, 2000. 53: p. 257-261. 
 
45. Koizumi, S., et al., Large-scale production of GDP-fucose and Lewis X by 
bacterial coupling. Journal of Industrial Microbiology & Biotechnology, 2000. 
25: p. 213-217. 
 
46. Boone, D.R., R.W. Castenholz, and G.M. Garrity, eds. Bergey's Manual of 
Systematic Bacteriology. 2001, Springer: New York. 324-361. 
 
47. Drummond, M.H. and M.D. Chilton, Tumor-inducing (Ti) plasmids of 
Agrobacterium share extensive regions of DNA homology. Jounral of 
Bacteriology, 1978. 136(3): p. 1178-1183. 
 
48. Rosenberg, C., et al., Genes controlling early and late functions in symbiosis are 
located on a megaplasmid in Rhizobium meliloti. Molecular Genetics and 
Genomics, 1981. 184(2): p. 326-333. 
 
49. Young, J.M., et al., A revision of Rhizobium Frank 1889, with an emended 
description of the genus, and the inclusion of all species of Agrobacterium Conn 
1942 and Allorhizobium undicola de Lajudie et al. 1998 as new combinations: 
Rhizobium radiobacter, R. rhizogenes, R. rubi, R. undicola, R. vitis. International 
Journal of Systematic and Evolutionary Microbiology, 2001. 51: p. 89-103. 
 
50. Farrand, S.K., P.B. van Berkum, and P. Oger, Agrobacterium is a definable genus 
of the family Rhizobiaceae. International Journal of Systematic and Evolutionary 
Microbiology, 2003. 53: p. 1681-1687. 
 
51. Young, J.M., et al., Classification and nomenclature of Agrobacterium and 
Rhizobium - a reply to Farrand et al. (2003). International Journal of Systematic 
and Evolutionary Microbiology, 2003. 53: p. 1689-1695. 
 
52. Slater, S.C., et al., Genome sequence of three Agrobacterium biovars help 
elucidate the evolution of multichromosome genomes in bacteria. Jounral of 
Bacteriology, 2009. 191(8): p. 2501-2511. 
 
53. Matthysse, A.G., The genus Agrobacterium, in The Prokaroytes, Third Edition, 
M. Dworkin, et al., Editors. 2006, Springer. p. 91-107. 
 
54. Wood, D.W., et al., The genome of the natural genetic engineer Agrobacterium 
tumefaciens C58. Science, 2001. 294: p. 2317-2323. 
 
 38
55. Goodner, B., et al., Genome sequence of the plant pathogen and biotechnology 
agent Agrobacterium tumefaciens C58. Science, 2001. 294: p. 2323-2328. 
 
56. Arthur, L.O., et al., Carbohydrate metabolism in Agrobacterium tumefaciens. 
Jounral of Bacteriology, 1973. 116(1): p. 304-313. 
 
57. Arthur, L.O., et al., Carbohydrate catabolism of selected strains in the genus 
Agrobacterium. Applied Microbiology, 1975. 30(5): p. 731-737. 
 
58. Harada, T. and T. Yoshimura, Production of a new acidic polysaccharide 
containing succinic acid by a soil bacterium. Biochimica et biophysica acta, 1964. 
83: p. 374-376. 
 
59. Harada, T., et al., Production of firm, resilient gel-forming polysaccharide by a 
mutant of Alcaligenes faecalis var. myxogenes 10C3. Agricultural Biological 
Chemistry, 1966. 30: p. 196-198. 
 
60. Harada, T., A. Misaki, and H. Saito, Curdlan: A bacterial gel-forming beta-1,3-
glucan. Archives of Biochemistry and Biophysics, 1968. 124(1): p. 292-298. 
 
61. Amemura, A., M. Hisamatsu, and T. Harada, Spontaneous mutation of 
polysaccharide production in Alcaligenes faecalis var. myxogenes 10C3. Applied 
and Environmental Microbiology, 1977. 34(6): p. 617-620. 
 
62. Phillips, K.R., et al., Production of curdlan-type polysaccharide by Alcaligenes 
faecalis in batch and continuous culture. Canadian Journal of Microbiology, 
1983. 29(10): p. 1331-1338. 
 
63. Lee, I.-Y., Curdlan, in Biotechnology of Biopolymers: From Synthesis to Patents, 
A. Steinbuchel and Y. Doi, Editors. 2005, Wiley-VCH: Weinheim, Germany. p. 
457-480. 
 
64. Lawford, H.G., Continuous process for the production of gelable 
exopolysaccharide, U.S.P. Office, Editor. 1982, George Weston Limited: United 
States. p. 5. 
 
65. McIntosh, M., B.A. Stone, and V.A. Stanisich, Curdlan and other bacterial 
(1à3)-β-D-glucans. Applied Microbiology and Biotechnology, 2005. 68: p. 163-
173. 
 
66. Nakanishi, I., et al., Demonstration of curdlan-type polysaccharide and some 
other β-1,3-glucan in microorganisms with aniline blue. The Journal of General 
and Applied Microbiology, 1976. 22: p. 1-11. 
 
67. Toshiko, S., Sustained release suppository, J.P. Office, Editor. 1992: Japan. 
 39
68. Tsuneo, A., K. Koichi, and K. Junji, Blood coagulation inhibitor, J.P. Office, 
Editor. 1990: Japan. 
 
69. Hiroshi, Y., et al., Medicine for treating dementia, J.P. Office, Editor. 1997: 
Japan. 
 
70. Gordon, M., et al., A phase I study of curdlan sulfate--an HIV inhibitor. 
Tolerance, pharmacokinetics and effects on coagulation and on CD4 
lymphocytes. Journal of Medicine, 1994. 25(3-4): p. 163-180. 
 
71. Demleitner, S., J. Kraus, and G. Franz, Synthesis and antitumour activity of 
sulfoalkyl derivatives of curdlan and lichenan. Carbohydrate Research, 1992. 
226(2): p. 247-252. 
 
72. Lawford, H.G. and K.R. Phillips, A two stage continuous process for the 
production of thermogellable curdlan-type exopolysaccharide. Biotechnology 
Letters, 1982. 4: p. 689-694. 
 
73. Lee, I.-Y., et al., Production of curdlan using sucrose or sugar cane molasses by 
two-step fed-batch cultivation of Agrobacterium species. Journal of Industrial 
Microbiology & Biotechnology, 1997. 18: p. 255-259. 
 
74. Lee, J.-H., et al., Optimal pH control of batch processes for production of curdlan 
by Agrobacterium species. Journal of Industrial Microbiology & Biotechnology, 
1999. 23: p. 143-148. 
 
75. Lee, I.Y., et al., Influence of agitation speed on production of curdlan by 
Agrobacterium species. Bioprocess Engineering, 1999. 20: p. 283-287. 
 
76. Kim, M.K., et al., Residual phosphate concentration under nitrogen-limiting 
conditions regulates curdlan production in Agrobacterium species. Journal of 
Industrial Microbiology & Biotechnology, 2000. 25: p. 180-183. 
 
77. Kim, M.K., et al., Higher intracellular levels of uridinemonophosphate under 
nitrogen-limited conditions enhance metabolic flux of curdlan synthesis in 
Agrobacterium species. Biotechnology and Bioengineering, 1999. 62(3): p. 317-
323. 
 
78. Lee, J.H. and I.Y. Lee, Optimization of uracil addition for curdlan (β-1à3-
glucan) production by Agrobacterium sp. Biotechnology Letters, 2001. 23: p. 
1131-1134. 
 
79. Karnezis, T., et al., Topological characterization of an inner membrane (1à3)-β-
D-glucan (curdlan) synthase from Agrobacterium sp. strain ATCC 31749. 
Glycobiology, 2003. 13(10): p. 693-706. 
 
 40
80. Stasinopoulos, S.J., et al., Detection of two loci involved in (1à3)-β-glucan 
(curdlan) biosynthesis by Agrobacterium sp. ATCC31749, and comparative 
sequence analysis of the putative curdlan synthase gene. Glycobiology, 1999. 
9(1): p. 31-41. 
 
81. Karnezis, T., et al., Cloning and characterization of the phosphatidylserine 
synthase gene of Agrobacterium sp. strain ATCC 31749 and effect of its 
inactivation on production of high-molecular-mass (1à3)-β-D-glucan (curdlan). 
Journal of Bacteriology, 2002. 184(15): p. 4114 - 4123. 
 
82. Jin, L.H., et al., Proteomic analysis of curdlan-producing Agrobacterium sp. in 





METABOLIC ENGINEERING OF AGROBACTERIUM SP. FOR 
UDP-GALACTOSE REGENERATION AND LACNAC SYNTHESIS1 
 
2.1 Abstract 
Curdlan-producing Agrobacterium sp. is unique in possessing a highly efficient 
UDP-glucose regeneration system. A broad-host-range expression strategy was 
successfully developed to exploit the unique metabolic capability for UDP-galactose 
regeneration during oligosaccharide synthesis. The engineered Agrobacterium cells 
functioned as a UDP-galactose regeneration system, allowing galactose-containing 
disaccharides to be synthesized from glucose or other simple sugars. Unexpectedly, a lag 
period of 24 hours, which could be eliminated with rifampicin, preceded the active 
synthesis. An intracellular nucleotide profiling revealed that the UMP level was elevated 
by 3.8 fold in the presence of rifampicin, suggesting that rifampicin simulated a nitrogen-
limitation condition that triggered the metabolic change. Product selectivity was 
improved nearly 40-fold by using high acceptor concentration and restricting glucose 
supply. N-acetyllactosamine concentration near 20 mM (7 g/L) was obtained, 
demonstrating the effectiveness of the engineered strain in UDP-galactose regeneration. 
This organism could be engineered to regenerate other UDP-sugar nucleotides using the 
same strategy as illustrated here. 
 
1. Portions of this chapter were previously published: Ruffing A., Mao Z., Chen, R. Metabolic Engineering. 
2006. 8(5): 465-473. 
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2.2 Introduction 
Over the past decade, metabolic engineering has emerged as an effective tool for 
developing whole-cell biocatalysts for oligosaccharide synthesis [1-5]. Whole-cell 
catalysts provide facile regeneration of cofactors including sugar nucleotides, which are 
products of multiple interacting metabolic pathways (Figure 2.1). Unlike nicotinamide 
cofactors, sugar nucleotides are not easily regenerated using isolated enzymes. Not 
surprisingly, Escherichia coli was often used for whole-cell cofactor regeneration as it is 
one of most well-studied organisms and numerous genetic tools are well established [6, 
7]. Although E. coli is capable of synthesizing UDP-glucose, a precursor to other UDP-
sugars and cell wall synthesis, a high regeneration rate of UDP-glucose does not normally 
occur in wild type cells without significant metabolic engineering efforts.  Furthermore, 
sugar nucleotide synthesis interfaces with the primary metabolism, and therefore, any 
improvement in sugar nucleotide regeneration through metabolic engineering will 
involve or affect not only sugar nucleotide synthesis but also the primary metabolism. 
Importantly, this will also include other interacting pathways and regulations of all these 
pathways that often resist any carbon flux redistribution not optimal for cell growth [8]. 
Biosynthesis of sugar nucleotides directly involves high-energy compounds such as UTP, 
bringing additional complications from energy production, regulation, and the inter-
conversion of high-energy compounds. Hence, like any other metabolic engineering 
research, multiple cycles of trial and error may be necessary to achieve the desired 
outcome [9]. Judicious choice of organism is important to maximize the chance of 




Figure 2.1 Proposed metabolic network of UDP-glucose synthesis in Agrobacterium sp.  
The engineered metabolic pathway is indicated in red. Enzymes/Proteins: 1: glucose-
binding-protein for glucose uptake; 2: hexokinase; 3: phosphoglucomutase; 4: UDP-
glucose phosphorylase; 5: UDP-galactose-4’-epimerase; 6: β-1,4-galactosyl--transferase; 
7: glucose-6-phosphate dehydrogenase; 8: 6-phosphogluconate dehydrogenase; 9: ribose-
phosphate diphosphokinase; 10: orotate phosphoribosyltransferase and orotidine-5’-
phosphate decarboxylase; 11: uridylate kinase; 12: UDP kinase; 13: 6-phosphogluconate 
dehydrase; 14: 2-keto-3-deoxygluconate-6-phosphate aldolase; 15: glyceraldehyde-3-
phosphate dehydrogenase, phosphoglycerate mutase, and enolase; 16: pyruvate kinase; 















































Nature has evolved mechanisms for the regeneration of sugar nucleotides with 
efficiency unparalleled by any artificially assembled system reported thus far. In fact, 
these mechanisms are common and seem to operate in many species. Of particular 
interest is one such mechanism that operates in curdlan-producing Agrobacterium sp. 
strains. Curdlan, a β-1,3-glucose homopolymer, is synthesized in certain Agrobacterium 
strains under non-growing conditions. The synthesis is triggered by limitation of the 
nitrogen source [10]. During curdlan synthesis, glucose is transported and subsequently 
phosphorylated to glucose-6-phosphate, which is then converted to glucose-1-phosphate 
by phosphoglucomutase (Figure 2.1). The polymer precursor, UDP-glucose, is 
synthesized from UTP and glucose-1-phosphate, catalyzed by UDP-glucose 
pyrophosphorylase. The subsequent polymerization is catalyzed by curdlan synthase, 
which transfers a glucose molecule from UDP-glucose to the nascent polymer chain and 
releases a molecule of UDP. In the cytosol, UDP is converted back to UTP by UDP 
kinase using ATP derived from glycolysis or the TCA cycle. The glucose polymer 
synthesis is very efficient, with a productivity of 1.0 g-curdlan/hr/g-dry cell and a yield of 
0.5 g curdlan per gram of glucose consumed [11].  Final product could be accumulated to 
90 g/L [12]. This high efficiency suggests that the regeneration of the precursor molecule, 
UDP-glucose, must also be very efficient. When this high-capacity sugar nucleotide 
regeneration is compared to the best system reported [3], it surpasses the latter system by 
32-fold. The higher flux of UDP-glucose regeneration in this organism can be attributed 
to its exquisite mechanism that couples energy production, carbon metabolism, and UDP-
glucose synthesis, giving rise to an optimal rate of UDP-glucose regeneration during 
polymerization.  
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 In this work, we sought a metabolic engineering strategy to exploit this highly 
efficient sugar-nucleotide regeneration system for oligosaccharide synthesis. A curdlan-
deficient strain generated by mutagenesis with NTG (kindly provided by Dr. Stone and 
Dr. Stanisich, La Trobe University) ([13] and personal communication) was further 
engineered into a UDP-galactose regeneration system. We demonstrate its utility through 
the synthesis of a model disaccharide, N-acetyllactosamine (LacNAc). 
2.3 Results 
2.3.1 Engineering a UDP-galactose regeneration system for disaccharide synthesis 
To exploit the efficient UDP-glucose regeneration system in this organism for 
UDP-galactose regeneration and oligosaccharide synthesis, it is necessary to introduce 
new enzymes into this organism. The two required enzymes for synthesis of LacNAc are 
UDP-galactose 4’ epimerase and β-1,4-galactosyltransferase (Figure 2.1). Therefore, our 
first task is to construct a functional expression vector for this organism. A fusion 
expression strategy was adopted and a six-residue peptide linker (Ser-Ala-Ala-Gly-Gly-
Ser) was designed to place between the two enzymes (detailed in section 2.4). Figure 2.2 
illustrates the strategy used to construct the broad-range host expression vector, pKEL. 
The fused gene was first cloned into an E. coli T5-driven expression vector, pQE80L 
(Qiagen), resulting in pQEL. Successful expression of the fusion enzyme in E. coli was 
verified with SDS-PAGE gel analysis (data not shown) and activity assays (Table 2.1). 
To construct an expression vector functional in Agrobacterium sp., the replication region 
and kanamycin marker of a broad-host-range cloning vector pBBR122 (MoBiTec, 
Germany) was PCR-cloned into pQEL. The resulting plasmid, pKEL (Figure 2.2), is 
expected to be functional in a wide range of gram-negative bacteria, including 
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Agrobacterium and E. coli. To assess the effectiveness of this expression strategy in 
Agrobacterium, enzyme activities for the galactosyltransferase and fusion enzymes were 
measured and compared to those in E. coli (Table 2.1). Using the broad-host-range vector 
(pKEL), the enzyme activities were reduced 2 to 3-fold in E. coli, compared to the 
expression level from the smaller vector pQEL. The fusion enzyme was also active in 
Agrobacterium strains. The activity level obtained was about 50-70% of the level 
achieved in E. coli with the same plasmid. This is a significant improvement from our 
earlier work, where the expression level was only about 10% of that in E. coli [13]. A 
control plasmid containing no fusion genes, pBQ, was constructed in otherwise identical 
fashion for comparison studies.  
 
 




Table 2.1 Activities of β-1,4-galactosyltransferase and fusion enzyme in E. coli and 
Agrobacterium sp.2 
 
Vector  E. coli AD202 (U/L)       Agrobacterium sp. ATCC 31749 (U/L) 
  Fusion  LgtB       Fusion  LgtB 
 
pQEL  22 ± 2.2 25 ± 3.1      N/A  N/A 
 
pKEL  7.5 ± 0.67 10.5 ± 0.12      5.4 ± 0.51  5.0 ± 0.38 
 
2.  Data are averages of three independent determinations.  A unit of activity is defined as the amount of 
enzyme to synthesize 1 µmol of product per minute.  NA: not applicable. 
 
 To demonstrate that the above metabolic engineering strategy resulted in a 
functional UDP-galactose regeneration system in this organism, LacNAc synthesis was 
carried out with the curdlan-deficient strain transformed with pKEL (LTU265/pKEL). 
The synthesis was compared to the same Agrobacterium strain, LTU265, transformed 
with the control plasmid pBQ. The β-1,4-galactosyltransferase, as it turned out, was 
promiscuous, accepting both glucose and GlcNAc as substrates and resulting in the 
synthesis of both lactose and LacNAc simultaneously (Figure 2.1). As shown in Figure 
2.3, significant products were synthesized from glucose and GlcNAc with 
LTU265/pKEL, 0.83 mM LacNAc and 7.6 mM lactose (or a total of 8.4 mM UDP-
galactose derives disaccharides), while no product formation was detected in 
LTU265/pBQ. These results indicate the successful construction of pKEL, which allows 



























Figure 2.3 Disaccharides synthesized with LTU265/pKEL and LTU265/pBQ over a 
period of 48 hours under standard reaction conditions.  LTU265/pBQ, LacNAc and 
lactose (□); LTU265/pKEL, LacNAc (■); LTU265/pKEL, lactose (▲); LTU265/pKEL, 
LacNAc and lactose (●).  Data are averages of three independent determinations. 
 
2.3.2 Rifampicin effect and intracellular nucleotide concentrations 
  While the construction allowed the engineered strain to produce UDP-galactose 
derived sugars, a rather long lag period preceded the onset of synthesis (Figure 2.3), 
typically 12-24 hours. It is known that curdlan synthesis is initiated only after the 
nitrogen source is depleted, and there appears to be no lag phase with respect to curdlan 
production [10, 19]. The engineered Agrobacterium cells were grown in LB medium, and 
prior to synthesis, they were washed twice with 10 % glycerol before suspension in the 
reaction buffer. This process should remove any residual nitrogen source prior to transfer 
to the reaction buffer. Thus, the long lag phase preceding the synthesis was puzzling, as it 
cannot be explained by the time required to exhaust the residual nitrogen source. In the 
course of this work, we discovered that a potent transcriptional inhibitor, rifampicin, 
could eliminate the lag phase (Figure 2.4). Consequently, a significant increase in 
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synthesis (1.6 to 4-fold) was observed in the presence of the inhibitor. Rifampicin 
diffuses freely into bacteria and inhibits the DNA-dependent RNA synthesis by blocking 
the elongation of RNA when the transcript becomes 2-3 nt in length [20]. The mechanism 
of rifampicin implicates the involvement of nucleotides in the metabolic change 
accompanying the transition from lag phase to active synthesis. We therefore undertook 
an intracellular nucleotide profiling to probe the underlying mechanism for the observed 
rifampicin effect. The intracellular nucleotides were analyzed using an HPLC ion-pairing 
method [18]. Intracellular concentrations of UMP, UDP, UTP, ATP, and two sugar 
nucleotides, UDP-glucose and UDP-galactose, were measured during the 48-hour 
synthesis reaction. Data are tabulated in Table 2.2. Concentrations at 12 hr represent 
values during the lag phase for reactions without rifampicin and during active synthesis 
for reactions with rifampicin. Comparison of the six compounds at 12 hr shows that only 
the UMP concentration was significantly different from samples taken with and without 
rifampicin. The UMP value in the active synthesis phase was about 3.8-fold as high as 
that in the lag phase, and the UMP concentration remained high in subsequent hours, 
corresponding to a period with continued oligosaccharide synthesis. No appreciable 
concentration differences in ATP, UTP, and UDP were observed (Table 2.2). Neither 
were there significant differences in the sugar nucleotides UDP-glucose and UDP-
galactose. This result is reminiscent of the data reported by Kim et al. (1999). As shown 
in their study, active curdlan synthesis took place under nitrogen-limited conditions, and 
under these conditions, the UMP concentration was about 3.5 times as high as that during 
nitrogen-sufficient conditions with no curdlan synthesis. Their data also indicated 
negligible influence of other nucleotide concentrations on nitrogen-limited curdlan 
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production. Taken together, the data suggest that the addition of rifampicin simulates a 
nitrogen-limited condition, which triggers the synthesis of curdlan, and in our case, the 
synthesis of disaccharides. It is of interest to note that the rifampicin effect seemed to be 
limited to the elimination of lag phase. There were no significant differences in 



























Figure 2.4 Total disaccharides (LacNAc and lactose) synthesized with LTU265/pKEL 
over a period of 48 hours under the following conditions:  standard reaction conditions 
(□) and standard reaction conditions with 50µg/mL rifampicin (■).  Data are averages of 














Table 2.2 Comparison of cellular nucleotide levels under conditions of no rifampicin 
addition and 50µg/ml of rifampicin3 
 
Concentration  0 h   12 h   36 h 
(µmol / g DCW) No Rif      Rif  No Rif      Rif  No Rif      Rif 
 
UMP   0.23      0.32 0.23      0.87 0.91      0.69 
   ± 0.09      ± 0.14 ± 0.09      ± 0.22 ± 0.06      ± 0.23 
 
UDP   0.17      0.22 0.50      0.61 0.61      0.76 
   ± 0.03      ± 0.07 ± 0.13      ± 0.22 ± 0.03      ± 0.13 
 
UTP   0.04      0.05 0.09      0.10 0.11      0.14 
   ± 0.02      ± 0.03 ± 0.02      ± 0.04 ± 0.003     ± 0.03 
 
UDPG   0.28      0.33 0.27      0.39 0.44      0.60 
   ± 0.14      ± 0.25 ± 0.18      ± 0.36 ± 0.14      ± 0.15 
 
UDP-gal  1.37      0.82 1.85      1.34 0.98      1.31 
   ± 0.54      ± 0.54 ± 0.70      ± 0.35 ± 0.37      ± 0.97 
 
ATP   0.09      0.13 0.11      0.11 0.10       0.09 
   ± 0.02      ± 0.05 ± 0.03      ± 0.02 ± 0.01      ± 0.01 
 
3.  Nucleotide concentrations are measured in µmol per gram of dry cell weight.  Data are averages of three 
independent determinations and are given for four reaction times:  0, 12, 24, and 36 hours. 
 
2.3.3 Product selectivity 
β-1,4-galactosyltransferase (lgtB) has been shown to have a wide range of 
acceptor specificity, including both GlcNAc and glucose. In in-vitro studies, the enzyme 
was shown to have a slightly higher specificity for GlcNAc than glucose as the acceptor; 
the activity with glucose as the acceptor was approximately 60-70% of that with GlcNAc 
[17, 21]. In Agrobacterium sp., glucose is directly transported into the cell through 
glucose-binding proteins without phosphorylation [22, 23]. The presence of intracellular 
glucose in high concentration could compete with GlcNAc in the synthesis reaction to 
form the undesired byproduct, lactose. This was observed in this study (Figure 2.3, Table 
2.3). In fact, the initial conditions, 280 mM of glucose and 20 mM of GlcNAc, generated 
an unfavorable condition for LacNAc synthesis. Consequently, lactose was accumulated 
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as the predominant product. Reduction of intracellular glucose concentration using a fed-
batch addition led to a more than 2-fold increase in the ratio of product (LacNAc) to 
byproduct (lactose) (0.13 vs. 0.29, Table 2.3).  
 
Table 2.3 LacNAc and lactose synthesized after 48 hours reaction time with various 
carbon sources4    
 
   Carbon Source  LacNAc Lactose Total  LacNAc: 
       (mM)    (mM)    (mM)  Lactose 
 
   280 mM glucose  1.9 ± 1.3 14.6 ± 5.9 16.5 ± 7.2   0.13 
 
   10 mM glucose (fed batch) 5.1 ± 0.2 17.9 ± 8.9 23 ± 9.1   0.29 
 
   140 mM sucrose  6.4 ± 3.7 14.9 ± 4.8 21.3 ± 8.5   0.43 
 
   70 mM sucrose  6.4 ± 0.2 7.9 ± 3.1 14.3 ± 3.3   0.81 
 
   200 mM GlcNAc5  3.4 ± 0.07 0.0 ± 0.0 3.4 ± 0.07   N/A 
 
4.  All data are averages of two or three independent experiments. 
5.  The data point for 44.2g/L GlcNAc is after 22 hours reaction time (the maximum product synthesized).   
 
To further increase synthesis of the desired product, alternative carbon sources 
were investigated, including fructose, glycerol, and sucrose. Both fructose and glycerol 
led to significant decreases in the formation of both products (data not shown). In 
contrast, sucrose (140 mM) yielded a significant increase in LacNAc production 
compared to an equivalent monomer amount of glucose (280 mM), improving the 
product ratio to 0.43. Further enhancement in LacNAc selectivity was achieved by using 
a lower sucrose concentration (Table 2.4), increasing the LacNAc to lactose ratio to 0.81. 
The lower sucrose concentration apparently suppressed the formation of lactose, favoring 
synthesis of the desired product. The enzymatic breakdown of sucrose into its constituent 
components may have led to a low intracellular glucose concentration, similar to that 
observed with the fed-batch addition of 10 mM glucose, favoring LacNAc formation.  
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However, the increase observed with sucrose was higher than that seen with the fed-batch 
glucose addition. Sucrose, therefore, is a preferred carbon and energy source for this 
synthesis.  
In an effort to completely eliminate lactose synthesis, 200 mM GlcNAc was used 
as the sole carbon source. This led to the formation of 3.4 mM LacNAc with no 
byproduct synthesis. This suggests that eliminating glucose as the carbon and energy 
source could eliminate byproduct formation.  
 The product ratio could also be influenced by increasing GlcNAc concentrations. 
A combination of limiting intracellular glucose concentration (by using a relatively low 
concentration of sucrose) and a higher extracellular concentration of GlcNAc (up to 100 
mM) led to dramatic improvement in product ratio (Figure 2.5). These favorable 
conditions yielded LacNAc concentrations of up to 19.1 mM (7.3 g/L) with concomitant 
reduction of lactose formation to below 5 mM (Figure 2.5). A product ratio of 4.0, in 
favor of LacNAc, was obtained, representing a near 40-fold improvement over the initial 
value. This indicates the possibility to improve synthesis and product selectivity through 
judicious selection of process conditions. Further increase of product selectivity is 
possible, yet an alternative galactosyltransferase with better substrate specificity will be a 
























Figure 2.5 Comparison of LacNAc and lactose produced after 48 hours reaction time with 
increasing substrate concentrations of 20mM GlcNAc (gray), 40mM GlcNAc (white), 
and 100mM GlcNAc (black). 
 
2.3.4 Identification of oligosaccharide byproducts 
 In addition to the desired product, LacNAc, several other byproducts were formed 
during the oligosaccharide synthesis reaction (Figure 2.6). Based on retention time, the 
byproducts are likely disaccharides, and since the recombinant β1,4-
galactosyltransferase, LgtB, is known to allow several sugars to serve as acceptor, we 
suspect that the promiscuity of this enzyme led to the observed byproduct peaks. As 
evidence, β-galactosidase was found to hydrolyze all three products into their respective 
monosaccharide components. The only sugars initially present in the reaction medium are 
sucrose and GlcNAc, but the metabolism of ATCC 31749 can convert these sugars into 
other forms which may serve as acceptors to generate the β-galactose disaccharides. The 
most likely candidates are glucose and fructose, as these sugars are formed from sucrose 
hydrolysis. An enzymatic assay using the GalE:LgtB fusion enzyme revealed that glucose 
is readily used as an acceptor to produce lactose, with a retention time of 19.3 min. The 
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other byproduct (retention time 21.5 min) proved more difficult to identify. Replacing 
sucrose with other carbon sources provided some insight into the composition of this 
byproduct: the byproduct was formed with sucrose or fructose as the carbon source, but 
not with glucose. This suggests that the byproduct is formed from fructose metabolism. 
Since little is known about the metabolism of ATCC 31749, we considered the 
metabolism of a well-studied relative, Agrobacterium tumefaciens C58. From the 
predicted metabolic pathways of Agrobacterium tumefaciens C58, several potential 
acceptor sugars were identified: mannose, fructose, sorbitol, and mannitol. Of these 
candidates, only mannose yielded a product peak from the GalE:LgtB enzyme assay with 
a retention time matching that of the unidentified byproduct. Thus, the third product is 
likely galactose-β1,4-mannose. As this disaccharide is not commercially available, the 
concentration of this byproduct could not be determined and was therefore not shown in 
the analysis above. 
 
 






2.4 Discussion and Conclusions 
The high amount of product synthesized with the engineered Agrobacterium sp. 
demonstrates the advantage of utilizing the cell’s naturally efficient UDP-glucose 
regeneration system for oligosaccharide synthesis. This advantage is most clearly seen by 
comparing LTU265/pKEL to AD202/pQEL, an E. coli host containing a plasmid with the 
same fusion protein (galE:lgtB) [24]. The engineered E. coli produced a total of 
approximately 2.5 mM of UDP-galactose derived disaccharides (Table 2.4). Under 
similar conditions, the engineered Agrobacterium sp. yielded about 15.7 mM of 
disaccharides, indicating that its natural regeneration system is indeed superior to other 
organisms.  
 
Table 2.4 Maximum LacNAc and lactose synthesized with E. coli AD202/pQEL and 
Agrobacterium sp. LTU265/pKEL6 
 
   E. coli with galE:lgtB Agrobacterium sp. with galE:lgtB 
         
LacNAc (mM)  1.0     11.3 
Lactose (mM)   1.5     4.4 
 
6. The following reaction conditions were used for product synthesis:  E. coli – 200mM glucose, 50mM 
GlcNAc, and 16 hr reaction time; Agrobacterium sp. – 70 mM sucrose, 40mM GlcNAc, and 48 hr reaction 
time. 
 
The successful development of broad-host-range expression vectors allows 
exploitation of the efficient UDP-glucose regeneration system in this organism for 
oligosaccharide synthesis. In this paper, the naturally efficient UDP-glucose regeneration 
system in Agrobacterium sp. was metabolically engineered into an effective UDP-
galactose regeneration system. With one additional enzyme, UDP-glucose and UDP-
galactose can be converted into UDP-glucuronic acid and UDP-galacuronic acid, 
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respectively. Thus, Agrobacterium sp. could be similarly engineered to form effective 
UDP-galacuronic acid and UDP-glucuronic acid regeneration systems.  
 The use of sucrose as the carbon source leads to higher product concentrations 
than other sources including glucose, fructose, and glycerol. This result is in agreement 
with previous research on curdlan production with Agrobacterium sp. [19, 25]. Lee et al. 
not only found that sucrose led to a higher production of curdlan, they also found that 
more curdlan was produced with sucrose than with a comparable mixture of glucose and 
fructose. Sucrase activity was not detected in the culture broth or cell suspensions of 
Agrobacterium sp., suggesting that sucrose is directly transported into the cell [19]. The 
subsequent phosphorylation could be catalyzed by sucrose phosphorylase. Sucrose 
phosphorylase uses inorganic phosphate to convert sucrose to fructose and glucose-1-
phosphate. If this is true, the advantage it confers is two fold. (1) It eliminates ATP 
consumption for glucose phosphosphorylation. (2) As glucose-1-phosphate is directly 
formed by this enzyme, it eliminates the conversion of glucose-6-phosphate to glucose-1-
phosphate for UDP-glucose formation (Figure 2.1), avoiding the competition occurring at 
the glucose-6-phosphate node. The molecular basis for the superiority of sucrose as 
carbon source remains to be elucidated as our initial experiments failed to detect sucrose 
phosphorylase activity in a crude lysate of the engineered Agrobacterium sp. 
 The finding with rifampicin is intriguing, as it seems to relate to the regulation of 
polysaccharides synthesis. In a study where uracil was fed to ammonia-depleted cells, the 
synthesis of curdlan was initiated only when the uracil feeding occurred 24 hours after 
exhaustion of the nitrogen source [12]. Feeding uracil immediately after ammonia 
depletion resulted in more cell growth but no curdlan synthesis. Apparently, a waiting 
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period of 24 hours is necessary to prepare cells for the transition between the two 
metabolic states. Despite an 80% reduction in curdlan synthesis, the mutant (LTU265) 
used in this study retains the characteristic regulation observed with curdlan synthesis. It 
will be interesting to generate regulatory mutants that allow synthesis of oligosaccharides 
without the 24 hour lag phase. Recent advances in understanding curdlan synthesis in this 
organism have identified genes involved in the regulation [13, 26], paving the way for 
further metabolic engineering of the strain for practical applications. 
2.5 Materials and Experimental Methods 
2.5.1 Materials 
Molecular biology reagents, such as A addition kit, plasmid purification kit, gel 
DNA recovery kit, Taq and pfu DNA polymerase, PCR primers, restriction enzymes, T4 
DNA ligase, and SDS-PAGE ready gel were purchased from commercial sources, 
including Qiagen, Invitrogen, Promega, and BioRad. The chemicals used in this study 
were obtained from Sigma-Aldrich (lactose, LacNAc, UMP, UDP, UTP, UDP-glucose, 
UDP-galactose, ATP), Mallinckrodt (glucose), MP Biomedicals Inc.(GlcNAc), Fisher, 
and VWR (all other chemicals). 
2.5.2 Bacterial strains and plasmids 







Table 2.5 Bacterial strains and plasmids used in this study 
Strains/Plasmids Description      Source 
pQE80L  Commercial expression vector containing T5 Qiagen 
   promoter and lacIq 
 
pBBR122  Commercial broad-host-range vector   Mobitec 
 
pCW-lgtB  β-1,4-galactosyltransferase gene from Nesseria [14]   
   meningitidis 
 
pLysPTE7  T7 expression vector containing the E. coli UDP- [15] 
   galactose epimerase gene 
 
Teasy(-)GalE  pGEM-T Easy vector containing galE gene with  This study 
   BglII and BamHI sites 
 
T-ElgtBD  pGEM-T Easy vector containing fused galE:lgtB This study 
   With BglII and XhoI sites 
 
pQEL   pQE80L containing T5 driven galE:lgtB fusion  This study 
   expression vector 
 
pKEL   T5 directed galE:lgtB fusion gene for   This study 
   Agrobacterium sp. expression 
 
pBQ   Empty vector for pKEL, constructed from   This study 
   pQE80L and pBBR122 
 
Jm109   E. coli, F’ traD36 proA+B+ lacIq ∆(lacZ)   [16] 
M15/∆(lac-proAB) glnV44 e14- gyrA96 recA1  
relA1 endA1 thi hsdR17 
 
AD202  E. coli protease free host    W.W. 
Wakarchuk 
 
ATCC 31749  Agrobacterium sp., wild type    ATCC 
 
 
LTU265  locus II mutant of Agrobacterium sp.   B.A. Stone 
ATCC 31749      V.A. Stanisich 
 
 
2.5.3 Construction of Agrobacterium sp. expression vector, pKEL and analysis of 
GalE-LgtB fusion enzyme activity  
 The gene encoding E. coli UDP-galactose 4’-epimerase (galE) was amplified 
from pLysPTE7 [15]. The 5’ primer for galE, (5’-TGGAGATCTATGAGAGTTCTGG 
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TTACCGGTGGT-3’), contains a BglII site (in bold italics) and start codon (underlined). 
The 3’ primer for galE, (5'-TAGGATCCGCCAGCGCTGAATCGGGATATCCCTGTG 
GAT G-3’), contains a BamHI site (in bold italics) with the original stop codon, TAA, 
mutated to Ser codon, TCA (reverse complementary sequence underlined), and a mini-
linker sequence coding for a linker peptide, Ala-Ala-Gly-Gly-Ser. The PCR fragment 
(about 1 kb) was ligated into the pGEM-T easy vector to give the plasmid pT-GalE. The 
gene for β-1,4-galactosyltransferase from Nesseria meningitidis was cloned from plasmid 
pCW-lgtB [14]. The 5’ primer for lgtB, (5'-TAGGATCCATGCAAAACCACGTTATCA 
GCTTAG-3’), contains a BamHI site (in bold italics) and start codon (underlined); the 3’ 
primer for lgtB, (5'-TACTCGAGTTATTGGAAAGGCACAATGAACTG-3'), contains 
an XhoI site (in bold italics). The amplified PCR fragment (about 0.8 kb) was inserted 
into the pGEM-T easy vector to give the plasmid pT-lgtB. The lgtB gene fragment, 
obtained from pT-LgtB by the double digestion by BamHI and SacII, was inserted into 
pT-GalE downstream from galE to give pT-EL. The fusion gene fragment, obtained by 
BglII and XhoI digestion, was fused into the BamHI and SalI sites of pQE80L to give 
pQEL. To construct the expression vector for Agrobacterium sp. strains, a fragment from 
pBBR122 (MoBiTec, Germany), containing its replica region and kanamycin marker, 
was amplified with the primers derived from the pBBR122 sequence (GenBank accession 
Y14439). Both the 5’ primer (5'-TGGTGTCGACCTTGCCAGCCCGTGGATATGTGG-
3') and the 3’ primer (5'-AGGTGTCGACTCTGTGATGGCTTCCATGTCGGCAG-3') 
contain a SalI site (in bold italics). After digestion with SalI, the 3.2 kb PCR fragment 
was ligated into the XhoI site of pQEL to obtain pKEL, a plasmid which can be 
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maintained in most gram negative bacteria with both ampicillin and kanamycin markers. 
The organization of the plasmid pKEL is shown in Figure 2.2. 
E. coli strain AD202, Agrobaterium sp. ATCC 31749 and its mutant strain 
LTU265 were transformed with the expression vector pKEL by electroporation. The 
overnight inoculums of all transformants were prepared at 30oC in a culture tube with 3 
mL of LB containing 100 µg/L ampicillin and 100 µg/L kanamycin. The cells were 
diluted 100 times and grown in freshly prepared LB medium supplemented with 
antibiotics until OD600 reached 0.3-0.4, upon which IPTG was added to a final 
concentration of 1 mM, and cells were incubated for another 6 hours. The induced cells 
were collected by centrifugation and used for the enzyme activity assay. 
The enzyme activity assay was performed as described by Blixt et al. with 
modification [17]. The cell pellets were resuspended to 1/10 of the culture volume and 
washed in buffer containing Tris-HCl (25 mM, pH 7.5), MnCl2 (10 mM), and Triton X 
(0.25% v/v). After an additional 15 min of centrifugation at 5,000 g, the cell pellets were 
resuspended in the same buffer to 1/20 of the culture volume. The cells were lysed by 
Branson Mode 250 Sonifer (6 x 15 sec sonication, 1min ice cooling), and the lysates were 
centrifuged for 15 min at 10,000 g. The supernatant was used as crude enzyme for the 
activity analysis. The β-1,4-galactosyltransferase assay contained the crude enzyme (10% 
w/v), N-acetylglucosamine (10 mM), and UDP-galactose (2 mM) in 25 mM Tris-HCl 
(pH 7.5 containing 100 mM NaCl, 10 mM MnCl 1% bovine serum albumin) with a final 
reaction volume of 100 µl. The assay was conducted at 30°C for 30 min, and the reaction 
was stopped by heating in boiling water for 10 min. The acceptor (N-acetylglucosamine) 
consumption was limited to 20% by the low donor (UDP-galactose) concentration. After 
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centrifugation at 13,000 rpm for 5 min, the product (LacNAc) was analyzed by the 
method described below (carbohydrate analysis). The fusion enzyme activity assay is 
identical to the β-1,4-galactosyltransferase assay with a donor substrate of UDP-glucose 
in place of UDP-galactose. The results of both enzyme activity assays are shown in Table 
2.1. 
2.5.4 LacNAc and lactose synthesis with LTU265 transformants 
Agrobacterium sp. transformants ATCC 31749/pKEL and LTU265/pKEL were 
prepared as described above. The 10 mL reaction mixture contained 50 mM Tris-HCl 
(pH 7.5), 1 g/L K2HPO4•3H2O, 5 g/L MgSO4•7H2O, 5 g/L sodium citrate, 5 mM MnCl2, 
50 g/L glucose, and 20 mM GlcNAc. The cell concentration was 10% (wet weight), and 
the reaction vessel was a 50 mL flask. The reaction was carried out at 30ºC and 250 rpm 
in a biological shaker. Samples were heated at 97°C for 10 min. The supernatant was 
obtained by centrifugation and analyzed with a Dionex BioLC system (details below). 
Any changes in these standard reaction conditions are explicitly stated in the results 
section. 
2.5.5 Analytical methods 
2.5.5.1 Carbohydrate analysis 
 A Dionex BioLC system with a CarboPac PA20 analytical column was used for 
carbohydrate analysis. The Dionex ED50 electrochemical detector measured 
carbohydrate concentrations through pulsed amperometry (waveform:  t = 0.41 sec, p = -
2.00 V; t = 0.42 sec, p = -2.00 V; t = 0.43 sec, p = 0.60 V; t = 0.44 sec, p = -0.10 V; t = 
0.50 sec, p = -0.10 V). Lactose and LacNAc concentrations were determined using 
calibration curves prepared from standards (Sigma-Aldrich).  The mobile phase consisted 
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of degassed 200 mM sodium hydroxide (A) and 18 MΩ-cm water (B), pressurized with 
inert gas (He) at a flow rate of 0.5 mL/min.  The following linear gradient was used:  t = 
0 min, 5:95 (A:B); t = 5 min, 5:95; t = 10 min, 20:80; t = 20 min, 20:80; t = 21 min, 
100:0; t = 30 min, 100:0; t = 35 min, 5:95; t = 50 min, 5:95. 
2.5.5.2 Nucleotide extraction and assay 
 The intracellular nucleotides were extracted using a previously established 
method [18]. Nucleotide analysis was performed using an Agilent 1100 series HPLC 
system with a reverse-phase ODS column (Waters Jsphere ODS H80, 150 x 4.6 mm i.d., 
4 µm-particle size). The buffers and gradient used in HPLC analysis were modified from 
the nucleotide assay used by Kim et al. A two-buffer system was used: (1) Buffer A - 100 
mM potassium phosphate monobasic (KH2PO4) and 8 mM tetrabutylammonium 
hydrogen sulfate with pH adjusted to 5.3 with 2M KOH (2) Buffer B - 70% buffer A and 
30% methanol (pH 5.9). Both buffers were filtered with a 0.22 µm cellulose acetate filter. 
The gradient described by Kim et al. was used, with an extended equilibrium phase of 
100% buffer A for 14 min instead of 4 min. The injection volume was 20 µL, and the 
flow rate was 1 mL/min.  Using this method, the nucleotides had the following retention 
times: UMP 4.1 min, UDP 9.8 min, UTP 22.7 min, UDP-glucose 8.9 min, UDP-galactose 
8.4 min, and ATP 28.8 min. Nucleotide concentrations were determined using calibration 
curves prepared from standards (Sigma-Aldrich). 
2.5.5.3 β-Galacotsidase assay 
β-Galacotsidase was used to aid in the identification of disaccharide byproducts. 
The assay included 1x PBS buffer (pH 7.4), 30 units/mL of β-galacotsidase, and reaction 
sample with a total volume of 100 µL. The enzyme mixture was incubated at 37°C for 30 
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min, followed by heating at 97°C for 10 min to deactivate the β-galacotsidase. After 
centrifugation at 13,200 rpm for 2 min, the sample was diluted and analyzed using the 
method described in section 2.4.5.1 (above). 
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METABOLIC ENGINEERING OF AGROBACTERIUM SP. STRAIN 
ATCC 31749 FOR PRODUCTION OF AN α-GAL EPITOPE1 
 
3.1 Abstract 
Oligosaccharides containing a terminal Gal-α1,3-Gal moiety are collectively 
known as α-Gal epitopes. α-Gal epitopes are integral components of several medical 
treatments under development, including flu and HIV vaccines as well as cancer 
treatments. The difficulty associated with synthesizing the α-Gal epitope hinders the 
development and application of these treatments due to the limited availability and high 
cost of the α-Gal epitope. In this work, Agrobacterium sp. ATCC 31749 was engineered 
to produce Gal-α1,3-Lac by the introduction of a UDP-galactose 4’-epimerase:α1,3-
galactosyltransferase fusion enzyme. The engineered Agrobacterium synthesized 0.4 g/L 
of the α-Gal epitope. Additional metabolic engineering efforts addressed the factors 
limiting α-Gal epitope production, namely the availability of the two substrates, lactose 
and UDP-glucose. Through expression of a lactose permease, the intracellular lactose 
concentration increased by 60 to 110%, subsequently leading to an improvement in Gal-
α1,3-Lac production. Knockout of the curdlan synthase gene increased UDP-glucose 
availability by eliminating the consumption of UDP-glucose for synthesis of the curdlan 
polysaccharide. With these additional engineering efforts, the final engineered strain 
synthesized   approximately  1 g/L   of   Gal-α1,3-Lac.   The   Agrobacterium   biocatalyst  
 
1. Portions of this chapter were submitted for publication: Ruffing, A. and Chen, R. Microbial Cell 
Factories. 2009. 
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developed in this work synthesizes gram-scale quantities of α-Gal epitope and does not 
require expensive cofactors or permeabilization, making it a useful biocatalyst for 
industrial production of the α-Gal epitope.  
3.2 Introduction 
α-Gal epitopes are oligosaccharides containing terminal Gal-α1,3-Gal residues. In 
nature, three main α-Gal epitopes are produced: two trisaccharides (Gal-α1,3-Gal-β1,4-
GlcNAc and Gal-α1,3-Lac) and a pentasaccharide (Gal-α1,3-Gal-β1,4-GlcNAc-β1,3-Gal-
β1,4-Glc). These epitopes are components of glycolipids and glycoproteins displayed on 
the cell surface of non-primate mammals and New World monkeys via expression of an 
α1,3-galactosyltransferase (α1,3-GalT). The α1,3-GalT was inactivated in ancestral Old 
World primates approximately 20-28 million years ago, resulting in the absence of α-Gal 
epitopes in humans, apes, and Old World monkeys today [1, 2]. These evolutionary 
descendents of Old World primates produce an antibody to Gal-α1,3-Gal-containing 
oligosaccharides known as anti-Gal. Anti-Gal is the most abundant natural antibody in 
humans, and as a result, exposure to α-Gal epitopes generates a strong immune response 
[3]. Many current research efforts exploit the human immune response to α-Gal epitopes. 
The efficacy of a vaccine is often determined by uptake of the vaccine by antigen 
presenting cells. Uptake can be greatly enhanced by the presence of an IgG antibody, 
such as anti-Gal, bound to its associated antigen. Based on this principle, several vaccines 
have been modified with α-Gal epitopes in an effort to improve vaccine uptake and 
efficacy. This strategy was applied to flu and HIV vaccines and was found to be more 
effective than the non-modified vaccine in animal studies [4, 5]. In addition to enhancing 
vaccine efficacy, the immunogenicity of α-Gal epitopes has been applied to improve 
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cancer treatments. Autologous tumor vaccines with α-Gal epitopes on the tumor cells and 
injections of α-Gal-containing glycolipids were shown to generate an immune response 
against malignant tumors in mice [6, 7]. The promising results of these α-Gal-based 
treatments have stimulated the demand for α-Gal epitope production. 
The increasing interest in α-Gal epitopes for various medical applications 
necessitates an efficient and economical means of synthesizing α-Gal epitopes. 
Traditional chemical synthesis requires numerous reaction steps, leading to low overall 
yields, a high cost, and a process that is not applicable for large-scale production. 
Enzymatic production of α-Gal epitopes can be achieved in just one step through the use 
of an α1,3-GalT; however, enzymatic synthesis requires provision of an expensive sugar 
nucleotide, UDP-galactose. To reduce cost, enzymatic synthesis schemes often employ a 
UDP-galactose 4’-epimerase to provide the UDP-galactose from a less expensive sugar 
nucleotide, UDP-glucose [8, 9]. As UDP-glucose is still quite expensive, other enzymatic 
synthesis schemes have been developed to regenerate UDP-galactose through the use of 
additional enzymes [10, 11]. While these synthesis schemes reduce the cost of sugar 
nucleotide provision, they require production and purification of multiple enzymes, 
generally 4 to 6, and may also require other high energy compounds such as PEP which 
can still lead to high synthesis cost.  
Alternatively, whole cell biocatalysts can synthesize α-Gal epitopes in just one 
step without enzyme purification. Different hosts and engineering strategies were 
explored by Wang and coworkers for whole-cell Gal-α1,3-Lac synthesis. An engineered 
E. coli was constructed by overexpressing five enzymes: three enzymes of the Gal operon 
(GalK, GalT, GalU) for UDP-galactose synthesis, a pyruvate kinase for energy 
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production, and an α1,3-GalT. In this strategy, glucose and catalytic amounts of other 
cofactors (ATP, UDPG, and G1P) were supplied to the engineered E. coli to provide the 
energy required for Gal-α1,3-Lac synthesis [12]. Alternatively, an engineered Pichia 
pastoris expressed a sucrose synthase which directly converts sucrose and UDP to UDP-
glucose with fructose as coproduct. With two additional enzymes (UDP-glucose 4’-
epimerase and α1,3-GalT), the modified P. pastoris required only sucrose, lactose, a 
catalytic amount of UDP, and a few essential nutrients to produce Gal-α1,3-Lac. The 
three recombinant enzymes in P. pastoris constituted an artificial pathway, whose 
operation was independent of cellular metabolism [13]. Both the engineered E. coli and 
P. pastoris were capable of synthesizing gram-scale amounts of Gal-α1,3-Lac. 
One key challenge with whole-cell catalysts is uptake of the acceptor sugar, 
lactose, along with the primary sugar (i.e. sucrose or glucose). In both the engineered E. 
coli and P. pastoris biocatalysts, permeabilization was found to be necessary [12, 13].  
While effective at improving lactose uptake, permeabilization also reduces cell viability 
and dissipates the proton gradient used for energy generation. This may not be a problem 
when cellular metabolism is not required to generate UDP-glucose, such is the case with 
sucrose synthase, but otherwise, it is detrimental to both cellular metabolism and α-Gal 
epitope synthesis. To avoid permeabilization, an E. coli biocatalyst was engineered to 
synthesize the acceptor sugar in vivo. Expressing a chitin oligosaccharide synthase 
(NodC) and several glycosyltransferases, the recombinant E. coli produced a 
heptasaccharide α-Gal epitope without permeabilization of the cell membrane [14]. While 
this method avoids the complications imposed by multiple sugar uptake, the diversion of 
cell resources for in vivo substrate synthesis may hinder α-Gal epitope production. 
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We have previously demonstrated that Agrobacterium sp. strain ATCC 31749 is a 
good host for oligosaccharide production through the synthesis of β1,4-Gal disaccharides 
[15]. ATCC 31749 naturally produces high amounts of a β1,3-glucan polysaccharide 
known as curdlan. High curdlan production in ATCC 31749 implies an efficient 
mechanism for regeneration of the requisite sugar nucleotide, UDP-glucose. In our 
previous work, ATCC 31749 was engineered to convert the UDP-glucose regeneration 
system into a UDP-galactose regeneration system. This current study utilizes the efficient 
UDP-galactose production for synthesis of the medically-relevant α-Gal epitope, Gal-
α1,3-Lac. Instead of using permeabilization or in vivo substrate synthesis, an alternative 
strategy will be employed to address insufficient uptake of the substrate sugar, lactose. A 
lactose permease (LacY) from E. coli will be introduced in the Agrobacterium host to 
facilitate lactose transport across the cell membrane. In addition, sugar nucleotide 
availability will be improved by eliminating curdlan production, a competing pathway for 





Figure 3.1 Metabolic pathway for Gal-α1,3-Lac synthesis in ATCC 31749. Cofactors are 
shown in bold and enzymes are in bold italics. The double dashed lines indicate the cell 




3.3.1 α-Gal epitope synthesis in ATCC 31749/pBQET 
 ATCC 31749 naturally produces high amounts of curdlan polysaccharide, 
suggesting an abundant supply of the sugar nucleotide precursor, UDP-glucose. In order 
to utilize UDP-glucose for synthesis of Gal-α1,3-Lac, two additional enzymes are 
required: a UDP-galactose 4’-epimerase and an α1,3-galactosyltransferase (Figure 3.1). 
In previous work, we demonstrated that the expression of a galE:lgtB fusion gene in 
ATCC 31749 can efficiently produce β1,4-Gal oligosaccharides [15]. Adopting a similar 
strategy for α-Gal epitope synthesis, a galE:α1,3-galT fusion gene was constructed using 
a UDP-galactose 4’-epimerase (galE) from E.coli and a truncated bovine α1,3-
galactosyltransferase (α1,3-galT) (Section 3.4 Figure 3.2A). Inserting the fusion gene into 
the Agrobacterium expression vector, pBQ, yielded pBQET, which was transformed into 
ATCC 31749 for synthesis of the α-Gal epitope. Successful expression of the GalE:α1,3-
GalT fusion enzyme was confirmed with an enzyme activity assay using ATCC 
31749/pBQET. Concentrations of IPTG ranging from 0 to 1 mM were investigated to 
maximize activity of the fusion enzyme in the ATCC 31749 host. From 0 to 0.5 mM 
IPTG, the fusion enzyme activity increased with increasing IPTG concentration and 
reached a plateau from 0.5 to 1 mM IPTG (3.1). A concentration of 1 mM IPTG was 






Table 3.1 Enzyme activity of GalE:α1,3-GalT fusion enzyme with varying IPTG 
concentration2  
 
Strain     IPTG       Fusion enzyme activity  
     (mM)           [µmol/(min•L)] 
 
ATCC 31749/pBQET       0      1.2 ± 0.76 
         0.05    10.7 ± 1.1 
         0.1    28.0 ± 0.52 
         0.5    53.4 ± 16.3 
         1    54.1 ± 5.3 
 
ATCC 31749/pBQETY      0      6.4 ± 0.96 
         0.05    13.2 ± 0.058 
         0.1    15.6 ± 1.6 
         0.5    14.3 ± 0.72 
         1    11.6 ± 1.2 
 
ATCC 31749∆crdS/pBQET      1    38.2 ± 1.7 
 
ATCC 31749∆crdS/pBQET      1    12.6 ± 0.79 
 
2. Data are reported as averages of at least two independent experiments with the associated standard 
deviation serving as an estimation of error. 
 
 The engineered Agrobacterium, ATCC 31749/pBQET, was utilized for small-
scale α-Gal epitope synthesis. The synthesis process includes two phases. In the first 
phase, the engineered Agrobacterium is grown and induced. After recombinant protein 
production, the cells are transferred to a nitrogen-limited minimal media for synthesis of 
Gal-α1,3-Lac. Nitrogen-limited conditions are employed for α-Gal epitope synthesis as 
curdlan production, and hence UDP-glucose production, is activateded by this 
environmental signal. In the α-Gal epitope synthesis reaction, the engineered strain 
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synthesized 0.39 g/L of the desired product, Gal-α1,3-Lac (Figure 3.3). While this result 
confirms the successful engineering of ATCC 31749 for α-Gal epitope synthesis, the 
concentration of Gal-α1,3-Lac produced is lower than expected. In our previous work, the 
engineered Agrobacterium synthesized up to 7.5 g/L of β1,4-Gal oligosaccharides, nearly 
20-fold greater than the amount of Gal-α1,3-Lac produced by ATCC 31749/pBQET [15]. 
Since ATCC 31749 has the potential to produce much higher levels of the α-Gal epitope, 
additional metabolic engineering strategies were investigated, focusing mainly on 























Figure 3.3 Synthesis of Gal-α1,3-Lac by ATCC 31749/pBQ (□) and ATCC 
31749/pBQET (■). Data points are averages of three independent experiments with the 
standard deviation indicated by error bars. 
 
3.3.2 Increased uptake of the acceptor, lactose 
 A major challenge of whole-cell synthesis is the efficient transport of reactants 
across the cell membrane. This task is particularly difficult for oligosaccharide synthesis 
reactions such as α-Gal epitope synthesis. The synthesis reaction requires uptake of two 
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sugars: the acceptor sugar (lactose) and a carbon source for production of the sugar 
nucleotide and cellular energy (sucrose) (Figure 3.1). Simultaneous uptake of multiple 
sugars is often prohibited by catabolite repression systems which allow for uptake of only 
a preferred carbon source [16]. Nominal uptake of the acceptor, lactose, was suspected to 
limit synthesis of the α-Gal epitope in ATCC 31749/pBQET. Measurement of lactose 
uptake by ATCC 31749 supported this hypothesis, as the rate of lactose consumption was 
more than 45-fold lower than the rate of sucrose consumption. To confirm that lactose is 
limiting for Gal-α1,3-Lac synthesis, the extracellular concentration of lactose was 
increased from 25 g/L to 50 g/L in an effort to increase the intracellular lactose 
concentration by means of diffusion. The higher lactose concentration led to a 28% 
increase in Gal-α1,3-Lac synthesis. An estimate of the intracellular lactose concentration 
indicates that roughly 1 mM of lactose is present intracellularly, which is more than 7-
fold lower than the reported Km for the GalE:LgtB fusion enzyme (Km = 8.5 mM) [17]. 
These results indicate that lactose availability may limit α-Gal epitope synthesis.  
While doubling the concentration of lactose was successful at increasing α-Gal 
epitope production, diffusion-mediated transport across the cell membrane is limited, 
requiring a large increase in lactose concentration to bring about a small improvement in 
synthesis. In this work, an alternative strategy is explored: introducing a heterologous 
lactose transporter to increase the availability of intracellular lactose. A lactose permease 
gene (lacY) from an E. coli K12 strain was expressed along with the fusion enzyme in the 
engineered Agrobacterium (Figure 3.2B). LacY is a lactose/proton symporter that 
transports lactose across the cytoplasmic membrane [18]. As expression of a 
transmembrane protein is generally not as straightforward as other soluble proteins, 
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additional steps were taken to provide evidence of successful expression of lacY. To 
analyze the expression and activity of LacY in the engineered Agrobacterium, uptake of 
lactose by ATCC 31749/pBQETY was compared to the lactose uptake of ATCC 
31749/pBQET through analysis of residual lactose concentration in the extracellular 
medium. The rate of lactose uptake in ATCC 31749/pBQETY was approximately 50% 
greater than that of ATCC 31749/pBQET, indicating successful expression and activity 
of LacY. This measurement relies on extracellular lactose measurement, however, which 
assumes that decreasing lactose concentration is due solely to uptake by the cell, with no 
degradation of lactose in the extracellular medium. To confirm that LacY expression does 
indeed enhance lactose uptake, the amount of intracellular lactose was directly measured 
throughout the time course of the α-Gal synthesis reaction. These measurements show a 
60 to 110% increase in intracellular lactose concentration for ATCC 31749/pBQETY 
compared to ATCC 31749/pBQET. Combining these results with the previous 
extracellular lactose measurements suggests successful expression of LacY and 
functional insertion of the protein into the cytoplasmic membrane. 
ATCC 31749/pBQETY was employed to determine the effect of increased lactose 
availability on α-Gal epitope synthesis. The LacY-expressing strain synthesized 0.65 g/L 
of Gal-α1,3-Lac, a 67% improvement over the initial engineered strain, ATCC 
31749/pBQET (Figure 3.4). Surprisingly, the activity of the GalE:α1,3-GalT fusion 
enzyme was 4.7-fold lower in ATCC 31749/pBQETY compared to ATCC 
31749/pBQET. The lower activity in the LacY-expressing strain is presumably due to 
lower expression of the fusion enzyme. Varying IPTG concentration revealed that the 
high fusion enzyme activity of ATCC 31749/pBQETY was achieved with low 
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concentrations of IPTG (Table 3.1). To determine if the lower fusion enzyme activity of 
ATCC 31749/pBQETY restricts Gal-α1,3-Lac production, 0.05 mM of IPTG was used 
for α-Gal epitope synthesis, as both ATCC 31749/pBQET and ATCC 31749/pBQETY 
have similar fusion enzyme activities at this IPTG concentration. The amount of Gal-
α1,3-Lac synthesized by the LacY-expressing strain was similar to that produced with 1 
mM IPTG; this was expected as the enzyme activity levels are very similar at both IPTG 
concentrations. Unexpectedly, the amount of Gal-α1,3-Lac produced by the ATCC 
31749/pBQET was similar for both 0.05 mM and 1 mM IPTG despite over a 5-fold 
reduction in fusion enzyme activity (Table 3.1). This suggests that the activity of the 
fusion enzyme is not a limiting factor in Gal-α1,3-Lac synthesis. With the higher 
concentration of intracellular lactose in ATCC 31749/pBQETY, the availability of UDP-






















Figure 3.4 Synthesis of Gal-α1,3-Lac after 150 hours by ATCC 31749/pBQET and 
ATCC 31749/pBQETY without and with rifampicin. Data are averages of three 
independent experiments with the standard deviation indicated by error bars. 
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3.3.3 Curdlan synthase knockout for improved UDP-glucose availability 
In addition to limitations imposed by low acceptor (lactose) availability, the 
amount of the sugar nucleotide, UDP-glucose, may also restrict α-Gal epitope synthesis 
by the GalE:α1,3-GalT fusion enzyme. Under the nitrogen-limited conditions of the 
synthesis reaction, the production of the α-Gal epitope competes with curdlan synthesis 
for the available UDP-glucose (Figure 3.1). To determine if UDP-glucose availability 
limits Gal-α1,3-Lac production, rifampicin was added to the synthesis reaction to prevent 
curdlan production. Since curdlan is only produced under nitrogen-limitation [19], it is 
suspected that the curdlan synthesis operon is only transcribed after exhaustion of the 
nitrogen source. Therefore, rifampicin, a transcription inhibitor, should prevent 
transcription of the genes responsible for curdlan synthesis during the production of Gal-
α1,3-Lac. The addition of rifampicin led to a 37% increase in Gal-α1,3-Lac synthesis in 
ATCC 31749/pBQETY (Figure 3.4), indicating that UDP-glucose availability may limit 
α-Gal epitope production. 
Curdlan, a β1,3-glucan polysaccharide, is not known to perform any essential or 
beneficial function for ATCC 31749. Therefore, by eliminating curdlan production, the 
amount of UDP-glucose available for α-Gal epitope synthesis will be increased without 
any detrimental impact on the cell. The gene responsible for the transfer of glucose from 
UDP-glucose to the growing curdlan polymer chain was previously determined to be 
curdlan synthase, crdS [20]. CrdS has been characterized and the nucleotide sequence 
reported, providing the necessary information required for gene knockout. 
This is the first reported attempt at gene knockout in Agrobacterium sp. strain 
ATCC 31749; however, successful gene knockout has been reported for a relative 
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organism, Agrobacterium tumefaciens. Gene knockout in A. tumefaciens employed the 
standard method of insertional mutagenesis via homologous recombination of a 
disruption cassette [21]. To determine an effective antibiotic resistance cassette for gene 
knockout, ATCC 31749 was tested for resistance against several antibiotics. Two 
antibiotics, gentamicin and tetracycline, were found to be effective at preventing ATCC 
31749 growth at concentrations greater than 50 µg/mL. Since the genome of A. 
tumefaciens contains several tetracycline resistance genes, gentamicin was selected for 
the antibiotic resistance cassette in the crdS knockout plasmid. Sequences homologous to 
the 5’ and 3’ ends of crdS (500 bp) were added to each side of the gentamicin resistance 
cassette to allow for homologous recombination. The resulting fragment was inserted into 
the pBluescript II (KS-) phagemid to give the crdS knockout plasmid, pBScrdShG 
(Figure 2C). After transformation of the crdS knockout plasmid into ATCC 31749, 
gentamicin-resistant colonies were screened using PCR for the presence of a 2236 kb 
fragment containing the interrupted crdS with gentamicin resistance cassette and the 
absence of the 1965 kb fragment corresponding to the intact crdS. A functional screening 
was also performed to confirm successful disruption of crdS, using aniline blue staining 
to detect curdlan production. The aniline blue dye binds to β1,3-glucan linkages in 
curdlan and produces a bright blue color [22]. In Figure 3.5, two candidate crdS mutants 
are compared to the wild type ATCC 31749 strain and a curdlan-deficient mutant 
produced via NTG mutagenesis, LTU265. The two crdS mutants show only a faint blue 
color, similar to LTU265, indicating curdlan synthesis was drastically reduced. As 
additional evidence for successful crdS knockout, ATCC 31749∆crdS was tested for the 
formation of curdlan gel. Heating an aqueous curdlan solution above 80°C and cooling 
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will lead to the formation of a curdlan gel [23]. The crdS mutant strain was cultivated in 
nitrogen-limited media to initiate curdlan production, yet the mutant did not form any 
visible curdlan gel after the requisite heating and cooling (data not shown). The cell 
growth profile for ATCC 31749∆crdS in LB media showed no deviation from the wild-
type strain, indicating that the crdS knockout did not effect cell growth (Figure 3.6). 
Since curdlan is not produced during cell growth, but rather, under nitrogen-limited 
conditions, the cell viability of ATCC 31749∆crdS was studied in minimal, nitrogen-free 
media. The cell viability of the crdS mutant under curdlan-producing conditions showed 
no significant difference from the wild-type strain (Figure 3.7). Therefore, curdlan 
production does not appear to contribute to cell survival under nitrogen-limited 




Figure 3.5 Aniline blue staining of curdlan. A: ATCC 31749; B: ATCC 31749∆crdS 











































ATCC 31749 ATCC 31749 ∆crdS
 
Figure 3.7 Cell viability of ATCC 31749 and ATCC 31749∆crdS in minimal, nitrogen-
free media. Data are averages of two independent experiments with the standard 
deviation indicated by error bars. 
 
 
To determine the effect of the curdlan synthase knockout on α-Gal epitope 
synthesis, ATCC 31749∆crdS was transformed with pBQET and pBQETY. ATCC 
31749∆crdS/pBQETY produced 0.96 g/L of Gal-α1,3-Lac (Figure 3.8), a concentration 
similar to that achieved with the addition of rifampicin (Figure 3.4). On the other hand, 
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ATCC 31749∆crdS/pBQET synthesized only 0.40 g/L of the α-Gal epitope, indicating 
that synthesis remains limited by lactose availability. Overall, both lactose and UDP-
glucose availability contributed to the low levels of Gal-α1,3-Lac produced by the initial 
engineered strain, ATCC 31749/pBQET. The construction of ATCC 
31749∆crdS/pBQETY, with increased levels of intracellular lactose and UDP-glucose, 
demonstrates the potential of ATCC 31749 as host for production of the α-Gal epitope. 
Requiring only a carbon source, the acceptor sugar, and a few essential nutrients (a 
phosphate source, buffer, and metal cofactors), the engineered Agrobacterium is capable 

























Figure 3.8 Synthesis of Gal-α1,3-Lac by ATCC 31749∆crdS/pBQET and ATCC 
31749∆crdS/pBQETY. Data points are averages of three independent experiments with 








3.4 Discussion and Conclusions 
 The whole-cell biocatalysts developed in this study provide a basis for an efficient 
and cost-effective means for large-scale production of the Gal-α1,3-Lac epitope. 
Enzymatic and whole-cell methods developed for α-Gal epitope synthesis face many 
obstacles including (1) low synthesis levels, (2) inefficient substrate transport across the 
cell membrane, and (3) expensive cofactors (Table 3.2). This work addresses all three of 
these issues. Host selection is a critical factor in determining product synthesis levels. To 
provide an adequate host for synthesis of the oligosaccharide, Gal-α1,3-Lac, a 
polysaccharide-producing microorganism was selected, Agrobacterium sp. ATCC 31749. 
This microorganism can produce up to 93 g/L of curdlan polysaccharide [24], 
demonstrating a natural proclivity for synthesizing the sugar nucleotide precursor, UDP-
glucose. With ATCC 31749 as the host, gram-scale quantities of Gal-α1,3-Lac were 
produced, demonstrating an advantage over traditional hosts such as E. coli. Insufficient 
uptake of substrate and acceptor sugars is yet another obstacle in whole-cell 
oligosaccharide synthesis. To enhance sugar uptake, other strategies have used 
permeablization techniques to weaken the cell membrane or have expressed additional 
enzymes to synthesize the acceptor sugar in vivo [12-14]. In this work, a lactose permease 
was introduced into the Agrobacterium host to increase uptake of the acceptor, lactose. 
This strategy increased lactose uptake without the undesirable consequences of cell 
permeablization techniques, leading to a 67% improvement in Gal-α1,3-Lac synthesis. 
The LacY-expressing Agrobacterium may also be used to synthesize other lactose-
containing oligosaccharides such as Globo-H, the major component of a vaccine for 
metastatic breast cancer [25]. Lastly, expensive cofactors are often added to enhance 
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production of the sugar nucleotide, including UDP, ATP, PEP, or even UDP-glucose 
itself. By deleting the gene responsible for curdlan synthesis, the efficient UDP-glucose 
synthesis pathway of the Agrobacterium host was exploited for α-Gal epitope synthesis, 
negating a need for expensive cofactors. Without the requirements of cell 
permeablization or cofactors, the engineered Agrobacterium developed in this work is a 
suitable biocatalyst for industrial-scale production of the α-Gal epitope, and with only 
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 While the Agrobacterium biocatalysts developed in this work have some 
advantages over other methods of α-Gal epitope synthesis, the amount of Gal-α1,3-Lac 
produced is lower than expected. The metabolic engineering strategies of lacY expression 
and crdS knockout resulted in only moderate improvements in α-Gal epitope synthesis. 
Based on the high levels of curdlan produced by ATCC 31749, the Agrobacterium host 
has the theoretical potential to produce over 270 g/L of the α-Gal epitope. Unfortunately, 
little is known regarding the mechanism and regulation of curdlan synthesis in ATCC 
31749. Perhaps, once this regulatory mechanism is elucidated, additional metabolic 
engineering could reveal the full potential of the Agrobacterium host for α-Gal epitope 
and oligosaccharide synthesis. Until this information is available, several other strategies 
may help improve Gal-α1,3-Lac production. Other reported methods of whole-cell α-Gal 
epitope synthesis utilize fermenters for either high cell density growth or both growth and 
the epitope synthesis reaction [12-14]. Large-scale fermentation may be particularly 
beneficial with the engineered Agrobacterium as high curdlan synthesis requires high 
levels of dissolved oxygen and pH control at pH 5.5 [26, 27]. Under these conditions, the 
engineered crdS mutant should produce high levels of UDP-glucose for Gal-α1,3-Lac 
synthesis. Unfortunately, initial fermentation attempts with the engineered 
Agrobacterium were unsuccessful due to low recombinant protein production. 
Chromosomal integration of the galE:α1,3galT fusion enzyme and expression using a 
natural host promoter may overcome the limited recombinant protein production to allow 
large-scale fermentation. Chromosomal integration of lacY may also improve α-Gal 
epitope production. As shown in Table 3.1, the addition of lacY to pBQET leads to nearly 
a 5-fold reduction in GalE:α1,3-GalT fusion enzyme activity. Through chromosomal 
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integration of lacY, lactose uptake will be improved while maintaining the high fusion 
enzyme activity of the pBQET strain. Lastly, expression of a sucrose synthase may 
increase UDP-glucose production. Sucrose synthase conserves cellular energy by directly 
converting sucrose and UDP to fructose and UDP-glucose, saving two energy equivalents 
for each molecule of UDP-glucose synthesized compared to the traditional UDP-glucose 
synthesis pathway (Figure 3.1). Sucrose synthase has been successfully used in both 
enzymatic and whole-cell production of α-Gal epitopes [10, 13]. Implementation of the 
additional strategies outlined in this discussion should generate a biocatalyst for 
economical, large-scale production of Gal-α1,3-Lac. 
 
3.5 Materials and Experimental Methods 
3.5.1 Materials 
 The chemicals used in this study were obtained from Sigma-Aldrich (lactose, 
K2HPO4·3H2O, and MnCl2·4H2O); Acros organics (aniline blue); V-labs, Inc. (Gal-α1,3-
Gal-β1,4-Glc); and Fisher (all other chemicals). 
3.5.2 Bacterial strains and plasmids 









Table 3.3 Bacterial strains and plasmids used in this study 
 
Strain or plasmid Description      Source 
 
ATCC 3179  Curdlan-producing Agrobacterium sp.  ATCC 
 
LTU265  ATCC 31749 locus II mutant with decreased B.A. Stone 
   curdlan production     V.A. Stanisich 
 
JM109   E. coli K12 strain used for lacY cloning  Promega 
 
ATCC 31749∆crdS ATCC 31749 with interrupted curdlan synthase This study 
   gene (crdS) 
 
pGEM-T easy  Vector used for gene cloning    Promega 
 
pBQ   Broad-host-range expression vector constructed [15] 
   for gene expression in ATCC 31749 
 
pET15b-αGalT Plasmid containing truncated bovine α1,3-  [11] 
   galactosyltransferase gene 
 
pT-α1,3-galT  pGEM-T easy vector containing truncated   This study 
   bovine α1,3-galactosyltransferase with BamHI 
   and SacI restriction sites 
 
pT-GalE  pGEM-T easy vector containing UDP-galactose  [15] 
   4’-epimerase (galE) from E. coli with a shor 
   linker sequence for fusion enzyme construction 
 
pTET   pGEM-T easy vector containing the galE:α1,3galT This study 
   fusion gene 
 
pBQET  pBQ with galE:α1,3galT for fusion enzyme   This study 
   expression in ATCC 31749 and  
ATCC 31749∆crdS 
 
pT-lacY  pGEM-T easy vector containing lactose permease This study 
   gene (lacY) from JM109 with SacI and XhoI  
restriction sites 
 
pBQETY  pBQ with galE:α1,3galT and lacY for expression  This study 
   of the fusion enzyme and E. coli lactose permease 
in ATCC 31749 and ATCC 31749∆crdS 
 
pT-crdS  pGEM-T easy vector containing curdlan synthase This study 
   gene (crdS) with SacI and KpnI restriction sites 
 
pT-crdSh  pGEM-T easy vector containing two 500 bp  This study 
   regions of homology to crdS with SacI/KpnI 
   and EcoRI /HindIII restriction sites 
 
pBluescript II (KS-) Phagemid for gene knockout in ATCC 31749 Stratagene 
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Table 3.3 Continued 
 
Strain or plasmid Description      Source 
 
pBScrdSh  pBluescript II (KS-) containing two 500 bp  This study 
   regions of homology to crdS with EcoRI and 
   HindIII restriction sites 
 
pYanni2  Plasmid containing a gentamicin resistance  [28] 
   cassette 
 
pT-GmR  pGEM-T easy vector containing gentamicin  This study 
   resistance cassette with EcoRI and HindIII 
   restriction sites 
 
pBScrdShG  crdS knockout plasmid; pBluescript II (KS-)  This study 
   containing a gentamicin resistance cassette flanked 
   by two 500 bp regions of homology to crdS 
 
 
3.5.3 Construction of pBQET and pBQETY for α-Gal epitope synthesis  
 A fusion enzyme containing the E. coli UDP-galactose 4’-epimerase (galE) and 
truncated bovine α1,3-galactosyltransferase (α1,3-galT) was constructed and inserted into 
the Agrobacterium expression vector, pBQ, to form pBQET for α-Gal epitope synthesis. 
The truncated bovine α1,3-galT was amplified from pET15b-αGalT [11]. The 5’ primer 
for α1,3-galT (5’-TCGGATCCATGGAAAGCAAGCTTAAGCTATC-3’) contains a 
BamHI site (in bold italics) and a start codon (underlined). The 3’ primer for α1,3-galT 
(5’-TCGAGCTCTCAGACATTATTTCTAACCACATT-3’) contains a SacI site (in bold 
italics) and a stop codon (underlined). The amplified α1,3-galT was inserted into the 
pGEM-T easy vector to form pT-α1,3-galT. The α1,3-galT fragment, obtained by double 
digestion with BamHI and SacI, was inserted into the respective restriction sites of the 
pT-GalE plasmid containing galE with a linker sequence [15]. Successful ligation of the 
α1,3-galT fragment to the digested pT-GalE yielded pTET, containing the galE:α1,3-
galT fusion gene for α-Gal epitope synthesis. The fusion gene fragment, obtained from 
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BglII and SacI digestions, was fused to the BamHI and SacI sites of pBQ. The resulting 
plasmid, pBQET, is shown in Figure 3.2A. 
 The lactose permease gene (lacY) was cloned from the genomic DNA of E. coli 
K12 strain JM109. The 5’ primer for lacY (5’-ACGAGCTCAAAGAGGAGAAAT 
TAACTATGTACTATTTAAAAAACACAAAC-3’) contains a SacI site (in bold italics), 
a ribosome binding site (underlined), and a start codon (in bold and underlined). The 3’ 
primer (5’-GTCTCGAGTTAAGCGACTTCATTCACCTG-3’) contains an XhoI site (in 
bold italics) and stop codon (underlined). The amplified lacY fragment was inserted into 
the pGEM-T easy vector, yielding pT-LacY. The lacY fragment, obtained by SacI and 
XhoI digestions, was ligated to the SacI and SalI sites of pBQET to form pBQETY 










Figure 3.2 Plasmids constructed in this study. A: pBQET, containing the galE:α1,3-galT 
fusion enzyme for Gal-α1,3-Lac synthesis; B: pBQETY, containing the galE:α1,3-galT 
fusion enzyme and lacY for Gal-α1,3-Lac synthesis and lactose uptake; C: pBScrdShG, 
containing homologous regions of crdS interrupted by a gentamicin resistance cassette 
for crdS knockout.  
 
3.5.4 Gene knockout of curdlan synthase (crdS) in ATCC 31749 
 The knockout plasmid for gene knockout of the curdlan synthase gene, crdS, was 
constructed using a gentamycin resistance cassette flanked on each side by 500 bp of 
homology to the curdlan synthase gene. The 5’ primer for crdS amplification (5’-CGGA 
GCTCATGTATTTCAGTGCTGAAGG-3’) contains a SacI site (in bold italics) and the 




TCACCCGAATGCCCGTGC-3’) contains a KpnI site (in bold italics) and crdS stop 
codon (underlined). The amplified crdS gene was inserted into the pGEM-T easy vector 
to produce pT-crdS. Using pT-crdS as template, the pGEM-T easy vector along with 500 
bp of homology at the 5’ end of crdS and 500 bp of homology at the 3’ end of crdS were 
amplified using phosphorylated primers. The 5’ primer (5’-pGGCCGAATTCTCGCAA 
TAGGTTCTTACCTC-3’) contains an EcoRI site (in bold italics) while the 3’ primer (5’-
pGGCAAGCTTTTCGTGACCCTGTCTTCGGC-3’) contains a HindIII site. The 
amplified pGEM-T easy vector with homologous regions of crdS was self-ligated to form 
pT-crdSh. pT-crdSh was digested using SacI and KpnI, and the resulting fragment 
containing crdS homology (crdSh) was inserted into the corresponding restriction sites of 
pBluescriptII (KS-), generating the plasmid pBScrdSh. The gentamicin resistance gene 
(GmR), along with its promoter and transcription terminator, was amplified from pYanni2 
[28]. The 5’ primer for GmR amplification (5'-CCGAATTCGTCTAGTGAGTAGTG 
GGTAC-3’) contains an EcoRI site (in bold italics), and the 3’ primer (5’-CGAAGCTT 
GCTTGCAAACAAAAAAACCACC-3’) contains a HindIII site. The amplified fragment 
containing GmR was inserted into the pGEM-T easy vector, forming pT-GmR. pT-GmR 
was digested using EcoRI and HindIII, and the fragment containing GmR was inserted 
into the corresponding restriction sites in pBScrdSh to form pBScrdShG (Figure 3.2C). 
The knockout plasmid, pBScrdShG, was transformed into ATCC 31749 using 
electroporation, followed by a 5 hour cultivation without antibiotics, and growth on 
LB/agar plates containing 50 µg/mL of gentamicin. The KO candidate colonies were 
grown four times in LB media at 30°C and 250 rpm to cure pBScrdShG.   
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3.5.5 Cell growth and GalE:α1,3GalT enzyme activity assay 
 ATCC 31749/pBQET, ATCC 31749/pBQETY, ATCC 31749∆crdS/pBQET, and 
ATCC 31749∆crdS/pBQETY inoculums were prepared at 30°C and 250 rpm in a culture 
tube with 4 mL of LB media containing 100 µg/mL of kanamycin and 100 µg/mL of 
ampicillin. The inoculums were diluted 500x and grown in 150 mL of freshly prepared 
LB media supplemented with antibiotics until an OD600 of 0.3 - 0.4 was reached, upon 
which IPTG was added to a final concentration of 1 mM. After IPTG addition, the cell 
culture was incubated at 30°C and 250 rpm for another 6 hours.  
For the enzyme activity assay, the induced cells were collected by centrifugation 
at 5,000 x g and 4°C for 2 min. The cell pellet was resuspended in a buffer containing 25 
mM Tris-HCl (pH 7.5), 10 mM MnCl2, 100 mM NaCl, and 0.25% Triton X to a final cell 
concentration of 20% wet wt/v. Using a Branson Mode 250 Sonifer, the mixture was 
sonicated 6 times for 15 second intervals with 1 min rest on ice. The lysates were 
centrifuged for 2 min at 10,000 x g at 4°C, and 50 µL of supernatant was added to the 
substrate mixture for the enzyme activity assay. The substrate mixture consists of 20 mM 
lactose (10 mM final concentration) and 8 mM of UDP-glucose (4 mM final 
concentration) in the enzyme activity buffer described previously. The assay was 
conducted at 30°C for 40 min followed by 10 min at 97°C to stop the reaction. The 
deactivated enzyme mixture was diluted 50x, and the Gal-α1,3-Lac product was analyzed 
using the protocol detailed below (3.4.8.2 Carbohydrate analysis). 
3.5.6 Cell viability  
ATCC 31749 and ATCC 31749∆crdS inoculums were prepared at 30°C and 250 
rpm in a culture tube with 4 mL of LB media containing 10 µg/mL of gentamicin for the  
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crdS  mutant. The inoculums were diluted 1000x and grown in 150 mL of freshly 
prepared LB media, supplemented with antibiotics for ATCC 31749∆crdS. After 12 
hours of growth in LB, the cells were collected by centrifugation at 3000 x g for 10 min 
at 4°C. The cell pellets were washed with 10% glycerol and then resuspended in 
nitrogen-free media. The nitrogen-free media consisted of 70 g/L sucrose, 1 g/L 
K2HPO4·3H2O, 5 g/L MgSO4·7H2O, 5 g/L sodium citrate, 1 g/L MnCl2·4H2O, and 50 
mM Tris-HCl (pH 7.5). The cells were cultivated in nitrogen-free media at 30°C and 250 
rpm in a biological shaker for 72 hours. Samples were taken at intervals of 12 hours and 
diluted using sterile LB media. The diluted cultures were spread on LB/agar plates, and 
colony forming units (cfu’s) were counted as a measure of cell viability. 
3.5.7 α-Gal epitope synthesis  
The induced cells were prepared as described in 3.4.5 Cell growth and GalE:α1,3-
GalT enzyme activity assay. The cells were then collected by centrifugation for 10 min at 
3,000 x g and 4°C. The cell pellets were washed once with sterile 10% glycerol, and then 
resuspended in the reaction media. The reaction media contained 50 g/L sucrose, 25 g/L 
lactose, 1 g/L K2HPO4·3H2O, 5 g/L MgSO4·7H2O, 5 g/L sodium citrate, 1 g/L 
MnCl2·4H2O, and 50 mM Tris-HCl (pH 7.5). The final cell concentration was 10% wet 
wt/v, and the reaction vessel was a 50 mL Erlenmeyer flask. The reaction vessel was 
placed in a biological shaker at 30°C and 250 rpm. Samples were centrifuged for 3 min at 
13,200 rpm. The supernatant was heated in boiling water for 10 min and then centrifuged 
again at 13,200 rpm for 3 min. The supernatant was appropriately diluted and analyzed as 
described in 3.4.8.2 Carbohydrate analysis. 
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3.5.8 Analytical techniques 
3.5.8.1 SDS-PAGE 
SDS-PAGE was used to confirm the successful expression of the GalE:α1,3-GalT 
fusion enzyme. JM109/pBQET was inoculated in 4 mL of LB media containing 100 
µg/mL of kanamycin and 100 µg/mL of ampicillin. After overnight growth at 37°C with 
250 rpm, 3 mL of the inoculum was transferred to 150 mL of LB media with antibiotics 
and grown at 37°C with 250 rpm. When an OD600 of 0.2 - 0.3 was reached, the cultures 
were induced with IPTG (final concentration 1 mM). Immediately after the addition of 
IPTG, the temperature was shifted to 25°C. After an induction period of 4 hours, the 
culture was centrifuged at 3,000 x g and 4°C for 10 min. The cell pellet was washed with 
0.4 M NaCl and collected by centrifugation. A buffer containing 100 mM Tris-HCl and 
100 mM NaCl (pH 8.0) with protease inhibitor cocktail (Sigma-Aldrich) was used to 
resuspend the cell pellet to a final concentration of 0.2 g/mL (wet weight). The cell 
suspension was sonicated 8 times for 10 second intervals with 1 min rest on ice. Cellular 
debris was removed by centrifugation at 3,000 x g and 4°C for 20 min. The GalE:α1,3-
GalT fusion enzyme was purified from the supernatant using a HIS select HF nickel 
affinity gel (Sigma-Aldrich). A 12% Tris-HCl gel (Bio-Rad) was used for SDS-PAGE to 
analyze the His-tag purified and soluble protein fractions. 
3.5.8.2 Carbohydrate analysis 
Diluted samples were analyzed using a Dionex BioLC system with a CarboPac 
PA20 analytical column. The Dionex ED50 electrochemical detector measured 
carbohydrate concentrations through pulsed amperometry (waveform:  t = 0.41 sec, p = -
2.00 V; t = 0.42 sec, p = -2.00 V; t = 0.43 sec, p = 0.60 V; t = 0.44 sec, p = -0.10 V; t = 
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0.50 sec, p = -0.10 V). Sucrose, lactose, and Gal-α1,3-Lac concentrations were 
determined using calibration curves prepared from standards. The mobile phase consisted 
of degassed 200 mM sodium hydroxide (A) and 18 MΩ-cm water (B), pressurized with 
inert gas (He) at a flow rate of 0.5 mL/min.  The following linear gradient was used for 
sucrose and lactose detection:  t = 0 min, 5:95 (A:B); t = 5 min, 5:95; t = 10 min, 20:80; t 
= 25 min, 20:80; t = 25 min, 100:0; t = 40 min, 100:0; t = 40 min, 5:95; t = 55 min, 5:95. 
The linear gradient for Gal-α1,3-Lac detection entails the following steps:  t = 0 min, 
30:70 (A:B); t = 35 min, 30:70; t = 35 min, 100:0; t = 50 min, 100:0; t = 50 min, 30:70; t 
= 60 min, 30:70. 
3.5.8.3 Intracellular lactose measurement 
 ATCC 31749/pBQET and ATCC 31749/pBQETY were prepared as described in 
3.4.7 α-Gal epitope synthesis. Samples (1 mL) were taken from both reaction vessels at 
34 and 45 hours after the start of the synthesis reaction and centrifuged for 5 min at 5,000 
x g and 4°C. The supernatant was removed and used for analysis of extracellular lactose 
and Gal-α1,3-Lac. The cell pellet was washed with 50 mM of Tris-HCl buffer (pH 7.5) 
and centrifuged a total of three times to remove any residual extracellular lactose. After 
washing, the cell pellet was resuspended in 600 µL of 50 mM Tris-HCl buffer (pH 7.5). 
The cells were disrupted using sonication (6 x 10 sec, 1 min rest on ice). Cell debris was 
removed by centrifugation, and the supernatant containing the intracellular lactose was 
heated for 10 min in boiling water to denature any proteins. After centrifugation, the 
sample was diluted 50x and analyzed as described in 3.4.8.2 Carbohydrate analysis to 
determine the amount of lactose in mmol. The intracellular volume was determined by 
taking another 1 mL sample and collecting the cell pellet by centrifugation. The cell 
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pellet was washed with DI water and centrifuged three times to remove any residual 
media. The wet weight of the cell pellet was measured, and then, the cell pellet was dried 
in an oven at 80°C until a constant dry weight was obtained. The difference in weight 
between the wet and dry cell pellets was used to calculate the intracellular volume. The 
intracellular lactose concentration was then calculated using the amount of lactose 
determined through carbohydrate analysis and the intracellular volume. 
3.5.8.4 Curdlan detection 
 The elimination of curdlan production in ATCC 31749∆crdS was detected using 
an aniline blue staining method [22]. Candidate colonies were streaked on LB/agar plates 
containing 0.005% aniline blue. The plates were incubated for 5 days at 30°C, and the 
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CITRATE STIMULATION OF OLIGOSACCHARIDE SYNTHESIS 
IN METABOLICALLY ENGINEERED AGROBACTERIUM SP. 
 
4.1 Abstract 
Agrobacterium sp. ATCC 31749 was previously shown to be an advantageous 
host for oligosaccharide production. Unexpectedly, the addition of citrate to the 
oligosaccharide synthesis reaction resulted in up to a 7-fold improvement in the 
production N-aceytllactosamine, a disaccharide. The possible mechanisms for this citrate-
induced stimulation of oligosaccharide production were investigated. The enhanced 
solubility of metal ions from citrate chelation was shown to have a negligible influence 
on oligosaccharide synthesis. Energy production from the metabolism of citrate proved to 
be a major contribution to the increase in oligosaccharide production, with other TCA 
cycle metabolites also having a stimulatory effect. ATCC 31749 was able to metabolize 
citrate along with sucrose, a preferred carbon source, and surprisingly, the consumption 
of sucrose was enhanced with the addition of citrate to the reaction. This phenomenon 
was not unique to sucrose, as glucose consumption also increased with the addition of 
citrate. The role of citrate as a buffer was also shown to be a major factor for enhanced 
oligosaccharide synthesis. Metabolic flux analysis revealed a dramatic increase in ATP 
for the citrate-containing reaction mixture, confirming the importance of energy for 
enhanced oligosaccharide production. Furthermore, the citrate stimulation of 
oligosaccharide synthesis was shown to be unique to Agrobacterium sp. ATCC 31749, as 
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a similarly engineered E. coli strain did not show significant improvement in 
oligosaccharide production with the addition of citrate.  
4.2 Introduction 
Oligosaccharides are important biomolecules, participating in various cellular 
processes, yet until recently, the significance of oligosaccharides in disease and other 
medical conditions has been largely overlooked. Currently, oligosaccharides are key 
components of potential vaccines and treatments for diseases including cancer, HIV, 
malaria, and anthrax [1-2]. While initial investigation of these treatments may show 
promise, they are often limited by the cost and difficulty of synthesizing the 
oligosaccharide component. Oftentimes, the oligosaccharides used in medical 
applications are naturally synthesized using enzymes, yet the sugar nucleotide cofactors 
required for enzymatic synthesis are also costly and challenging to produce. 
Alternatively, a whole cell synthesis strategy can produce the oligosaccharide from a 
cheap carbon source by generating the sugar nucleotide in vivo. Many efforts at whole 
cell oligosaccharide synthesis produced only small amounts of the desired 
oligosaccharide [3]. We have recently shown that using an unconventional bacterium, 
Agrobacterium sp., oligosaccharides can be synthesized at concentrations as high as 20 
mM [4].  
 In our previous work, Agrobacterium sp. ATCC 31749 was engineered to produce 
N-acetyllactosamine (LacNAc), a disaccharide basal structure found in antigens 
overexpressed on the surface of cancerous cells. While LacNAc synthesis was successful 
in the engineered Agrobacterium, the amount of LacNAc produced was dramatically 
improved by the addition of sodium citrate to the reaction medium. This work 
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investigates the possible mechanisms for the observed citrate stimulation of 
oligosaccharide synthesis in the engineered Agrobacterium. 
 Agrobacterium sp. ATCC 31749 is primarily studied for its production of curdlan, 
a β1,3-glucose polymer. Initial investigation of ATCC 31749 indicates the presence of 
the Entner Doudoroff and pentose phosphate pathways as well as the TCA cycle, yet little 
else is known about the bacterium’s metabolism [5]. ATCC 31749 has been shown to 
utilize citrate as a sole carbon source, presumably by the metabolism of citrate through 
the TCA cycle [6]. Since oligosaccharide synthesis requires a significant amount of 
energy, the energy generated from citrate consumption may explain the observed increase 
in oligosaccharide production. However, the oligosaccharide synthesis reaction includes 
sucrose, a preferred carbon source of ATCC 31749, which may prevent citrate uptake. 
Several other possible mechanisms may explain the citrate-induced stimulation of 
oligosaccharide production. Citrate is a known chelating agent, and as such, it may 
increase the solubility of metal ions in the reaction medium. Metal ions are important 
cofactors for many metabolic reactions. In particular, manganese is a cofactor for the 
β1,4-galactosyltransferase which synthesizes LacNAc [7]. An increase in manganese 
availability due to citrate chelation may explain the increase in oligosaccharide 
production. Citrate may also act as a buffer to control pH during oligosaccharide 
synthesis. This study investigates the possible mechanisms for the citrate stimulation of 
oligosaccharide production, utilizing metabolic flux analysis to gain insight about the 
effect of citrate on the entire metabolic network. Furthermore, we investigate whether the 




4.3.1 Citrate stimulation of oligosaccharide synthesis 
The addition of citrate to the reaction medium stimulated oligosaccharide 
synthesis in the engineered Agrobacterium strain, ATCC 31749/pKEL. To optimize the 
amount of citrate for oligosaccharide production, various concentrations of sodium citrate 
were added to the reaction buffer, ranging from 0 g/L to 10 g/L (Figure 4.1). The most 
dramatic improvement in oligosaccharide production was observed with the addition of 5 
g/L sodium citrate. Increasing the concentration of sodium citrate from 2 g/L to 5 g/L, a 
2.5-fold increase, led to nearly an equivalent improvement in oligosaccharide production, 
a 2.7-fold increase for LacNAc and a 2.4-fold increase for lactose. Doubling the 
concentration of sodium citrate to 10 g/L did not yield a similar increase in 
oligosaccharide production, indicating that an additional increase in citrate concentration 
will result in minimal improvement. The highest oligosaccharide concentrations were 
achieved with addition of 10 g/L sodium citrate, representing nearly a 7-fold 
improvement in LacNAc and over a 4-fold improvement in lactose production compared 



























Figure 4.1 Oligosaccharide production in ATCC 31749/pKEL with varying 
concentrations of sodium citrate. 
 
4.3.2 Mechanisms of citrate stimulation 
From the known biological and chemical functions of citrate as a carbon and 
energy source, chelating agent, and buffer, there are several possible mechanisms for the 
observed stimulation of oligosaccharide production in ATCC 31749/pKEL. These 
potential mechanisms were investigated to gain insight into oligosaccharide synthesis in 
the engineered Agrobacterium. 
4.3.2.1 Citrate as carbon source for energy production 
Past reports have indicated that Agrobacterium sp. can grow using citrate as the 
sole carbon source [6]. As an intermediate of the TCA cycle, citrate can be directly 
consumed to provide both cellular energy and the carbon building blocks for other 
important metabolites. Citrate concentrations throughout the oligosaccharide synthesis 
reaction were measured to determine if citrate is consumed. Nearly 40% of the initial 
amount of citrate was consumed by ATCC 31749/pKEL during oligosaccharide 
synthesis, indicating that citrate is utilized as a carbon and energy source (Figure 4.2). 
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Surprisingly, the consumption of citrate as a carbon source did not prevent the uptake of 
sucrose for oligosaccharide production. In fact, sucrose consumption increases by 79% 
with the addition of citrate. Many microorganisms possess strict catabolite repression 
systems, preventing the simultaneous uptake of two carbon sources. However, it appears 
that ATCC 31749 does not employ this type of regulation with regard to citrate 





























Sucrose - 0 g/L
Sucrose - 5 g/L
Citrate
 
Figure 4.2 Sucrose and citrate concentrations during oligosaccharide synthesis. Sucrose  
concentration in citrate-free reaction (■). Sucrose concentration in reaction containing 5 
g/L sodium citrate (□). Citrate concentration in reaction containing 5 g/L sodium citrate 
(*). 
 
To confirm that the energy produced from citrate consumption leads to increased 
oligosaccharide synthesis, several other metabolites in the TCA cycle were investigated 
as potential energy sources. Both α-ketoglutarate and succinate stimulated 
oligosaccharide synthesis, with approximately a 3-fold increase in LacNAc (Figure 4.3) 
and 2-fold increase in lactose (data not shown). The effect of α-ketoglutarate and 
succinate on oligosaccharide synthesis is not as dramatic as the effect of citrate, yet this is 
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to be expected since the energy yield from α-ketoglutarate (9 ATP equivalents) and 
succinate (5 ATP equivalents) is less than that from citrate (12 ATP equivalents). 
However, both α-ketoglutarate and succinate, like citrate, can serve as chelating agents 




















Figure 4.3 LacNAc synthesis in ATCC 31749/pKEL with addition of TCA cycle 
metabolites. Control with 0mM TCA cycle metabolites (□). Addition of 17mM citrate 
(■). Addition of 17mM α-ketoglutarate (▲). Addition of 17mM succinate (●). 
 
4.3.2.2 Citrate as chelating agent 
Many cellular enzymes require metal ions as cofactors, including the recombinant 
β1,4-galactosyltransferase (LgtB) from Neisseria meningitidis which is used for 
production of the β1,4-galactose-containing disaccharides in ATCC 31749/pKEL. 
Manganese (Mn2+) is an essential cofactor for LgtB activity, with magnesium (Mg2+) and 
calcium (Ca2+) substitutions yielding only half the activity observed with Mn2+ [8]. As a 
chelating agent, citrate may enhance the solubility of Mn2+ in the reaction medium, 
thereby increasing the intracellular concentration of Mn2+ available as cofactor for LgtB. 
Subsequently, the enhanced activity of LgtB may lead to higher production of the 
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disaccharides LacNAc and lactose. To test this theory, oligosaccharide production was 
measured using a manganese-free reaction buffer and a reaction buffer containing an 
alternative chelating agent, phytic acid (Figure 4.4). 
 
Figure 4.4 Chemical structure of phytic acid with manganese chelation. 
 
 
 When manganese, the preferred cofactor of LgtB, is eliminated from the reaction 
medium, the only available metal cofactor is magnesium. The magnesium ion will 
provide active LgtB, yet the activity will be reduced compared to that observed with 
Mn2+. With the manganese-free reaction medium, LacNAc synthesis was reduced from 
8.9 mM to 6.9 mM, and a similar decrease was observed for lactose. Despite this 
reduction, oligosaccharide synthesis is still more than 3-fold greater than that observed 
without citrate. This indicates that the citrate stimulation of oligosaccharide production is 
not solely due to increased manganese solubility. However, citrate may also influence 
magnesium solubility, requiring additional evidence to rule out chelation as a possible 
mechanism of the observed citrate stimulation. 
 Similar to citrate, phytic acid is a well-known chelating agent, yet unlike citrate, it 




























in previous fermentations for oligosaccharide synthesis, presumably due to its chelating 
ability [9-10]. Substituting phytic acid for citrate in the reaction medium yields 
oligosaccharide levels comparable to the control reaction, containing neither citrate nor 
phytic acid (Figure 4.5). These results indicate that citrate chelation does not contribute 


























Figure 4.5 Oligosaccharide synthesis with the addition of a chelating agent. 
 
4.3.2.3 Citrate as buffer 
As a weak acid, citrate may act as a buffer to maintain the pH at an optimal level 
for oligosaccharide synthesis. In fact, citrate is a common buffer for enzymatic studies 
[11]. Citrate may either control the extracellular pH of the reaction, or if transported into 
the cell, citrate may regulate intracellular pH. During the course of oligosaccharide 
synthesis, the pH of the reaction becomes more acidic with time. In an effort to maintain 
constant pH, a Tris-HCl buffer (pH 7.5) was added to the reaction medium. With the 
presence of this buffer, it is unlikely that the addition of citrate had a significant buffering 
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effect on the reaction. Nevertheless, the influence of citrate’s buffering capacity was 
investigated.  
First, the optimum pH for LacNAc synthesis was determined. The optimal pH for 
polysaccharide production in ATCC 31749 is pH 5.5 [12], yet the optimal pH ranges for 
the recombinant enzymes GalE and LgtB are pH 7-8 and pH 6.5-7.0, respectively [7, 13]. 
Therefore, the oligosaccharide synthesis reaction was conducted at constant pH levels of 
5.5, 6.0, 6.5, 7.0, and 7.5. At pH 6.0, ATCC 31749/pKEL synthesized the highest amount 
of LacNAc and lactose, indicating an optimum pH for oligosaccharide synthesis. 
Maintaining a constant pH of 6.0, ATCC 31749/pKEL was utilized for LacNAc synthesis 
both with and without the addition of citrate, and these results were compared reactions 
with no pH adjustment. 
Surprisingly, the buffering capacity of citrate had a significant influence on 
oligosaccharide production (Figure 4.6). Over 60% of the increase in LacNAc production 
with the addition of citrate can be accounted for by the buffering mechanism. During 
oligosaccharide production, the pH of the reaction drops precipitously at the beginning of 
the reaction, reaching a minimum after 16 hours. Without the addition of citrate, the pH 
falls to 4.8, while with citrate, the pH of the reaction is 5.4. This small change in pH 
clearly has a dramatic effect on enzyme activity and oligosaccharide production. The 
increase in sucrose consumption with the addition of citrate can also be attributed to the 
buffering effect. With pH adjustment, the rate of sucrose consumption is similar for both 
reactions, regardless of the presence of citrate. While the buffering mechanism is a 
significant contribution to citrate stimulation of oligosaccharide production, a 
considerable increase in oligosaccharide production remains even with pH adjustment. 
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This additional improvement may be due solely to the use of citrate as a carbon and 




















No citrate + pH
5 g/L citrate + pH
 
Figure 4.6 LacNAc synthesis by ATCC 31749/pKEL with and without citrate and pH 
adjustment. Conditions: 0 g/L sodium citrate, no pH adjustment (○); 5 g/L sodium citrate, 
no pH adjustment (●); 0 g/L sodium citrate with pH adjustment (□); 5 g/L sodium citrate 
with pH adjustment (■). 
 
4.3.3 Simultaneous uptake of multiple carbon sources 
With the ubiquitous evolution of catabolite repression mechanisms in bacteria, the 
simultaneous consumption of sucrose and citrate is an unexpected occurrence. To 
determine if this phenomenon is due to the specific combination of sucrose and citrate, 
glucose, an alternative carbon source, was tested with citrate for simultaneous 
consumption. ATCC 31749/pKEL consumed both glucose and citrate throughout the 
reaction, and similarly, oligosaccharide synthesis and glucose consumption increased 
with the addition of citrate (Table 4.1). However, the increase in oligosaccharide 
production is much higher when sucrose is used as the carbon source (4.5-fold increase) 
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than when glucose is employed (1.8-fold increase). This may be due to the fact that 
sucrose is a preferred carbon source of ATCC 31749. As evidence, the increase in 
sucrose consumption with the addition of citrate, a 79% increase, is greater than the 
increase in glucose consumption, a 55% increase. Overall, these results indicate that the 
simultaneous consumption of multiple carbon sources is not restricted to the use of 
sucrose, but instead, appears to be independent of the carbon source. 
 
Table 4.1 Oligosaccharide synthesis with different carbon sources 
 
Carbon       Sodium LacNAc Lactose Carbon source         Citrate 
Source1       citrate    (mM)   (mM)   consumed (mM)     consumed (mM) 
 
Sucrose      0 g/L 1.48 ± 0.58 2.47 ± 1.22 80.1 ± 9.62          N/A 
       5 g/L 8.93 ± 1.64 8.97 ± 1.56 143 ± 2.03          6.25 ± 2.04 
 
Glucose      0 g/L 0.74 ± 0.18 5.30 ± 0.08 58.4 ± 19.6          N/A 
        5 g/L 1.92 ± 0.33 8.93 ± 0.93 90.5 ± 18.1          4.64 ± 1.84 
 
1. The concentration of carbon source is 50 g/L. 
 
4.3.4 Metabolic flux analysis 
From the results presented above, it is apparent that the addition of citrate 
influences multiple pathways including oligosaccharide synthesis, energy production, and 
carbon uptake. Metabolic flux analysis was performed to gain further insight into the 
effect of citrate on the entire metabolic network of the cell. Metabolic flux analysis is a 
method for calculating the intracellular mass fluxes using the stoichiometric reactions of 
the cell’s metabolism and measured extracellular metabolites [14]. This method assumes 
a pseudo-steady state, where intracellular metabolites to not accumulate within the cell. 
The metabolic reaction network and equation used for the metabolic flux analysis are 
described in the materials and experimental methods section (5.4). 
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The first challenge in applying metabolic flux analysis is to determine which 
pathways are active during the oligosaccharide synthesis reaction. Previous experimental 
results indicate the Entner-Doudoroff (ED) pathway is utilized for sugar metabolism in 
Agrobacterium sp. [5]; therefore, this pathway was included in the metabolic network. 
The primary purpose of the pentose phosphate pathway is to produce reducing 
equivalents for anabolic reactions and to provide the cell with ribose-5-phosphate for 
synthesis of nucleotides. Under the conditions of the oligosaccharide synthesis reaction, 
both anabolic reactions and the need for nucleotides are minimal, allowing the pentose 
phosphate pathway to be excluded from the metabolic network. The oxygen level during 
oligosaccharide synthesis is a major influence on the metabolic network. The synthesis 
occurs under agitation, which provides a supply of oxygen; however, high cell 
concentration may lead to anaerobic conditions. To determine the oxygen status, the 
oligosaccharide synthesis reaction was conducted in a fermenter under two conditions: 1) 
dissolved oxygen controlled at 10% (aerobic) and 2) no air flow (anaerobic). Under 
aerobic conditions, the substrate, GlcNAc, was rapidly consumed as a nitrogen source for 
cell growth, resulting in no oligosaccharide synthesis. Under anaerobic conditions, very 
little carbon source was utilized, and oligosaccharide synthesis was minimal. These 
results suggest that oligosaccharide synthesis occurs under microaerobic conditions: 
oxygen is supplied to provide energy for oligosaccharide production, yet the oxygen level 
is too low to allow for the consumption of GlcNAc as a nitrogen source. To confirm that 
the anaerobic metabolism is active, the supernatant was analyzed for common anaerobic 
products, including lactate, acetate, ethanol, and succinate. Evidence of acetate 
production was found, and this anaerobic pathway was added to the metabolic network 
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along with the TCA cycle for aerobic respiration. To the best of our knowledge, this is 
the first report of anaerobic metabolism in ATCC 31749. Combining the oligosaccharide 
synthesis, ED, and acetate production pathways with the glyoxylate and TCA cycles 
provides the basic metabolic network for ATCC 31749 during oligosaccharide synthesis. 
In metabolic flux analysis, the metabolic fluxes are assumed to be pseudo-steady 
state. In reality, however, fluxes are rarely pseudo-steady state, and metabolites 
frequently accumulate within the cell. Several metabolites were found to accumulate 
during oligosaccharide synthesis, namely glucose and fructose. Additional reactions were 
added to the metabolic network to account for the accumulation of these sugars. 
Furthermore, ATCC 31749 was found to consume the residual glycerol remaining from 
the wash step of cell preparation, and subsequently, the metabolic network was altered to 
reflect this additional carbon source. (See the Appendix A for a list of all reactions 
included in the network.) 
With the metabolic network established, metabolic flux analysis was performed 
using fluxes measured from oligosaccharide synthesis reactions with and without the 
addition of citrate. (See Appendix A for calculations.) Figures 4.3 and 4.6 show three 
distinct phases within the LacNAc synthesis reaction. In the first phase (0-12 hours), both 
reactions, with and without citrate, synthesize LacNAc, and a negligible amount of citrate 
is consumed during this phase. In the second phase (12-60 hours), citrate is consumed, 
allowing the citrate-containing reaction mixture to continue LacNAc synthesis, while 
synthesis no longer occurs in the citrate-free reaction. In the third phase (60 – 120 hours), 
sucrose and citrate consumption slowly decrease for the citrate-containing reaction 
mixture, leading to a lower rate of oligosaccharide synthesis. Because the fluxes are very 
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similar during the first phase and the fluxes are not constant in the third phase, only the 
second phase will be compared using metabolic flux analysis. The results from this 
analysis are shown in Table 4.2, with the fluxes corresponding to the metabolic network 
in Figure 4.7. The citrate-containing reaction has higher rates of consumption for both 
sucrose and glycerol. In fact, no glycerol is consumed in the citrate-free reaction. The 
high rate of carbon consumption leads to a higher flux through the ED pathway, nearly a 
400% increase compared to the citrate-free reaction, but surprisingly, the production of 
acetate only increased by 47%. Instead, the increased flux from the ED pathway was 
directed through the TCA cycle, leading to over a 6-fold increase in ATP production. 
This high rate of ATP generation may be responsible for the increase in oligosaccharide 
synthesis in the citrate-containing reaction. As expected, the flux through the glyoxylate 
cycle is negligible for both reactions since the glyoxylate cycle is primarily used for 










Table 4.2 Metabolic flux analysis2 
 
Flux Enzyme(s)      Citrate-free 5 g/L sodium  
               citrate  
 
v1* sucrose hydrolase            19         100 
v2* glucose accumulation              3.3          24 
v3* fructose accumulation              4.3            8.8 
v4 glucokinase             16           73 
v5 fructokinase             15           91 
v6 phosphoglucose isomerase           15           90 
v7 phosphoglucomutase             -0.08            9.0 
v8 UTP glucose-1-phosphate uridylyltransferase         -0.08            9.0 
v9* curdlan synthase              0.39            0.44 
v10 UDP-galactose 4’-epimerase            -0.47            8.6 
v11* β1,4-galactosyltransferase (glucose as substrate)         -0.23            3.6 
v12* β1,4-galactosyltransferase (GlcNAc as substrate)         -0.17            3.3 
v13* β1,4-galactosyltransferase (mannose as substrate)         -0.07            1.6 
v14 glucose-6-phosphate dehydrogenase; 6-phospho-        31         153 
               glucolactonase 
v15 6-phosphogluconate hydrolase; 2-keto-3-deoxy-         31         153 
   gluconate aldolase 
v16 glycerol-3-phosphate dehydrogenase           -3.5          24 
v17* glycerol kinase             -3.5          24 
v18 glyceraldehyde-3-phosphate dehydrogenase;         27         177 
   phosphoglycerate kinase; phosphoglycerate mutase;  
   pyruvate kinase 
v19 pyruvate dehydrogenase           58         330 
v20* acetyl-CoA synthetase           17           25 
v21 citrate synthase            41         308 
v22* citrate uptake               0             2.8 
v23 aconitase             41         310 
v24 isocitrate dehydrogenase          41         314 
v25 α-ketoglutarate dehydrogenase complex         41         314 
v26 succinyl-CoA synthetase          41         314 
v27 succinate dehydrogenase; fumarase          41         311 
v28 malate dehydrogenase           41         308 
v29 isocitrate lyase; malate synthase            0           -2.8 
v30 oxidative phosphorylation (NAD/NADH)        205      1466 
v31 oxidative phosphorylation (FAD/FADH2)          41        311 
v32 maintenance energy (ATP consumption)        784      5516 
 
2. Values normalized based on sucrose consumption in the 5 g/L sodium citrate reaction. 





Figure 4.7 Metabolic network for ATCC 31749/pKEL. Metabolic fluxes are indicated by 
vi with i = 1 to 32. Fluxes v10 – v13 make up the engineered pathway for oligosaccharide 
synthesis, while all other fluxes are native to ATCC 31749. 
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4.3.5 Citrate effect unique to Agrobacterium sp. 
To determine if the citrate stimulation of oligosaccharide synthesis is unique to 
Agrobacterium sp., an engineered Escherichia coli strain, AD202/pMUEL, was also 
tested. Oligosaccharide synthesis in this E. coli strain increased slightly with the addition 
of citrate (Table 4.3), yet this 30% increase is insignificant compared to the 350% 
improvement observed with the engineered Agrobacterium strain. Furthermore, citrate 
consumption by AD202/pMUEL is negligible throughout the synthesis reaction, and 
glucose consumption is similar for both the citrate-free and citrate-containing reactions. 
Based on these results, the citrate effect appears to be a unique property of 
Agrobacterium sp. ATCC 31749. 
 
Table 4.3 Oligosaccharide synthesis and carbon consumption in AD202/pKEL with and 
without citrate addition 
 
     citrate-free   5 g/L sodium citrate 
 
LacNAc (mM)   0.30 ± 0.02  0.40 ± 0.01 
Lactose (mM)    0.09 ± 0.05  0.12 ± 0.06 
Glucose consumed (mM)  165 ± 15  180 ± 8.7 
Citrate consumed (mM)  N/A   2.89 ± 0.33 
 
 
4.4 Discussion and Conclusions 
 
From the results presented in this study, it appears that the citrate-induced 
stimulation of oligosaccharide synthesis in ATCC 31749/pKEL is due to two primary 
mechanisms: 1) the consumption of citrate as a carbon and energy source and 2) pH 
maintenance due to the buffering capacity of citrate. While metal ions are important 
cofactors for oligosaccharide synthesis, citrate chelation does not appear to be significant.  
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 A major finding of this work is the simultaneous uptake and utilization of 
multiple carbon sources by the engineered Agrobacterium sp. In many bacteria, catabolite 
repression prevents the simultaneous uptake of multiple carbon sources, making the co-
metabolism of sucrose and citrate in ATCC 31749 a unique property. Only a few other 
bacterial species have been found to co-metabolize citrate and another carbon source. 
Microorganisms from the Enterococcus, Leuconostoc, Lactobacillus, and Lactococcus 
genera have been identified which can simultaneously utilize citrate and another carbon 
source such as glucose or lactose [16-21]. Most of these bacteria are grown under 
anaerobic or microaerophilic conditions, similar to the microaerobic conditions used for 
oligosaccharide synthesis with ATCC 31749/pKEL. Unlike ATCC 31749, these other 
citrate co-metabolizing organisms are all members of the Lactobacillales order. Several 
Pseudomonas species also co-metabolize citrate along with other carbon sources [22-23], 
yet to the best of our knowledge, this is the first report of multiple carbon source 
utilization by a member of the Rhizobiaceae family.  
 The synthesis of oligosaccharides in ATCC 31749/pKEL is an energy-intensive 
process, requiring two high-energy compounds, ATP and UTP, for each glycosidic 
linkage. The utilization of citrate by the TCA cycle provides additional energy for 
oligosaccharide production, with each citrate molecule generating 12 molecules of ATP 
for each turn through the TCA cycle. Assuming each citrate molecule goes through one 
complete turn of the TCA cycle, the consumption of 65 µmol of citrate would produce 
780 µmol of ATP. The measured increase in oligosaccharide production due to citrate 
stimulation is 140 µmol, requiring 280 µmol of ATP. Thus, the energy required for 
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increased oligosaccharide production (280 µmol) can be completely accounted for by the 
ATP generated from citrate consumption (780 µmol). 
Metabolic flux analysis revealed a large increase in the maintenance energy flux 
with the addition of citrate. The high maintenance energy flux, v32, indicates that other 
ATP-consuming reactions may be active during oligosaccharide synthesis. For example, 
carbon uptake may occur via active transport. Close relatives of ATCC 31749, A. 
radiobacter and A. tumefaciens, are reported to use active transport for the uptake of 
glucose, galactose, fructose, xylose, and lactose [24-28]. It is likely that ATCC 31749 
transports sucrose in a similar manner, requiring the use of ATP as an energy source.  
This method of sucrose transport may also explain the lack of carbon catabolite 
repression (CCR) in ATCC 31749 when both sucrose and citrate are present, for most 
bacterial CCR systems are associated with PTS-mediated sugar transport [29]. Assuming 
sucrose uptake does occur via active transport, this would only account for less than 3% 
of the citrate-induced increase in maintenance energy. Acidocalcisomes are another 
possible source of ATP consumption. Acidocalcisomes are intracellular organelles 
containing high amounts of inorganic polyphosphate (polyP), and these organelles are 
known to be produced in A. tumefaciens, a close relative of ATCC 31749 [30]. 
Furthermore, the genome sequence of ATCC 31749 contains two polyphosphate kinases 
for polyP synthesis, two exopolyphosphatases for polyP degradation, and a membrane-
bound proton-translocating pyrophosphatase, enzymes shown to be associated with the 
acidocalcisomes of A. tumefaciens. Therefore, it is likely that ATCC 31749 also produces 
acidocalcisomes, requiring large quantities of ATP to produce polyP. The use of ABC 
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transporters for sucrose uptake and the storage of polyP in acidocalcisomes may explain 
the high maintenance energy flux for the citrate-containing reaction. 
4.5 Materials and Experimental Methods 
4.5.1 Materials 
The chemicals used in this study were obtained from Sigma-Aldrich (lactose, 
LacNAc, GlcNAc, ATP, methyl blue), Mallinckrodt (glucose), Wako Chemicals USA 
(curdlan), and Fisher (all other chemicals). 
4.5.2 Bacterial strains 
The Agrobacterium sp. and E. coli strains used in this study, ATCC 31749/pKEL 
and AD202/pMUEL, were previously constructed [4, 31]. 
4.5.3 Oligosaccharide synthesis 
The ATCC 31749/pKEL inoculums were prepared by overnight incubation at 
30°C with agitation of 250 rpm in 3 mL of LB containing 100 µg/mL ampicillin and 100 
µg/mL kanamycin. The cells were diluted 100 times and grown in freshly prepared LB 
medium supplemented with antibiotics until OD600 reached 0.3-0.4, upon which, IPTG 
was added to a final concentration of 0.75 mM, and cells were incubated for another 6 
hours. The cells were harvested by centrifugation at 3,000 g and 4°C for 10 minutes. 
Cells were washed once with 10% glycerol prior to addition of the reaction buffer. The 
10 mL reaction buffer contained 50 mM Tris-HCl (pH 7.5), 1 g/L K2HPO4•3H2O, 5 g/L 
MgSO4•7H2O, 5 mM MnCl2, 50 g/L sucrose (or glucose for E. coli strain), 10 g/L 
GlcNAc, and varying concentrations of sodium citrate. The cell concentration was 10% 
(wet weight), and the reaction vessel was a 50 mL flask. The reaction was carried out at 
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30ºC (or 25°C for E. coli) and 250 rpm in a biological shaker. For reactions with constant 
pH, HCl or NaOH were added every 2 hours to adjust the pH to the target level. 
For reactions conducted in the Multifors fermenter system, two 150 mL 
inoculums were prepared as described above. These were concentrated to 50 mL by 
centrifugation at 3,000 g and 4°C for 10 minutes, followed by resuspension of the cell 
pellet. The 50 mL inoculums were added to 450 mL of sterilized LB media in the 500 mL 
fermenter vessels. The growth conditions include agitation at 600 rpm, an air flowrate of 
0.5 vvm, temperature of 30°C, and pH 7.0. The pH was controlled using 1 M NaOH and 
1 M HCl. Once the fermenter cultures reached an OD600 of 0.9, IPTG was added to a final 
concentration of 1 mM. After 10 hours of induction, the cells were collected by 
centrifugation. The cell pellets were resuspended in 300mL of sterile reaction buffer 
(described above). The reaction conditions for the fermenter are the same as the growth 
conditions with the following exceptions: pH was adjusted to 5.5, and there was no air 
flow for the anaerobic reaction. 
4.5.4 Analytical methods 
4.5.4.1 Carbohydrate analysis 
Samples were heated in boiling water for 10 min. The supernatant was obtained 
by centrifugation and analyzed using a Dionex BioLC system with a CarboPac PA20 
analytical column. The Dionex ED50 electrochemical detector measured carbohydrate 
concentrations through pulsed amperometry (waveform:  t = 0.41 sec, p = -2.00 V; t = 
0.42 sec, p = -2.00 V; t = 0.43 sec, p = 0.60 V; t = 0.44 sec, p = -0.10 V; t = 0.50 sec, p = 
-0.10 V). Sucrose, glucose, fructose, lactose and LacNAc concentrations were determined 
using calibration curves prepared from standards.  The mobile phase consisted of 
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degassed 200 mM sodium hydroxide (A) and 18 MΩ-cm water (B), pressurized with 
inert gas (He) at a flow rate of 0.5 mL/min.  The following linear gradient was used for 
LacNAc and lactose detection:  t = 0 min, 5:95 (A:B); t = 5 min, 5:95; t = 10 min, 20:80; 
t = 25 min, 20:80; t = 25 min, 100:0; t = 40 min, 100:0; t = 40 min, 5:95; t = 55 min, 5:95. 
The following linear gradient was used for sucrose, glucose, and fructose detection:  t = 0 
min, 16:84 (A:B); t = 40 min, 16:84; t = 40 min, 100:0; t = 55 min, 100:0; t = 55 min, 
16:84; t = 70 min, 16:84. 
4.5.4.2 Citrate measurement 
Samples (300 µL) were centrifuged at 13,200 rpm for 3 minutes. The supernatant 
was appropriately diluted, and citrate concentrations were measured using the pyridine-
acetic anhydride method outlined by Marier and Boulet [32]. A Beckman Coulter DU 
530 Life Sciences UV/Visible spectrophotometer was used for measurement. 
4.5.4.3 Acetate and glycerol measurement 
Samples (100 µL) were centrifuged at 13,200 rpm and 4°C for 10 min. A 10 % 
solution of trichloroacetic acid (100 µL) was added to 50 µL of the supernatant. The 
sample was placed on ice to allow for protein precipitation. After 10 min, the sample was 
centrifuged at 13,200 rpm and 4°C for 10 min. The supernatant was analyzed using an 
Agilent 1100 series HPLC with a 59346 Supelcogel H HPLC column. The mobile phase 
was a 0.1% (w/v) phosphoric acid solution. Analysis was performed using an isocratic 
program with a flowrate of 0.17 mL/min and a duration of 60 min.  
4.5.4.4 Curdlan measurement 
Samples for curdlan measurement were prepared using a standard method of 
curdlan isolation and dissolving the precipitated curdlan in 1 M NaOH  [33]. Because 
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curdlan concentrations were below the level detectable by the common dry cell weight 
measurement, a more sensitive aniline blue assay for detecting β1,3-glucan was used [34-
35]. Since aniline blue is very light sensitive, this assay was performed in the dark to 
prevent photobleaching. The microplate reader of a Molecular Devices SpectraMax M5 
spectrophotometer was used for measurement, and for this instrument, the optimum 
excitation and emission wavelengths were determined to be 400 nm and 498 nm, 
respectively with a cutoff of 475 nm.  
4.5.5 Metabolic flux analysis 
The metabolic network for metabolic flux analysis was generated from the 
genome sequence of ATCC 31749 (to be described in a future publication) and from 
biochemical evidence found in the literature [36-38]. The specific pathways included in 
the metabolic network are discussed in the results. Overall, the network consists of thirty-
two metabolic reactions and twenty-five metabolites. The metabolic reactions are listed in 
the appendix. Ten metabolic fluxes were measured (indicated in Appendix A), yielding 
an overdetermined system of equations. Using MATLAB, the system of equations was 
solved by applying the following equation: 
   A = -(inv(C*C’)*C)*M’*V     (1) 
where A is a vector of calculated intracellular fluxes, C is the stoichiometric matrix of 
intracellular metabolic fluxes, M is the stoichiometric matrix of measured metabolic 
fluxes, and V is a vector of measured metabolic fluxes. 
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CHAPTER 5 
GENOME SEQUENCING OF AGROBACTERIUM SP. ATCC 31749 
 
5.1 Abstract 
 Agrobacterium sp. ATCC 31749 is an important industrial microorganism for its 
production of the natural polysaccharide known as curdlan. Our previous work has also 
shown this organism to be a good host for the production of valuable oligosaccharides for 
medical applications. Despite the importance of ATCC 31749 for poly- and 
oligosaccharide production, very little is known regarding the genetic composition of this 
organism. In this study, the genome sequence of ATCC 31749 is obtained using the 
Genome Sequencer FLX system from 454 Life Sciences. Subsequent assembly, gene 
prediction, and annotation resulted in a genome size of 5.4 Mb with 5,585 predicted 
genes and metabolic pathways including the Entner-Doudoroff and pentose phosphate 
pathways as well as the TCA and glyoxylate cycles. Comparative genomics showed 
ATCC 31749 to be highly homologous to the plant pathogen Agrobacterium tumefaciens, 
with 87% of genes having homologs in A. tumefaciens. Lastly, genes were identified 
which may contribute to the regulation of curdlan synthesis, including those involved in 
exopolysaccharide, nitrogen-limited, oxygen-limited, and phosphate-limited regulation as 
well as genes important for energy production. 
5.2 Introduction 
 The parent strain of Agrobacterium sp. ATCC 31749 was first isolated from a soil 
sample in 1964 by Harada and Yoshimura [1], and this microorganism was studied for its 
ability to produce two polysaccharides, succinoglycan and curdlan. After several 
 130
spontaneous mutations, the curdlan-producing strain, ATCC 31749, was isolated [2] (see 
Chapter 1, section 1.3.2 History of ATCC 31749, for details). Since its isolation in 1983, 
ATCC 31749 has primarily been used for the production of the curdlan polysaccharide. 
Curdlan itself is used in a wide variety of commercial applications, ranging from a 
thickener and gelling agent in the food industry to an additive in the production of 
superworkable concrete [3]. Curdlan and its derivatives have also been applied in the 
medical industry as a drug release vehicle, anticoagulant, HIV treatment, and anti-tumor 
agent [4, 5]. With the wide range of applications and extensive use of curdlan, Takeda 
Chemical Industries Ltd., a commercial provider of curdlan, produces 600 to 700 tons of 
curdlan annually [3]. The economical production of curdlan from ATCC 31749 and its 
close relatives enables the use of curdlan in applications ranging the relatively low-value 
products of the food industry to traditionally high-cost medical applications such as HIV 
treatments. 
 In more recent work, ATCC 31749 was employed for a process other than curdlan 
production. We have shown that ATCC 31749 can be successfully engineered to produce 
medically-relevant oligosaccharides, namely LacNAc and Gal-α1,3-Lac, and a 
polysaccharide, hyaluronan [6, 7] (Chapters 2 and 3). These oligo- and poly-saccharides 
are essential components of medical treatments including vaccines for the flu, HIV, and 
cancer, as well as treatment for inflammation and applications in surgical procedures. 
ATCC 31749 was selected as host for the whole-cell production of oligo- and poly-
saccharides due to its high rate of curdlan production. Curdlan, a glucose polymer, is 
synthesized from UDP-glucose in ATCC 31749, and the high rate of curdlan production 
requires a high rate of UDP-glucose synthesis in this microorganism. The sugar 
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nucleotide UDP-glucose is also a precursor for UDP-galactose, the substrate for 
synthesizing the LacNAc and Gal-α1,3-Lac oligosaccharides, and UDP-glucuronic acid, 
a precursor for hyaluronan synthesis. Based on this reasoning, the high UDP-glucose 
production of ATCC 31749 can be exploited for oligosaccharide synthesis with the 
addition of only one or two enzymes. While the initial engineering of ATCC 31749 
yielded modest amounts of the oligo- and polysaccharide products (7.5 g/L LacNAc, 1 
g/L Gal-α1,3-Lac, and 0.3 g/L hyaluronan), a high production rate is required for 
industrial-scale synthesis. Further improvement of oligo- and poly-saccharide production 
in ATCC 31749 will require additional metabolic engineering. 
 The production of oligo- and polysaccharides in ATCC 31749 may be enhanced 
by modifying the genes involved in curdlan synthesis and regulation. Unfortunately, little 
is known regarding the genetics of ATCC 31749 and curdlan production. Initial 
investigation of ATCC 31749 identified 5 genes as important for curdlan production [8]. 
A phosphatidylserine synthase, which produces a component of the cell membrane, was 
shown to impact curdlan synthesis [9]. In addition, three genes of unidentified function, 
crdA, crdC, and crdR, were also necessary for producing curdlan. The fifth gene, curdlan 
synthase (crdS), was determined to be the enzyme catalyzing the transfer of the glucose 
residue from UDP-glucose to the growing polymer chain of curdlan [10]. Of these 5 
genes, only one gene sequence is reported, that of the curdlan synthase. Based on the 
nucleotide sequence, Stanisich and coworkers suspect that crdR is somehow involved in 
regulating curdlan synthesis, but no additional information is known about the genes 
involved in the regulation of curdlan production [11]. These regulatory genes are primary 
targets for future metabolic engineering to improve oligo- and polysaccharide production 
 132
in ATCC 31749. The primary metabolic pathways of ATCC 31749 are also likely to 
impact curdlan synthesis. Biochemical studies have indicated that the Entner-Doudoroff 
pathway, TCA cycle, and pentose phosphate pathway are active in ATCC 31749 [12, 13]. 
However, the genetics of these pathways have not been confirmed and many of the 
organism’s metabolic pathways remain unknown. Future improvement of oligo- and 
polysaccharide production by ATCC 31749 requires additional genetic information 
regarding the metabolism of ATCC 31749 as well as the identification of genes involved 
in regulating curdlan production. 
5.3 Results 
5.3.1 ATCC 31749 genome sequence and annotation 
The genomic DNA of Agrobacterium sp. ATCC 31749 was isolated and 
sequenced according to the protocol described in the methods section (5.4). A total of 
92,994,272 base pair (bp) were sequenced in 399,219 reads, with an average read length 
of 233 bp. The read length distribution, as illustrated in Figure 5.1, indicates good quality 
sequencing results, with the majority of reads falling between 220 to 270 bp. The GS De 
Novo Assembler from 454 Life Sciences assembled the reads into 176 contigs with an 
average contig size of 31,122 bp. The genome sequence assembly gives an approximate 
genome size of 5.5 Mbp with 59% GC content and approximately 16 x sequence 
coverage. The 176 contigs were arranged in random order with stop codons inserted 
between each contig to generate a pseudochromosome, and this pseudochromosome was 
used for gene prediction and annotation. The pseudochromosome of ATCC 31749 
includes 5,585 predicted genes, of which 3,466 have assigned function, 1,635 are 
conserved hypothetical proteins, and the remaining 484 are hypothetical proteins. 
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Analysis of transfer RNA’s identified tRNA genes for each of the 20 amino acids, often 
with multiple genes for the same amino acid (Table 5.1). The tRNA distribution is similar 
to other Agrobacterium species, yet as shown in Table 5.1, this distribution differs 
significantly from other organisms like E. coli. In general, E. coli K12 has more tRNA 
genes, which may explain why recombinant protein production is higher in E. coli 
compared to Agrobacterium. Using the ribosomal RNA sequences from other 
Agrobacterium as template, the 5S, 6S, 16S, and 23S rRNA genes were located in ATCC 
31749.  
 















Table 5.1 tRNA gene distribution in ATCC 31749 genome sequence compared to an E. 
coli K12 strain. 
 
tRNA     ATCC 31749     E. coli K12 tRNA    ATCC 31749    E. coli K12 
 
Ala  2  5  Leu  5  8 
 
Arg  3  7  Lys  2  6 
 
Asn  1  4  Met  3  6 
 
Asp  2  3  Phe  1  2 
 
Cys  1  1  Pro  3  3 
 
Gln  2  4  Ser  4  5 
 
Glu  2  4  Thr  3  4 
 
Gly  4  6  Trp  1  1 
 
His  1  1  Tyr  1  3 
 
Ile  1  5  Val  2  7 
 
 
The genome sequence and annotation were uploaded into the Pathway Tools 
software for operon and metabolic pathway prediction. An overview of the predicted 
metabolic pathways is shown in Figure 5.2. This includes the Entner-Doudoroff (ED) 
pathway for glycolysis, the pentose phosphate pathway (PPP) for regeneration of 
reducing equivalents, and the tricarboxylic acid (TCA) and glyoxylate cycles for energy 
generation. Genetic evidence of these metabolic pathways confirms previous pathway 
predictions based on biochemical evidence [12, 13]. Unexpectedly, there are also genes 
present for a functional Embden-Meyerhof-Parnas (EMP) pathway for glycolysis. ATCC 
31749 lacks a major enzyme of the EMP pathway: phosphofructokinase, the enzyme 
typically used to catalyze the conversion of fructose-6-phosphate to fructose-1,6-
bisphosphate with concomitant consumption of ATP. However, the genome does contain 
a pyrophosphate-fructose-6-phosphate 1-phosphotransferase gene which catalyzes the 
same conversion yet uses pyrophosphate (PPi) instead of ATP for the phosphorylation. 
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Despite possessing genes for a functional EMP pathway, experimental evidence shows 
that ATCC 31749 utilizes the lower energy-yielding ED pathway for glycolysis [12].  
The ATCC 31749 genome also revealed genetic evidence to support other 
experimental observations. Sucrose has been shown to be a preferred carbon source of 
ATCC 31749, with higher levels of curdlan produced with sucrose as the carbon source 
compared to other sugars including glucose, fructose, galactose, lactose, and raffinose 
[14]. Several genes for sucrose degradation were identified in the genome: a sucrose 
hydrolase and three α-glucosidases. The genome sequence of A. tumefaciens includes a 
putative sucrose phosphorylase which converts sucrose and UDP directly to UDP-glucose 
and fructose. This enzyme saves two energy equivalents over the traditional pathway for 
UDP-glucose synthesis and could help explain why ATCC 31749 can produce more 
curdlan using sucrose compared to other sugars. Surprisingly, ATCC 31749 did not have 
a sucrose phosphorylase gene in the draft genome sequence, and the reason for sucrose as 
a preferred carbon source remains unknown. ATCC 31749 has also been shown to be 
capable of utilizing citrate as the sole carbon source [3]. In support of this observation, 
four iron (III) dicitrate ABC transporter genes were identified for citrate uptake as well as 
a citrate lyase gene for citrate metabolism. The ATCC 31749 genome provides crucial 







Figure 5.2 Overview of predicted metabolic pathways in ATCC 31749 using Pathway 
Tools. Each dot represents a metabolite, and each blue line represents an enzyme or 





















Figure 5.3 Major metabolic pathways predicted from the ATCC 31749 genome. Dashed 




 As ATCC 31749 is primarily known for production of the curdlan polysaccharide, 
the genome sequence was also analyzed for genes involved in exopolysaccharide 
production. Of the five genes identified to be important for curdlan production, four 
genes were identified in the genome sequence: the three genes of the curdlan synthesis 
operon (crdA, crdS, crdC) and the phosphatidylserine synthase pssAG. The fifth gene, 
crdR, is most likely present in the sequence, but since the nucleotide sequence for this 
gene has not been reported, it could not be identified at this time. Genes were identified 
for the synthesis of other polysaccharides, including succinoglycan, cyclic β1,3-glucan, a 
generic exopolysaccharide, and cellulose. It is of interest to note that both ATCC 31749 
and A. tumefaciens C58 genomes contain the genes needed for both curdlan and cellulose 
synthesis, yet only ATCC 31749 is reported to produce curdlan and only A. tumefaciens 
is reported to produce cellulose. Cellulose, a β1,4-glucan polymer, and curdlan, a β1,3-
glucan polymer, are very similar in chemical composition and structure (both are linear 
polymers). Thus, it would be interesting to investigate why each microorganism has a 
propensity for the production of just one particular glucan polysaccharide. As an initial 
investigation, the nucleotide sequences of the curdlan and cellulose synthesis operons for 
ATCC 31749 and A. tumefaciens C58 were compared to identify sequence changes that 
may explain this phenomenon. Comparison of the curdlan synthesis operons revealed 
only a few changes in the amino acid sequence of the crdASC genes and in the nucleotide 
sequence of the promoter and intergenic regions of the operon (Table 5.2). The only gene 
with known function and catalytic active sites is the curdlan synthase gene, crdS. Of the 5 
amino acid mutations in crdS for A. tumefaciens, only one falls within the substrate 
binding site, but this residue is not known to directly participate in substrate binding [10]. 
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As the mechanism and regulation of curdlan synthesis is largely unknown, the reason for 
the lack of curdlan synthesis in A. tumefaciens cannot be determined. Sequence alignment 
of the cellulose synthesis operons of ATCC 31749 and A. tumefaciens revealed a 852 bp 
insertion between the celD and celE genes in the ATCC 31749 cel operon. This insertion 
may prevent the transcription of celE, a gene which was shown to be necessary for 
cellulose synthesis in A. tumefaciens [15]. The absence of CelE in ATCC 31749 may 
explain why this microorganism does not produce the cellulose polysaccharide. 
 
Table 5.2 Comparison of curdlan synthesis operons in ATCC 31749 and A. tumefaciens 
 
   Region   Total (bp) Mismatches (bp) Amino acid changes  
 
   Promoter        466   0      - 
   crdA     1458            13      2 
   crdA-crdS intergenic   131   2      - 
   crdS    1956            23      5 
   crdS-crdC intergenic   153   3      - 
   crdC    1166            20      6 
 
 
5.3.2 Phylogeny and comparative genomics of ATCC 31749 
 ATCC 31749 is an α-proteobacterium of the Rhizobium family. Species in the 
Rhizobia family are typically plant-associated microorganisms. Many Rhizobium species 
are plant symbionts, forming root nodules on leguminous plants wherein the Rhizobium 
fixes nitrogen for the plant and the plant provides the bacterium with essential nutrients 
[16]. On the other hand, many Agrobacterium species are plant pathogens, causing gall 
(i.e. tumors) or a condition known as hairy root. It has been found that the pathogenicity 
of Agrobacteria is determined by a plasmid, either a Ti plasmid for tumor-inducing 
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species or a Ri plasmid for rhizogenic species [17]. As ATCC 31749 is not known to be 
either a plant symbiont or a phytopathogen, the relationship between ATCC 31749 and 
other members of the Rhizobia family was investigated. 
 
 
Figure 5.4 Phylogenetic tree constructed using 16S rRNA sequences of species in the 
Rhizobia family. 
 
 Prior to genome sequencing, the 16S rRNA gene of ATCC 31749 was identified 
and sequenced. Comparing the 16S rRNA sequence of ATCC 31749 to that of other 
Rhizobia revealed that ATCC 31749 is closely related to the phytopathogen, A. 
tumefaciens (Figure 5.4). After genome sequencing and annotation, the gene sequences of 
ATCC 31749 were compared to the protein-coding genes of the three other 
Agrobacterium species with sequenced genomes. Table 5.3 shows the number of genes in 
ATCC 31749 with predicted homologs in each respective genome. These results confirm 
that ATCC 31749 is closely related to A. tumefaciens, with more than 87% of genes 
having orthologs in A. tumefaciens. The protein-coding genes of the four sequenced 
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Agrobacteria (ATCC 31749, A. tumefaciens C58, A. radiobacter K84, and A. vitis S4) 
were compared to identify the core genome (homologous genes in all four genomes) and 
genes specific to ATCC 31749. Of the 599 genes specific to ATCC 31749, 74% are 
hypothetical proteins, 17% are conserved hypothetical proteins, and less than 9% have a 
predicted function. While all four Agrobacteria had homologs of curdlan synthase, only 
ATCC 31749 and A. tumefaciens C58 possessed all 3 genes of the curdlan synthesis 
operon. Similarly, all four strains had cellulose synthase homologs, but just three of the 
four strains (ATCC 31749, A. tumefaciens C58, and A. radiobacter K84) had homologs 
of the 6 genes required for cellulose synthesis. The 3,994 genes of the Agrobacterium 
core genome were also compared to other species of the Rhizobia family with available 
genome sequences (Table 5.4). Surprisingly, the six Rhizobium and two Sinorhizobium 
species have high homology with the Agrobacterium core genome, containing homologs 
for 95 to 98% of the genes of the core genome. This comparison suggests that the 
primary metabolic pathways are conserved throughout the Rhizobia family as well as 
many of the secondary pathways. 
 
Table 5.3 Comparison of ATCC 31749 with three Agrobacterium species with sequenced 
genomes 
 
Strain   # homologous genes  %  of ATCC 31749 genes  
that are homologs 
 
A. tumefaciens C58   4868    87.2 % 
A. radiobacter K84   4311    77.2 % 




Table 5.4 Comparison of the Agrobacterium core genome with other Rhizobia species 
 
Strain       # homologous genes      %  of Agrobacterium core 
               genes that are homologs 
 
   Rhizobium etli CFN 42     3884        97.2 % 
   Rhizobium etli CIAT 652     3852        96.4 % 
   R. leguminosarum bv. trifolii WSM 1325   3892        97.4 % 
   R. leguminosarum bv. trifolii WSM 2304   3888        97.3 % 
   R. leguminosarum bv. viciae 3841    3912        97.9 % 
   Rhizobium sp. NGR 234     3832        95.9 % 
   Sinorhizobium medicae WSM 419    3833        96.0 % 




5.3.3 Genes relevant to curdlan synthesis and regulation  
 The main motivation for sequencing the genome of ATCC 31749 is to discover 
genes involved in curdlan synthesis and regulation. From information available in 
literature, several gene categories were identified which may participate in curdlan 
synthesis and regulation. The ATCC 31749 genome was analyzed for genes associated 
with these categories, and the resulting list can be found in Table 5.5. 
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Table 5.5 ATCC 31749 genes with potential involvement in curdlan synthesis or 
regulation 
 
   Gene category     Genes in ATCC 31749 genome 
 
EPS regulation (cyclic di-GMP) GGDEF-containing proteins (31), EAL-
containing proteins (12), 2’,3’-cyclic 
nucleotide phosphodiesterase (1) 
 
Nitrogen regulation    rpoN, ntrB, ntrC, ntrX, ntrY, glnB, glnD,  
glnK, fixK, nifR, ptsN 
 
   Oxygen regulation    fnrN, nolR 
 
   Phosphate regulation   phoB 
 
   pH regulation    chvG, chvI, nolR 
 
Energy     PPi-F6P-phosphotransferase (pfp), exopoly- 
phosphatase (ppx), polyphosphate kinase  
(ppk), membrane-bound H+-translocating  
pyrophosphatase (rrpP) 
    
 
 Several exopolysaccharides have been shown to be regulated by bis-(3’,5’)-
cyclic-dimeric-guanosine monophosphate (c-di-GMP) [18-20]. This includes cellulose 
synthesis in Gluconacetobacter xylinus (formerly Acetobacter xylinum) and A. 
tumefaciens, alginate synthesis in Pseudomonas aeruginosa, and extracellular PEL 
polysaccharide synthesis also in P. aeruginosa. C-di-GMP is synthesized by diguanylate 
cyclases which contain a conserved GGDEF motif as the catalytic active site. On the 
other hand, c-di-GMP is degraded by phosphodiesterases containing EAL domains. The 
relative activities of GGDEF and EAL domain proteins regulate the level of the c-di-
GMP signal. GGDEF and EAL domain proteins often contain N-terminal domains that 
respond to sensory input, allowing for activation or inactivation of the enzyme in 
response to environmental signals such as oxygen, light, starvation, redox conditions, and 
other signaling molecules [21]. This may explain how curdlan synthesis levels change in 
response to different environmental signals such as nitrogen or phosphate limitation, 
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oxygen, and pH. To regulate cellulose production, the c-di-GMP binds to the cellulose 
synthase to enhance the enzyme’s activity. The c-di-GMP binding site on the cellulose 
synthase was identified as a PilZ domain. PilZ domains are also found on other enzymes 
regulated by c-di-GMP, including those necessary for alginate biosynthesis [22]. The 
amino acid sequence of the curdlan synthase in ATCC 31749 was analyzed using Pfam, 
yet the PilZ domain was not found. Despite the absence of the PilZ domain, curdlan 
synthesis may still be regulated by c-di-GMP as other proteins regulated by c-di-GMP 
also lack the PilZ domain. In addition to the direct binding of c-di-GMP to enhance 
enzyme activity, c-di-GMP has also been shown to act as a riboswitch, controlling the 
expression of genes involved in many cellular processes [23]. The genome sequence of 
ATCC 31749 was analyzed for GGDEF and EAL domain proteins via gene annotation 
and domain searches of all hypothetical proteins using Pfam. This search revealed 31 
GGDEF domain proteins, 12 of which also contain EAL domains, and one 2’,3’-cyclic 
nucleotide phosphodiesterase. Experimental evidence is required to determine what, if 
any, role c-di-GMP plays in regulating curdlan synthesis in ATCC 31749. 
 Previous investigations of ATCC 31749 and other closely-related strains 
identified several environmental factors that regulate curdlan synthesis. Nitrogen 
limitation is the main factor for curdlan synthesis; ATCC 31749 only produces curdlan 
after the nitrogen source has been exhausted [24]. Interestingly, nitrogen limitation is also 
an important factor for other Rhizobia. Under nitrogen-limited conditions, the Rhizobium 
species develop a symbiotic relationship with legumous plants by fixing nitrogen [25]. 
While ATCC 31749 cannot fix nitrogen due to the absence of a nitrogenase (nifH), it 
does possess many genes related to nitrogen metabolism and regulation (Table 5.5). In 
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addition to the sigma factor associated with nitrogen metabolism (rpoN), ATCC 31749 
also contains genes involved in the nitrogen signal cascade (ntrB, ntrC, ntrX, ntrY, glnB, 
glnD, glnK) and in nitrogen fixation (fixK, nifR, ptsN). Oxygen is also an important 
environmental factor for curdlan synthesis, with higher oxygen levels corresponding to 
increased curdlan synthesis [26]. Thus, oxygen-responsive global regulators such as fnrN 
and nolR may play a role in curdlan synthesis regulation. Furthermore, phosphate 
concentration and pH also influence curdlan synthesis [27, 28], indicating that genes 
involved in phosphate (phoB) and pH (chvG, chvI) regulation may be relevant in 
regulating curdlan production. With the numerous environmental conditions effecting 
curdlan synthesis, there are many possible genes participating in the regulation of curdlan 
production in ATCC 31749. 
 Lastly, exopolysaccharide production is an energy-intensive process, and as such, 
energy-conserving and energy-generating enzymes may be required for curdlan 
production. Surprisingly, ATCC 31749 uses the lower energy producing ED pathway for 
glycolysis as opposed to the EMP pathway. However, ATCC 31749 does have a 
pyrophosphate-dependent F6P 1-phosphotransferase (pfp) which may allow for an active 
EMP pathway. Although the energy-conserving pfp may help to reserve energy for 
curdlan synthesis, there is likely another mechanism for generating the energy required 
for curdlan production. A close relative of ATCC 31749, A. tumefaciens, has been 
reported to generate acidocalcisomes containing polyphosphate (polyP) [29]. Genome 
sequencing shows that ATCC 31749 also has genes associated with acidocalcisomes and 
polyP (Table 5.5). PolyP can be broken down into pyrophosphate (PPi), a high energy 
compound, and thus, polyP may serve as an intracellular energy storage compound that is 
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utilized to provide energy for curdlan production. As energy is required for UDP-glucose 
synthesis, these energy-related genes are not only important for curdlan production but 
also for oligosaccharide production in the engineered ATCC 31749 strains developed in 
Chapters 2 and 3. 
5.4 Discussion and Conclusions 
 Genome sequencing alone does not provide conclusive evidence of the 
mechanisms for curdlan synthesis and regulation, but the information garnered from this 
endeavor is essential in deciphering the metabolic pathways and genetic interactions 
contributing to curdlan production. The genome sequence of ATCC 31749 also 
contributes to the understanding of the Agrobacterium species and the Rhizobia family of 
microorganisms. Through comparative genomics, a core genome of the Agrobacterium 
species was identified and found to have significant homology with other sequenced 
Rhizobium and Sinorhizobium species. Despite the seemingly different phenotypes of 
symbiotic, pathogenic, and free-living species, microorganisms of the Rhizobia family 
share many common metabolic pathways. The genome sequence of ATCC 31749 
contains many genes which may play a role in curdlan synthesis and regulation, including 
genes involved in exopolysaccharide, nitrogen, oxygen, phosphate, and pH regulation as 
well as genes for energy-conserving and energy-generating enzymes. Experimental 
investigation of these genes will reveal which are important for curdlan production. 
 
5.5 Methods 
5.5.1  16S rRNA sequencing and phylogenetic tree construction 
 The following universal primers were used for cloning the 16S rRNA gene from 
ATCC 31749: 5’- AGAGTTTGATCCTGGCTCAG – 3’ (forward primer) and 5’ – 
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AAGGAGGTGATCCAACCGCA – 3’ (reverse primer). The amplified 16S rRNA gene 
was ligated into the pGEM T-easy vector (Promega) for sequencing. The 16S rRNA 
sequence of ATCC 31749 was aligned with 16S rRNA gene sequences of other Rhizobia 
using ClustalX. The Rhizobia gene sequences were obtained from the NCBI database. A 
phylogenetic tree of the aligned 16S rRNA gene sequences was constructed using 
TreeView. 
5.5.2 Genomic DNA isolation, sequencing, and annotation 
 ATCC 31749 was cultivated overnight in a test tube containing 4 mL of LB media 
at 30°C with agitation at 250 rpm. The overnight culture was used for genomic DNA 
(gDNA) isolation with the GenElute Bacterial Genomic DNA Kit from Sigma-Aldrich. 
The genome of ATCC 31749 was sequenced at the BioMedical Genomics Center at the 
University of Minnesota using the Genome Sequencer FLX System from 454 Life 
Sciences. The reads obtained from gDNA sequencing were assembled into contigs using 
the GS De Novo Assembler from 454 Life Sciences. The contigs were arranged in 
random order with stop codons inserted between each contig to form a 
pseudochromosome. This pseudochromosome was used for gene prediction with two 
gene prediction programs: GeneMarkS and Glimmer v3.02. The predicted genes from 
GeneMarkS and Glimmer were combined, and any repeated open reading frame (orf) (i.e. 
predicted by both programs) was removed along with orfs with unusual start codons to 
obtain a list of unique predicted genes. The predicted genes were annotated by comparing 
the nucleotide sequences to those of the non-redundant (nr) database of NCBI using 
Netblast (blastcl3), an E-value cutoff of 10-4, and XML format for the output. A perl 
script (blast_XML_extraction.pl) was written to extract the gene query, query length, hit 
 147
number, hit ID, hit length, hit definition, score, E-value, identities, and positives (see 
Appendix B for Perl script). The hit definition of the top hit for each gene was used to 
annotate the predicted gene list. All conserved hypothetical and hypothetical proteins 
were entered into Pfam to identify any conserved domains and assign a proposed 
function. Transfer RNA genes were identified using tRNAscan-SE 1.21, and ribosomal 
RNA genes were identified using blastn with the 5S, 6S, 16S, and 23S rRNA sequences 
from A. tumefaciens C58, A. radiobacter K84, and A. vitis S4 as query and the 
pseudochromosome of ATCC 31749 as database. 
5.5.3 Operon and metabolic pathway prediction  
 The genome sequence and annotation was formatted using a Perl script 
(Pathologic_format.pl) (see Appendix B for Perl script) as specified by the PathoLogic 
component of the Pathway Tools software. With the formatted sequence and annotation 
file, PathoLogic was used to create a Pathway/Genome Database (PGDB) for ATCC 
31749. Enzymes not automatically assigned by PathoLogic were manually annotated. 
PathoLogic functions were employed to predict transcription units (i.e. operons) and 
identify transporters. Lastly, the Pathway Hole Filler identified any genes missing from 
the pathways predicted for the genome. 
5.4.4 Crd and cel operon analysis 
 The crd and cel operons of A. tumefaciens C58 were obtained from the genome 
sequence in the NCBI database. The A. tumefaciens C58 and ATCC 31749 operons were 
aligned using ClustalW2 to identify differences in the nucleotide sequences. The amino 
acid sequences of crdS from ATCC 31749 and A. tumefaciens C58 were aligned with 
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ClustalW2 to identify differences. The amino acid changes in the CrdS of A. tumefaciens 
C58 were compared to the catalytic active sites identified previously [10]. 
5.5.5 Comparative genomics 
The genome sequences of the Agrobacterium, Rhizobium, and Sinorhizobium 
species listed in Tables 5.3 and 5.4 were obtained from the NCBI database. The predicted 
gene sequences of ATCC 31749 were compared to the protein-coding sequences of A. 
tumefaciens C58, A. radiobacter K84, and A. vitis S4 using blastx with an E-value cutoff 
of 10-3 and XML output format. The hits from each genome comparison were sorted 
using a Perl script (matchandsort.pl, Appendix B) to identify the genes of the 
Agrobacterium core genome. The nucleotide sequences associated with the genes of the 
core genome were compared to the protein-coding sequences of other Rhizobia using 
blastx with an E-value cutoff of 10-3 and XML output format. 
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TRANSCRIPTOME ANALYSIS OF AGROBACTERIUM SP. ATCC 
31749 REVEALS GENES IMPORTANT FOR CURDLAN 
SYNTHESIS AND REGULATION 
 
6.1 Abstract 
 To determine which genes are important for curdlan synthesis and regulation, the 
transcriptome of ATCC 31749 was analyzed under different environmental conditions. 
Two conditions were investigated using DNA microarrays: pH and nitrogen. The pH-
dependent study compares gene expression levels during curdlan synthesis at pH 7 and 
pH 5.5, where increased curdlan production is observed at pH 5.5. The nitrogen-
dependent study compares gene expression levels before curdlan synthesis (nitrogen-rich) 
and during curdlan synthesis (nitrogen-limited). Both transcriptome comparisons 
revealed genes significantly up- and down-regulated that may influence curdlan 
production. Genes associated with three functional categories were selected for gene 
knockout: 1) nitrogen-limited regulation, 2) energy-related, and 3) GTP-derived second 
messengers. Genes from all three categories were found to affect curdlan production. The 
nifR/ntrB/ntrC operon was shown to regulate curdlan production in an RpoN-independent 
manner. Polyphosphate was also determined to be an important factor for curdlan 
synthesis, but surprisingly, gene knockout of the two exopolyphosphatases in ATCC 
31749 had opposing effects on curdlan production. Lastly, the GTP-derived second 
messengers, (p)ppGpp and c-di-GMP, were also shown to be important for curdlan 
 152
synthesis. Several mechanisms are discussed based on the curdlan produced by the gene 
knockout mutants and supporting information in the literature. 
 
6.2 Introduction 
 Genome sequencing of ATCC 31749 identified many genes with possible 
influence over curdlan synthesis. In particular, regulatory genes associated with nitrogen, 
oxygen, and phosphate limitation were found, three environmental factors shown to 
influence curdlan production [1-3]. The genome also includes numerous genes 
participating in the synthesis and degradation of c-di-GMP, a second messenger shown to 
regulate production of polysaccharides such as cellulose, alginate, and PEL 
exopolysaccharide [4-6]. As curdlan synthesis requires high energy compounds (ATP and 
UTP), genes related to energy production and storage are also likely to be important for 
curdlan production. Lastly, conserved hypothetical proteins and hypothetical proteins 
may play a significant role in curdlan synthesis and regulation. With 5,585 predicted 
genes in the genome of ATCC 31749, how can those related to curdlan production be 
identified? 
 DNA microarrays are powerful tools to analyze global gene expression (i.e. the 
transcriptome) of a microorganism under various conditions. Transcriptome analysis via 
DNA microarray identifies genes with changes in transcript level, and as the level of gene 
expression generally correlates to the amount of functional protein present, this analysis 
can indicate enzymes, transporters, or transcriptional regulators that are active under 
specific environmental conditions. In this study, custom DNA microarrays were designed 
from the genome sequence of ATCC 31749. Two factors important for curdlan 
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production were investigated using transcriptome analysis: pH and nitrogen. The pH-
dependent analysis evaluates changes in transcript level during curdlan synthesis at pH 7 
and pH 5.5 while the nitrogen-dependent analysis compares gene expression levels before 
(nitrogen-rich) and after (nitrogen-limited) the start of curdlan synthesis. The pH and 
nitrogen-dependent transcriptome comparisons identified significantly up- and down-
regulated genes associated with curdlan and enhanced curdlan production. From the list 
of up- and down-regulated genes, several genes were selected for gene knockout to 
investigate their potential influence on curdlan synthesis. The experimental results of 
these gene knockout studies are presented along with an analysis of their significance in 
context with other experimental results reported in the literature. Based on the data and 
subsequent analysis, several possible mechanisms are discussed for the regulation of 
curdlan synthesis in ATCC 31749. 
 
6.3 Results 
6.3.1 Microarray analysis of ATCC 31749 at pH 7 vs. pH 5.5 
 Many environmental conditions have been optimized to maximize curdlan 
production by Agrobacterium sp. ATCC 31749. One condition found to have a 
significant impact on curdlan synthesis is the pH of the cell culture. A two-phase reaction 
was found to be optimal for curdlan synthesis, where the growth phase is controlled at pH 
7 and the nitrogen-limited phase is controlled at pH 5.5. By shifting the pH from 7 to 5.5 
at the time of nitrogen depletion, there is a 50% increase in curdlan production compared 
to curdlan production at a constant pH of 7 [2]. In an attempt to determine which genes 
are responsible for the increased curdlan production under acidic conditions, gene 
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transcript levels were compared under the two different pH conditions (pH 7 and pH 5.5) 
using a DNA microarray. For this pH-dependent microarray analysis, samples were taken 
70 hours after the point of nitrogen depletion, which corresponds to approximately 100 
hours after the start of cultivation in the bioreactor. The concentrations of curdlan and dry 
cell weight under the two pH conditions are shown in Figure 6.1. Surprisingly, the dry 
cell weight measurement for the pH 7 reaction shows an increase after nitrogen depletion, 
which is not observed for the pH 5.5 culture. To determine if this increase is due to cell 
growth or a result of the dry cell weight measurement, the total protein content was 
measured for each sample using the Bradford assay. If the increase in the dry cell weight 
measurement is due to cell growth, there should also be a corresponding increase in the 
amount of total protein. For both the pH 7 and pH 5.5 reactions, the protein concentration 
increased during growth, reached a peak at the time of nitrogen depletion, and decreased 
slightly during nitrogen-limitation. This suggests that the measured increase in dry cell 
weight is artifact of the measurement technique. Based on the method of dry cell weight 
measurement, the production of an insoluble product or the accumulation of an 
intracellular product may account for the observed increase in dry cell weight for the pH 
7 reaction. While this putative product is a notable difference between the pH 7 and pH 










































Figure 6.1 Dry cell weight (DCW) and curdlan concentrations for the pH-dependent 
cultivations. For the pH 7 reactor, the pH was held constant throughout the reaction. For 
the pH 5.5 reactor, the pH was set to 7 for the growth phase (0-30h) and shifted to pH 5.5 
at the time of nitrogen depletion (~30h). 
 
The microarray data for the pH comparison identified a total of 338 genes with 
more than 2-fold changes in gene expression level. The split between up and down-
regulated genes was nearly equal, with 170 up-regulated genes and 168 down-regulated 
genes. A list of these genes and their corresponding fold-changes in expression will be 
made publicly available online after publication of this work. For the pH comparison, 
both samples are in the stationary phase, are subject to nitrogen-limitation, and are 
producing curdlan. The only observable differences between the cultures are the pH 
value, the amount of curdlan production, and the production of an insoluble or 
intracellular product as indicated by the dry cell weight measurement. The significantly 
up- and down-regulated genes were grouped according to function, and the distribution of 
differentially expressed gene functions is listed in Table 6.1. The majority of up-regulated 
pH shift sample  
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genes (61%) are hypothetical, suggesting that an unknown mechanism may be 
responsible for the increased curdlan production at pH 5.5. The substantial number of up-
regulated regulatory genes indicates that transcriptional regulation may also be important. 
As expected, many of the down-regulated genes are transporters or metabolic genes, two 
processes known to have decreased activity under stress conditions like low pH. 
 
Table 6.1 Distribution of up- and down-regulated genes for the pH-dependent microarray 
comparison 
 
Category             Number  Percentage 




   cell replication and division       8       4.7 
 
   cell membrane and lipid synthesis and degradation   6       3.5 
 
   amino acid synthesis and metabolism     2       1.2 
 
   modification proteins       1       0.6 
 
   transporters         3       1.8 
 
   metabolism and cofactor synthesis      8       4.7 
 
   regulation        33     19.4 
 
   stress response and cell protection      4       2.4 
 
   symbiosis-related proteins       1       0.6 
 
   conserved hypothetical proteins     87     51.2 
 
   hypothetical proteins      17     10.0____         
 




   cell membrane and lipid synthesis and degradation   5       3.0 
 
   cell movement and extracellular appendages     6       3.6 
 





Table 6.1 Continued 
 
Category             Number  Percentage 




   amino acid synthesis and metabolism     5       3.0 
   
   protein folding, modification, secretion, and degradation   3       1.8 
 
   modification proteins       6       3.6 
 
   transporters        30     17.9 
 
   metabolism and cofactor synthesis     31     18.5 
 
   regulation        12       7.1 
 
   stress response and cell protection      6       3.6 
 
   polysaccharide synthesis and degradation     4       2.4 
 
   phage proteins        1       0.6 
 
   conserved hypothetical proteins     49     29.2 
 
   hypothetical proteins       7       4.2____         
 
Total           168              100.0 
 
 
 Genes with potential involvement or influence on curdlan production were 
identified from the list of differentially expressed genes for the pH comparison (Table 
6.2). A decrease in production of other glucan-containing products would increase the 
availability of UDP-glucose for curdlan production and may explain the observed 
increase in curdlan synthesis at pH 5.5. Genes involved in the production of cyclic β1,2-
glucan and an exopolysaccharide were found to be down-regulated at pH 5.5. In fact, a 
decrease in cyclic β1,2-glucan may explain the discrepancy in dry cell weight 
measurement after nitrogen exhaustion. Cyclic β1,2-glucan accumulates in the periplasm 
of the cell and therefore contributes to the dry cell weight measurement. So if cyclic β1,2-
glucan is produced at pH 7 after nitrogen depletion, there would be an increase in the dry 
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cell weight measurement. On the other hand, there would be no increase in dry cell 
weight measurement at pH 5.5 if little cyclic β1,2-glucan is produced, as is suggested by 
the decreased expression level of chvA and cgmA. Since cyclic β1,2-glucan also utilizes 
UDP-glucose, a decrease in cyclic β1,2-glucan may contribute to the increase in curdlan 
production. However, this is not likely the sole contributing factor as the dry cell weight 
measurement only increases during the early stages of curdlan production (Figure 6.1). 
An increase in carbon metabolism may also enhance curdlan production by supplying 
additional carbon and energy. Enhanced expression of aglE, an α-glucoside transporter, 
may improve uptake of the carbon source, sucrose. In addition, reduced expression of pfp 
may help to direct the carbon flux towards curdlan synthesis rather than through 
glycolysis. Lastly, a regulatory mechanism may be responsible for the improved curdlan 
production at pH 5.5. The conserved hypothetical protein Atu1112 contains a GGDEF 
domain with potential for c-di-GMP synthesis. Increased levels of c-di-GMP have been 
shown to improve the production of exopolysaccharides in other microorganisms [4-6]; 
thus, increased levels of Atu1112 may regulate curdlan production. Similarly, a decrease 
in c-di-GMP degrading enzymes such as GTP cyclohydrolase may stimulate curdlan 
synthesis. 
Table 6.2 Genes identified by the pH-dependent microarray analysis that may influence 
curdlan synthesis in ATCC 31749 
 
   Gene       Fold-change Symbol        Definition 
 
Glucan product synthesis 
 
    r0991 -2.9    chvA          cyclic β1,2-glucan ABC transporter 
 
r5576 -3.3    cgmA          cyclic glucan phosphoglycerol modification  
         protein 
 
    r0171 -4.1            exopolysaccharide production protein 
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Table 6.2 Continued 
 




   r2734  2.2    aglE          ABC transporter, substrate binding protein  
         (alpha-glucoside) 
 
   r0653 -2.0    pfp          pyrophosphate – fructose-6-phosphate  
         1-phosphotransferase 
 
c-di-GMP synthesis and degradation 
 
   r3955   2.4            hypothetical protein Atu1112 
 
   r3770 -2.3    folE          GTP cyclohydrolase I 
 
6.3.2 Nitrogen-dependent microarray analysis of ATCC 31749 
 Curdlan synthesis in ATCC 31749 involves two phases. The first phase is a 
growth phase where a nitrogen source is present and no curdlan is produced. The second 
phase occurs when the nitrogen source is exhausted, causing the cell culture to enter the 
stationary phase and begin to produce curdlan. A nitrogen-dependent microarray analysis 
of gene expression, comparing the growth phase (nitrogen-rich) and curdlan-producing 
phase (nitrogen-limited), should reveal which genes are important for curdlan production 
and regulation. Since this comparison also includes a shift from growth to stationary 
phase, the microarray is expected to yield a large number of genes with significant 
changes in gene expression level. For the nitrogen-dependent microarray comparison, 
samples were taken during the exponential growth phase at 22 hours and when the rate of 
curdlan synthesis is high, approximately 70 hours after depletion of the nitrogen source 
(~100 hours after inoculation of the culture). Figure 6.2 shows the cell and curdlan 
concentrations at each sample time. The pH for the nitrogen-dependent cultivation was 






































Figure 6.2 Dry cell weight (DCW) and curdlan concentrations for the nitrogen-dependent 
cultivation. 
 
 Analysis of the microarray data for the nitrogen-dependent comparison revealed a 
total of 2,456 genes with more than 2-fold changes in gene expression level. Of the 2,456 
genes, 985 genes were up-regulated and 1,471 genes were down-regulated. A list of these 
genes and their corresponding fold-changes in expression will be made publicly available 
online after publication of this work. As stated previously, the large number of genes with 
changes in gene expression level is due to the fact that the initiation of curdlan synthesis 
also accompanies a shift from growth to stationary phase. The up- and down-regulated 
genes were grouped according to function, and Table 6.3 lists the distribution of genes 
across the functional categories. A majority of the up-regulated genes code for 
hypothetical proteins of unknown function. This indicates that the genes active during 
stationary phase for ATCC 31749 differ from that of more well-studied organisms such 
as E. coli, suggesting unique pathways to be investigated in the future. These hypothetical 
22h 100h 
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proteins may also be important for curdlan synthesis and regulation. Many regulatory 
genes are up-regulated in the 100 hour sample and may be important for stationary phase 
survival or curdlan production. A significant number of stress response genes are also up-
regulated during the stationary phase. The down-regulated genes include a large number 
of transporters and metabolic genes. This is expected since the cell no longer requires the 
high level of nutrient uptake and metabolism that is required during the growth phase.  
 
Table 6.3 Distribution of up- and down-regulated genes for the nitrogen-dependent 
microarray comparison 
 
Category             Number  Percentage 




   cell replication and division      43       4.4 
 
   cell membrane and lipid synthesis and degradation  18       1.8 
 
   cell movement and extracellular appendages    9       0.9 
 
   amino acid synthesis and metabolism     9       0.9 
 
   protein folding, modification, secretion, and degradation  22       2.2 
 
   RNA-associated proteins       4       0.4 
 
   modification proteins      37       3.8 
 
   transporters        86       8.7 
 
   metabolism and cofactor synthesis     65       6.6 
 
   regulation                 105     10.7 
 
   stress response and cell protection     27       2.7 
 
   polysaccharide synthesis and degradation     8       0.8 
 
   phage proteins        6       0.6 
 
   conserved hypothetical proteins             424     43.0 
 
   hypothetical proteins               122     12.4____         
 




Table 6.3 Continued 
 
Category             Number  Percentage 




   cell replication and division        82       5.6 
 
   cell membrane and lipid synthesis and degradation  69       4.7 
 
   cell movement and extracellular appendages    25       1.7 
 
   amino acid synthesis and metabolism    62       4.2 
 
   protein folding, modification, secretion, and degradation  42       2.9 
 
   RNA-associated proteins      74       4.9 
 
   modification proteins      66       4.5 
 
   transporters                 210     14.3 
 
   metabolism and cofactor synthesis              290     19.9 
 
   regulation                 101       6.9 
 
   stress response and cell protection     26       1.8 
 
   polysaccharide synthesis and degradation    24       1.6 
 
   phage proteins        2       0.1 
 
   invasion/virulence-associated proteins     3       0.2 
 
   conserved hypothetical proteins             368     25.0 
 
   hypothetical proteins                27       1.8____         
 
Total          1471              100.0 
 
  
The list of up- and down-regulated genes identified by the nitrogen-dependent 
microarray comparison was analyzed for genes with functions potentially involved in 
curdlan synthesis and regulation. The few genes known to be involved in curdlan 
synthesis were significantly up-regulated. The gene for curdlan synthase (crdS) was up-
regulated more than 95-fold while the other genes in the curdlan synthesis operon, crdA 
and crdC, showed 99- and 66-fold increases respectively. Unfortunately, the nucleotide 
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sequence for the putative regulator crdR has not been reported so the change in 
expression level for crdR cannot be identified. Regardless, this gene expression data is 
the first reported evidence that the curdlan synthesis operon (crdASC) is transcriptionally 
regulated with respect to nitrogen-limitation. As such, there must be some factor which 
controls transcription of the operon. Based on information available in the literature 
regarding curdlan synthesis and exopolysaccharide regulation, the genes involved in three 
processes were identified for further investigation: nitrogen-limited regulation, energy 
production, and GTP-derived second messengers (Table 6.4).  
 
Table 6.4 Genes identified by the nitrogen-dependent microarray analysis that may 
influence curdlan synthesis in ATCC 31749 
 
   Gene       Fold-change Symbol        Definition 
 
Nitrogen-limited regulation 
   r1024   5.2  glnK          nitrogen regulatory protein PII 
   r0418  -5.8  glnD          PII uridylyl-transferase 
Energy-associated 
 
   r2510 -6.9  rrpP          membrane-bound proton-translocating  
               pyrophosphatase 
 
   r2544 -3.6  ppx2          exopolyphosphatase  
 
   r2335 -3.0            inorganic polyphosphate/ATP-NAD kinase 
 
   r3046 -2.4  galU          UTP:glucose-1-phosphate uridylyltransferase 
 
GTP-derived second messengers 
 
   r1444   6.7            hypothetical protein Atu0989 (GGDEF) 
   
   r1489   4.0  spoT          GTP pyrophosphohydrolase/synthetase 
 
   r3957   3.9            GGDEF/EAL family protein 
 
   r3770   3.8  folE          GTP cyclohydrolase I  
 
   r4126 -2.1            GGDEF/EAL family protein 
 
   r3899 -2.3            two component response regulator (GGDEF) 
 
   r5342 -2.5            hypothetical protein Atu0826 (GGDEF/EAL) 
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Table 6.4 Continued 
 
   Gene       Fold-change Symbol        Definition 
 
GTP-derived second messengers (continued) 
 
   r5566 -2.8            GGDEF/EAL family protein 
    
   r5364 -2.9            hypothetical protein Atu4353 (GGDEF/EAL) 
 
   r1177 -3.3            GGDEF/EAL family protein 
 
   r2487 -3.4            GGDEF family protein 
 
   r2433 -3.6            GGDEF family protein 
 
   r2855 -3.7            GGDEF/EAL family protein 
 
   r0742 -3.8            GGDEF family protein 
 
   r4090 -7.0            GGDEF/EALfamily protein 
    




6.3.3 Gene knockouts identify genes influencing curdlan production  
6.3.3.1 Nitrogen-limited regulatory genes 
The only factor that has been experimentally determined as necessary for curdlan 
production in ATCC 31749 is nitrogen limitation [7]. In other microorganisms, genes are 
transcriptionally regulated by nitrogen limitation via the nitrogen signaling cascade 
(Figure 6.3). Hence, the genes of the nitrogen signaling cascade may also regulate 
transcription of the curdlan synthesis operon. Briefly, the nitrogen signaling cascade 
includes a nitrogen sensor protein (GlnD), which under nitrogen-limited conditions, 
transfers UMP to a PII protein (either GlnB or GlnK). In its non-uridylylated form, the 
PII protein binds to NtrB, promoting dephosphorylating activity. The uridylylated form 
of the PII protein cannot bind NtrB, and subsequently, the free NtrB phosphorylates 
NtrC. The phosphorylated NtrC binds to the transcription factor RpoN. With NtrC•P, 
RpoN is active and initiates transcription of genes that contain an RpoN binding site in 
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their promoter region. The curdlan synthesis genes may be directly regulated by the 
nitrogen signaling cascade via activated RpoN, or the active RpoN may initiate 
transcription of another sigma factor or protein which regulates transcription of the 
curdlan synthesis operon (i.e. indirect regulation). From the nitrogen-dependent 
microarray analysis, two genes involved in the nitrogen signaling cascade were 
significantly up-regulated (glnK and glnD) (see Table 6.4), two proteins directly involved 
in sensing the nitrogen status of the cell. Other components of the nitrogen signaling 
cascade (ntrB, ntrC, and rpoN) are not transcriptionally regulated by nitrogen limitation 
[8], and therefore, these genes were not identified by the microarray analysis. In a review 
paper on curdlan, NtrB/NtrC were said to be required for curdlan synthesis in ATCC 
31749, but no experimental evidence was presented [9]. The genome sequence of ATCC 
31749 shows ntrBC to be in an operon with nifR (nifR>ntrB>ntrC). To determine the 
involvement of the nitrogen signaling cascade with respect to curdlan production, three 





























Successful gene knockout mutants (ATCC 31749∆rpoN and ATCC 31749∆nifR) 
were obtained using the method described in section 6.4. Despite numerous gene KO 
attempts targeting glnK, a successful KO mutant was not obtained for this target gene.  
This may indicate that glnK is essential for growth in ATCC 31749. The gene knockout 
technique used in this study may also affect transcription of any downstream genes 
contained in the same operon as the gene knockout target. Consequently, the results 
presented in this study may be attributed to other genes in the operon of the target gene, 
and any genes in the predicted operon which may be affected by the knockout will be 
included in the analysis. 
RpoN is required for transcription of genes associated with nitrogen-limitation, 
and thus, it is expected that the rpoN knockout will eliminate transcription of the curdlan 
synthesis operon, thereby eliminating curdlan production. Surprisingly, the rpoN mutant 
not only synthesized curdlan but it produced more curdlan than the wild-type (Figure 
6.4). This indicates that the nitrogen-limited regulation of curdlan production does not 
follow the traditional nitrogen signaling cascade. Furthermore, the results show that the 
nitrogen-limited regulation of curdlan production is RpoN-independent, and in fact, 
RpoN may inhibit curdlan synthesis. Combining this information with the literature claim 
that NtrB/C is required for curdlan synthesis suggests a novel mechanism for the 
























Figure 6.4 Curdlan synthesis in ATCC 31749 and gene KO mutants after 24 hours of 
cultivation in nitrogen-free media. 
 
The role of nifR in nitrogen-limited regulation has not yet been determined in any 
microorganism; however, the nifR/ntrB/ntrC operon is conserved across several species. 
Knockout of nifR will not determine its function, but it should indicate if it is important 
for curdlan synthesis. As nifR is in an operon with other components of the nitrogen 
signaling cascade (ntrB and ntrC), nifR knockout is expected to reduce or eliminate 
curdlan production. Indeed, curdlan synthesis in the nifR mutant was significantly 
reduced (Figure 6.4). At this point, it is not known whether the interruption of nifR or 
possible polar effects on ntrBC is responsible for the effect on curdlan production. 
However, this does suggest that at least some part of the nitrogen signaling cascade 
influences curdlan synthesis. 
From the study of curdlan synthesis in the gene knockout mutants, it is apparent 
that RpoN does not regulate the crd operon despite the involvement of other elements of 
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the nitrogen signaling cascade. Therefore, other sigma factors were investigated as 
potential transcriptional regulators of curdlan synthesis. The promoter region of the crd 
operon was analyzed using Virtual Footprint, a program for predicting transcription 
factor binding sites. This analysis predicted binding sites for two known transcription 
factors: AlgU from Pseudomonas aeruginosa and ArcA from E. coli. Using these two 
proteins as query, a BLAST search of the ATCC 31749 genome revealed several 
potential homologs. Of these homologs, r1722, an ECF family RNA polymerase sigma 
factor, was shown to be up-regulated 47-fold in the nitrogen-dependent transcriptome 
comparison. Furthermore, r1722 was the RNA polymerase sigma factor with the most 
significant increase in expression. Based on this analysis, r1722 was targeted for gene 
KO as a possible transcriptional regulator of the crd operon. As shown in Figure 6.4, 
however, the r1722 mutant was able to produce curdlan at levels similar to the wild-type, 
indicating that it is not involved in regulating curdlan production. 
6.3.3.2 Energy-related genes 
 Curdlan synthesis, similar to many other polysaccharides, is energy-intensive, 
requiring two high-energy molecules for each glucose monomer added to the polymer 
chain. With this energy requirement, it is surprising that curdlan is produced only under 
nitrogen-limitation, a condition of stress and typically associated with lower metabolic 
activity. How then can ATCC 31749 provide the energy required for curdlan synthesis?  
 The high-energy precursor for curdlan synthesis is the sugar nucleotide, UDP-
glucose. The genome of ATCC 31749 includes two predicted genes for synthesis of 
UDP-glucose, galU (r3046) and exoN (r3316). These genes are predicted to be 
UTP:glucose-1-phosphate uridylyltransferases. GalU is down-regulated 2.4-fold during 
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curdlan synthesis, suggesting that it is not important for curdlan production. As galU is 
typically associated with cell growth, this result was anticipated. To determine if exoN is 
solely responsible for providing the UDP-glucose for curdlan synthesis, exoN was 
targeted for gene knockout. 
Gene knockout of exoN was expected to have a deleterious effect on curdlan 
synthesis, as this gene participates in UDP-glucose synthesis. Hence, the main question is 
how significant will this impact be? Does exoN simply supply UDP-glucose for other 
polysaccharides produced by ATCC 31749, or is exoN the primary source for UDP-
glucose in curdlan synthesis? As shown in Figure 6.4, exoN gene knockout does affect 
curdlan synthesis in ATCC 31749; however, it is clearly not the only means of UDP-
glucose provision. Based on these experimental results, exoN supplies approximately 
40% of the UDP-glucose used for curdlan production. Presumably, the remaining supply 
of UDP-glucose is derived from galU, the other UTP:glucose-1-phosphate 
uridylyltransferase in ATCC 31749. By expressing multiple pathways for UDP-glucose 
production, ATCC 31749 is able to ensure an adequate supply of sugar nucleotide for 
high levels of curdlan production. While this result reveals the genes directly involved in 
UDP-glucose synthesis, the question of how energy is supplied for this synthesis still 
remains to be answered. 
As indicated in Table 6.4, several genes associated with the degradation of high-
energy compounds are down-regulated during curdlan synthesis, namely ppx2 and rrpP. 
Both of these genes are typically associated with acidocalcisomes. Acidocalcisomes are 
intracellular organelles that have been found in a limited number of organisms ranging 
from bacteria to man. The complete range of functions for acidocalcisomes remains to be 
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determined, yet they have been linked with nutrient storage (phosphate, Ca2+, Zn, K+, 
Na+, Fe, Mg), pH homeostasis, and osmotic regulation [10]. Acidocalcisomes contain 
large amounts of polyphosphate (polyP), a compound containing high-energy phosphate 
bonds. Polyphosphate kinase (ppk) is responsible for polyP synthesis, but it can also 
catalyze the reverse reaction, synthesizing ATP or other nucleoside triphosphates from 
polyP [11-12]. Thus, polyP could serve as an energy source for curdlan production. To 
determine the influence of polyP and of the possible presence of acidocalcisomes, 
knockout mutants were constructed for ppx2 (r2544), and rrpP (r2510). In addition to 
ppx2, the genome of ATCC 31749 contains another exopolyphosphatase (ppx1, r2763). 
As this gene may also degrade polyP, it too was targeted for gene knockout.  
 Acidocalcisomes, containing significant quantities of the high-energy compound 
polyP, may play an important role in curdlan synthesis. Three acidocalcisome-associated 
genes were targeted for gene knockout: rrpP, ppx1, and ppx2. The membrane-bound 
proton-translocating pyrophosphatase (rrpP) was down-regulated during curdlan 
production (Table 6.4). As RrpP consumes pyrophosphate, a high energy compound, it 
may compete with curdlan synthesis for the cell’s energy resources, and down-regulation 
of this gene may enhance the availability of energy for curdlan production. Based on this 
reasoning, rrpP gene knockout is expected to improve curdlan production. As depicted in 
Figure 6.4, however, curdlan production was found to be reduced in the rrpP mutant. 
Several possible theories may explain these results. First, a functional rrpP may be 
required for polyP accumulation in the acidocalcisome. If polyP does not accumulate in 
the acidocalcisome, this eliminates a potential energy source for curdlan synthesis. 
Another possible explanation is that rrpP may help to maintain the intracellular pH at a 
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level optimal for curdlan synthesis. Extracellular pH regulation has been shown to have a 
significant impact on curdlan synthesis [2, 13], and rrpP may be responsible for 
intracellular pH regulation, one of the many functions ascribed to the acidocalcisome. 
The remaining two acidocalcisome-associated genes are both exopolyphosphatases, 
enzymes that degrade polyP into inorganic phosphate. Despite having the same function, 
the ppx1 and ppx2 knockout mutants had different effects on curdlan synthesis. The ppx1 
mutant produced curdlan at levels similar to the wild-type while curdlan production was 
eliminated in the ppx2 mutant (Figure 6.4). This indicates that polyphosphate degradation 
via ppx2 is important for curdlan synthesis. For the curdlan measurements shown in 
Figure 6.4, the cells were grown in rich media until stationary phase was reached and 
were then transferred to the nitrogen-free media. If the cells are transferred to the 
nitrogen-free media before reaching the stationary phase, curdlan synthesis is greatly 
reduced for the wild-type (Figure 6.5). Interestingly, the ppx1 mutant is able to synthesize 
the same high level of curdlan as in the case of the stationary phase cells (Figure 6.5 and 
6.4). Hence, the elimination of polyphosphate degradation during growth in the ppx1 
mutant allows for high levels of curdlan synthesis. This further emphasizes the different 
roles played by the two exopolyphosphatases, ppx1 and ppx2. These seemingly 























Figure 6.5 Curdlan synthesis in ATCC 31749 and acidocalcisome-associated gene KO 
mutants from cells transferred to nitrogen-free media prior to reaching stationary phase. 
These measurements were taken after 48 hours of cultivation in nitrogen-free media. 
 
 
6.3.3.3 GTP-derived second messengers 
 Nucleotide-based second messengers are common regulatory molecules that are 
produced in response to environmental signals. They transmit the signal through 
interaction with cellular regulatory components to elicit the appropriate cellular response 
[14]. Two GTP-derived second messengers are of interest for their potential influence on 
curdlan production: (p)ppGpp and c-di-GMP.  
Guanosine tetraphosphate (ppGpp) and guanosine pentaphosphate (pppGpp) are 
collectively known as (p)ppGpp. These nucleotide-based second messengers were found 
to accumulate in response to multiple stress conditions, including nitrogen limitation. In 
turn, the elevated (p)ppGpp levels were shown to affect gene transcription and translation 
[15]. (p)ppGpp and its co-factor, DksA, can interact with RNA polymerase (RNAP) to 
directly promote or inhibit gene transcription, and (p)ppGpp/DksA can also indirectly 
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influence transcription by altering sigma factor utilization. Experimental evidence 
suggests that (p)ppGpp/DksA reduces transcription from RpoD (σ70) promoters, 
increasing the availability of the core RNAP for alternative sigma factors such as RpoS 
(σ38), RpoN (σ54), and RpoE (σ24) [16-17]. Hence, (p)ppGpp may play an important role 
in regulating transcription of the curdlan synthesis operon, crdASC. In E. coli, two 
proteins were shown to synthesize (p)ppGpp: RelA and SpoT [18]. A BLAST search of 
the ATCC 31749 genome revealed only one significant homolog of RelA (E-value = 7e-
099) and SpoT (E-value = e-127): r1489, a GTP pyrophosphohydrolase/synthetase. 
Interestingly, this potential (p)ppGpp synthase is significantly up-regulated under 
curdlan-producing conditions (Table 6.4).  
 The SpoT homolog, r1489, was targeted for gene knockout, resulting in the 
mutant strain, ATCC 31749∆spoT. This spoT mutant failed to synthesize the curdlan 
polysaccharide (Figure 6.4). The elimination of curdlan production, as opposed to simply 
a reduction in synthesis, suggests that (p)ppGpp may play an important role in regulating 
transcription of the crdASC operon in ATCC 31749. However, spoT may also affect the 
synthesis of GTP and other GTP-derived compounds, and these molecules may be 
responsible for the elimination of curdlan production in the spoT mutant. 
 Another GTP-derived second messenger, c-di-GMP, has been directly linked with 
the regulation of polysaccharide production in several organisms, including 
Gluconacetobacter xylinus (formerly Acetobacter xylinum), Agrobacterium tumefaciens, 
and Pseudomonas aeruginosa [4-5, 19]. In G. xylinus and A. tumefaciens, c-di-GMP acts 
as an allosteric regulator of cellulose synthase, improving enzyme activity to promote 
cellulose synthesis [20]. C-di-GMP is also an allosteric regulator of alginate synthesis in 
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P. aeruginosa, yet instead of binding to the alginate synthase, c-di-GMP binds to Alg44, 
a protein involved in controlling either alginate polymerization or transport [6]. This 
second messenger has also been shown to effect gene transcription. In P. aeruginosa, c-
di-GMP binds to FleQ, a transcriptional repressor of the pel operon involved in 
exopolysaccharide synthesis. While bound to c-di-GMP, FleQ can no longer bind to the 
promoter region of the pel operon, allowing for transcription of the pel genes and 
initiation of PEL exopolysaccharide biosynthesis [21]. A BLAST search of the ATCC 
31749 genome did not reveal any homologs for Alg44 or FleQ, and the c-di-GMP 
binding domain of cellulose synthase (PilZ domain) is not present in curdlan synthase. 
However, c-di-GMP may play a role in regulating curdlan synthesis in ATCC 31749, as 
many c-di-GMP binding domains have not yet been identified. Two types of enzymes are 
involved in c-di-GMP synthesis and degradation: diguanylate cyclases, identified by 
GGDEF domains, and 5’-phosphoguanylyl-(3’-5’)-guanosine phosphodiesterases, 
characterized by their EAL domains. In fact, it is common for a single protein to contain 
both GGDEF and EAL domains. From the nitrogen-dependent microarray comparison, 
only two GGDEF-domain genes were significantly up-regulated (r3957 and r1444), and 
twelve GGDEF-domain genes were significantly down-regulated, with eight of the 
twelve also having EAL domains (Table 6.4). While these genes may all influence c-di-
GMP levels in ATCC 31749, only the two up-regulated GGDEF-domain genes (r1444 
and r3957) were selected for gene knockout.  
 A successful gene KO mutant was obtained for r3957. Despite several attempts, 
gene KO of r1444 was unsuccessful, indicating this gene may be necessary for cell 
growth. The r3957 mutant showed a reduced level of curdlan synthesis with a 57% 
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decrease in curdlan synthesis (Figure 6.4). These results suggest that c-di-GMP may 
regulate curdlan production. To determine if the influence of c-di-GMP is specific to 
synthesis via r3957, two other GGDEF proteins (r0033 and r0631) were targeted for gene 
knockout. These two GGDEF proteins were expressed during curdlan synthesis but were 
not found to be significantly up- or down-regulated. The amount of curdlan produced by 
the r0033 and r0631 mutants is similar to that of the wild-type, confirming that the effect 
of c-di-GMP on curdlan production is specific to synthesis by the r3957 GGDEF domain-
containing protein. 
6.3.4 Analysis of possible mechanisms for the regulation of curdlan synthesis 
 From the curdlan synthesis experiments using the gene KO mutants, it is clear that 
multiple factors contribute to the regulation of curdlan synthesis in ATCC 31749. Figure 
6.6 depicts the gene KO mutants with significant effects on curdlan synthesis and gives 
possible explanations for the role that each gene plays in regulating curdlan synthesis. 
The exact mechanisms of regulation remain to be determined, yet from the experimental 
results presented above and information available in the literature, one can speculate on 
the possible mechanisms of regulation. First, the nitrogen signaling cascade plays a role 
in regulating curdlan production. This is indicated by previous experiments which show 
that nitrogen-limitation and NtrB/C are required for curdlan synthesis [3, 9]. As the 
experimental results showing the requirement of NtrB/C have not been published, we 
confirmed this claim by showing that an intact nifR/ntrB/ntrC operon is important for 
curdlan synthesis. Despite the involvement of ntrBC in regulating curdlan production, the 
mechanism is RpoN-independent. This is reminiscent of Rhodobacter capsulatus in 
which NtrC has been shown to regulate the transcription of genes in an RpoN-
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independent manner [22-24]. R. capsulatus is the only organism in which this RpoN-
independent NtrC regulation has been shown to operate extensively. Interestingly, R. 
capsulatus is also the first organism in which ntrBC was shown to be transcribed in an 
operon with a nifR-like gene (nifR3) [25]. Hence, there may be some connection between 
the nifR/ntrB/ntrC operon and RpoN-independent nitrogen-limited regulation. Evidence 
presented in this work suggests that curdlan synthesis is regulated by this RpoN-
independent mechanism. It still remains to be determined if this RpoN-independent 
activation is due to NtrC acting solely as a transcriptional activator or if NtrC interacts 
with another sigma factor to promote transcription. Not only is curdlan synthesis RpoN-
independent, it also appears to be inhibited by RpoN. As no RpoN binding site is present 
in the promoter region of the crd operon, the effect of RpoN is likely indirect. Sigma 
factor competition is a plausible explanation. With a limited amount of RNA polymerase 
holoenzyme in the cell, sigma factors must compete for the available RNAP [26]. 
Therefore, through gene KO of rpoN, the amount of RNAP available for the sigma factor 
which promotes transcription of the crd operon is increased. This relief of sigma factor 




Figure 6.6 Schematic representation of the effects of gene KO on curdlan synthesis and 
possible explanations for the observed results. The colors indicate the functional category 
of the gene: nitrogen signaling cascade (blue), energy-related (red), and GTP-derived 
second messenger (green). The plus (+) or minus (-) signs indicate whether the effect on 
curdlan production is positive or negative. 
 
In addition to regulation via the nitrogen signaling cascade, polyP also appears to 
be an important regulator of curdlan synthesis. Gene KO of the two exopolyphosphatases 
had opposing effects on curdlan production, with ppx1 KO leading to increased curdlan 
synthesis (Figure 6.5) and ppx2 KO resulting in the elimination of curdlan production 
(Figure 6.4). The exopolyphosphatase mutants also had different effects on cell growth. 
The ppx1 mutant had a much slower growth rate than the wild-type while the ppx2 
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mutant grew at the same rate as the wild-type (Figure 6.7). Although the ppx1 mutant 
displayed slower growth, the cell viability of ATCC 31749∆ppx1 during curdlan 
production remained similar to that of the wild-type. On the other hand, ppx2 was found 
to be important for cell viability under nitrogen-limited conditions, with no viable cells 
remaining after 96 hours in the nitrogen-free media (Figure 6.8). While ppx1 and ppx2 
both code for exopolyphosphatases, these genes clearly have different functions in ATCC 
31749. These seemingly contradictory results may be understood by examining the 
subcellular locations of polyP accumulation. As discussed previously, polyP accumulates 
in intracellular organelles known as acidocalcisomes. Only a limited number of 
organisms have been shown to produce acidocalcisomes [10], but polyP is a biopolymer 
common to nearly all bacterial species [27-28]. PolyP accumulates in the cytoplasm of 
these non-acidocalcisome-producing organisms. In particular, polyP is found to 
accumulate during the stationary phase and under stress conditions. The mechanism 
which allows for polyP accumulation is the inhibition of the exopolyphosphatase by 
(p)ppGpp [29]. This connects polyP with the GTP-derived second messenger (p)ppGpp, 
another factor shown to be important for curdlan synthesis. It is likely that ATCC 31749 


















Figure 6.7 Cell growth profiles for wild-type ATCC 31749 (■) and exopolyphosphatase 

























Figure 6.8 Cell viability for wild-type ATCC 31749 (■) and exopolyphosphatase 
mutants, ATCC 31749∆ppx1 (∆), and ATCC 31749∆ppx2 (○). 
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 To support this theory of two subcellular polyphosphate locations, the two 
exopolyphosphatase genes were analyzed with regard to genomic location and protein 
structure. In the literature, only two other bacterial species were shown to produce 
acidocalcisomes: Agrobacterium tumefaciens and Rhodospirillum rubrum [30-31]. 
Interestingly, the genomes of both A. tumefaciens and R. rubrum contain two 
exopolyphosphatase genes. In comparison, non-acidocalcisome-producing bacteria that 
have been shown to accumulate polyP in the cytoplasm, such as E. coli and Pseudomonas 
aeruginosa, only contain one exopolyphosphatase gene. The sole exopolyphosphatase 
gene in E. coli and P. aeruginosa is located adjacent to the polyphosphate kinase gene 
(ppk), with ppx and ppk in the same operon for E. coli (Figure 6.9). The acidocalcisome-
producing A. tumefaciens and R. rubrum also contain an exopolyphosphatase gene in an 
operon with the polyphosphate kinase gene, similar to the ppx2 gene of ATCC 31749. 
The second exopolyphosphatase gene of the acidocalcisome-producing microorganisms 
is located in an operon with ftsJ, coding for a cell division protein. This is analogous to 
ppx1 in ATCC 31749. Gene knockout of ppx1 in ATCC 31749 also likely prevents 
transcription of the cell division protein ftsJ, which may explain the slower growth rate of 
the ppx1 mutant in Figure 6.7. Using protein BLAST, the protein domains of ppx1 and 
ppx2 were analyzed and compared to both acidocalcisome-producing and non-
acidocalcisome-producing organisms (Figure 6.10). The Ppx-GppA catalytic domains of 
ppx2 are located near the N-terminal for all five organisms. On the other hand, the Ppx-
GppA domains of ppx1 are located near the C-terminal, with a 50-200 amino acid 
sequence at the N-terminal with no predicted function. It is possible that this N-terminal 
sequence is used to direct the protein to the acidocalcisome organelle, similar to leader 
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sequences of periplasmic or extracellular proteins. Overall, the conservation of both 
genome organization and protein domain architecture of the two exopolyphosphatases 
suggests that ppx1 is responsible for polyP degradation in the acidocalcisome while ppx2 














Figure 6.9 Genome organization of the exopolyphosphatase genes found in ATCC 31749 
as well as acidocalcisome-producing (A. tumefaciens and R. rubrum) and non-


































Figure 6.10 Predicted protein domains of the exopolyphosphatase genes found in ATCC 
31749 as well as acidocalcisome-producing (A. tumefaciens and R. rubrum) and non-







Figure 6.10 Continued. 
 





E. coli  
 
 




 The possibility of two different subcellular locations of polyP may explain the 
seemingly contradictory results of curdlan synthesis in the ppx1 and ppx2 mutants of 
ATCC 31749. The ppx2 mutant was shown to have no curdlan synthesis (Figure 6.4). If 
ppx2 is responsible for polyP degradation in the cytoplasm as predicted from the analysis 
of genome organization and protein structure, then the degradation of cytoplasmic polyP 
is important for curdlan synthesis. Perhaps the phosphate from polyP degradation is used 
for ATP generation, or cytoplasmic polyP may be a negative regulator of curdlan 
synthsis. On the other hand, ppx1 is predicted to be associated with the acidocalcisome. 
Gene knockout of ppx1 led to increased curdlan production from the pre-stationary phase 
cells (Figure 6.5). This suggests that the increased amount of acidocalcisome-associated 
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polyP in the ppx1 mutant is important for curdlan synthesis. The acidocalcisome polyP 
may be used as an energy source for curdlan synthesis or it may act as a transcriptional 
activator. 
 While polyP and (p)ppGpp have not been shown to directly regulate 
exopolysaccharide production, there is experimental evidence suggesting a possible 
connection between exopolysaccharide synthesis and polyP, (p)ppGpp, GTP, and even 
NtrC. In 1998, a regulatory protein in Pseudomonas aeruginosa (AlgR2) was found to 
positively regulate production of the exopolysaccharide alginate along with GTP, ppGpp, 
and polyP [32]. During the same year, a study on polyP accumulation in E. coli revealed 
that NtrC is required for polyP accumulation upon nitrogen exhaustion [33]. Furthermore, 
this NtrC-mediated regulation of polyP accumulation was found to be RpoN-
independent. It appears that the mechanisms regulating alginate synthesis and polyP 
accumulation in P. aeruginosa and E. coli are very similar to the regulation of curdlan 
synthesis in ATCC 31749. So while curdlan production may be unique to ATCC 31749, 
the mechanism of regulation may be a conserved stress response for many bacterial 
species. More than a decade has passed since the studies on alginate synthesis in P. 
aeruginosa and polyP accumulation in E. coli, yet there has been no additional 
investigation of the regulatory mechanisms involving ppGpp, polyP, and NtrC. With the 
addition of the results presented in this study, it appears that ppGpp and NtrC may be 
important regulators of polyP synthesis under nitrogen-limited conditions, and in turn, 





6.4 Discussion and Conclusions 
 In this study, pH-dependent and nitrogen-dependent transcriptome comparisons 
were used to identify genes important for curdlan synthesis in ATCC 31749. The pH-
dependent comparison revealed significant changes in gene expression for genes 
associated with glucan product synthesis, the primary metabolism, and c-di-GMP 
synthesis and degradation. These three gene categories may be responsible for the 
increase in curdlan production at pH 5.5. The down-regulation of biosynthetic genes 
associated with producing glucan products may increase the availability of carbon for 
curdlan synthesis. The up-regulation of a sucrose transporter and down-regulation of 
glycolytic genes may enhance the carbon flux for curdlan production. And if c-di-GMP is 
a positive regulator of curdlan production, up-regulation of c-di-GMP biosynthetic genes 
and down-regulation of c-di-GMP degrading genes would also promote curdlan 
synthesis. The nitrogen-dependent transcriptome comparison also showed significant 
changes in gene expression for several areas that may influence curdlan production: 
nitrogen-limited regulation, energy-related, and GTP-derived second messengers. Genes 
identified by the nitrogen-dependent transcriptome comparison were subjected to further 
experimental investigation. 
 Through gene KO of genes significantly up- or down-regulated under nitrogen-
limited conditions and subsequent production of curdlan from these mutants, a possible 
mechanism for the regulation of curdlan synthesis was proposed. Three factors are 
proposed to be important for regulating curdlan synthesis: NtrC, (p)ppGpp, and polyP. 
NtrC is a transcriptional activator that may directly regulate the genes involved in curdlan 
biosynthesis, or alternatively, NtrC may regulate curdlan synthesis indirectly through 
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regulation of polyP accumulation. The GTP-derived second messenger, (p)ppGpp, is a 
known inhibitor of exopolyphosphatase [29] and may also indirectly regulate curdlan 
synthesis via polyP accumulation. PolyP is a known regulatory factor found to 
accumulate during the stationary phase and under stress conditions [27]. PolyP has been 
shown to be involved in transcriptional regulation [28] and may also serve as an energy 
source for curdlan production. Interestingly, gene KO of the two exopolyphosphatases 
resulted in opposite effects on curdlan production, suggesting different roles for 
cytoplasmic and acidocalcisome-associated polyP. The other GTP-derived second 
messenger investigated in this study, c-di-GMP, appears to also affect curdlan synthesis, 
but unlike (p)ppGpp, c-di-GMP is not required for curdlan production. Further 
investigation is necessary to determine how all the factors identified in this study function 
to regulate curdlan synthesis in ATCC 31749. 
 Interestingly, polyP may also be a contributing factor to the increased curdlan 
production at pH 5.5 compared to pH 7. Several investigations of polyP-accumulating 
microorganisms have shown pH 5.5 to be optimal for polyP accumulation [34-36]. 
Furthermore, PhoB, a transcriptional activator of the phosphate regulon, was shown to be 
required for polyP accumulation in E. coli [37], and likewise, ChvI, a phoB homolog, 
was shown to be up-regulated at pH 5.5 in Agrobacterium tumefaciens [38]. This 
suggests a possible mechanism for improved curdlan synthesis at pH 5.5. Increased 
transcription of the transcriptional activator chvI at pH 5.5 enhances polyP accumulation, 
which in turn regulates curdlan synthesis either though transcriptional regulation or 
increased energy supply. 
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 While the details of the mechanism(s) regulating curdlan synthesis in ATCC 
31749 must be determined, the main factors influencing curdlan synthesis have been 
identified. These factors will serve as targets for future metabolic engineering efforts to 
improve oligosaccharide synthesis in the Agrobacterium biocatalysts developed 
previously in this work (Chapters 2 and 3). Several recommendations for improving the 
oligosaccharide-producing biocatalysts are discussed in the next chapter. 
 
6.5 Materials and Experimental Methods 
6.5.1 Materials 
 The chemicals used in this study were obtained from Sigma-Aldrich 
(FeSO4•7H2O and MnSO4•H2O) and Fisher (all other chemicals). The restriction 
enzymes, DNA polymerase, and ligase were obtained from New England Biolabs. The 
Zyppy plasmid miniprep and Zymoclean gel DNA recovery kits from Zymo Research 
were used for plasmid isolation and DNA recovery. All kits used for RNA isolation and 
purification and microarray analysis are indicated in section 6.4.4.  
6.5.2 Bacterial strains and plasmids 
 The bacterial strains used and generated in this study are listed in Table 6.5 along 
with the plasmids used for gene KO. 
Table 6.5 Bacterial strains and plasmids used in this study 
 
Strain or plasmid Description      Source    
 
ATCC 31749  Curdlan-producing Agrobacterium sp. (wild-type) ATCC 
ATCC 31749∆exoN ATCC 31749 mutant with gene KO of exoN  This study 
ATCC 31749∆nifR ATCC 31749 mutant with gene KO of nifR  This study 
ATCC 31749∆ppx1 ATCC 31749 mutant with gene KO of r2763 This study 
ATCC 31749∆ppx2 ATCC 31749 mutant with gene KO of ppx  This study 
 188
Table 6.5 Continued 
 
Strain or plasmid Description      Source    
 
ATCC 31749∆rpoN ATCC 31749 mutant with gene KO of rpoN  This study 
ATCC 31749∆rrpP ATCC 31749 mutant with gene KO of rrpP  This study 
ATCC 31749∆spoT ATCC 31749 mutant with gene KO of r1489 This study 
ATCC 31749∆0033 ATCC 31749 mutant with gene KO of r0033 This study 
ATCC 31749∆0631 ATCC 31749 mutant with gene KO of r0631 This study 
ATCC 31749∆1722 ATCC 31749 mutant with gene KO of r1722 This study 
ATCC 31749∆3957 ATCC 31749 mutant with gene KO of r3957 This study 
JM109   E. coli K12 strain used for cloning   Promega 
DH5α/pUCP30T E. coli strain containing suicide vector  H. Schweizer 
pGEM-T easy  Vector used for cloning internal gene fragments Promega 
pUCP30T-exoN Gene KO plasmid for interruption of exoN  This study 
pUCP30T-nifR Gene KO plasmid for interruption of nifR  This study 
pUCP30T-ppx1 Gene KO plasmid for interruption of r2763  This study 
pUCP30T-ppx2 Gene KO plasmid for interruption of ppx  This study 
pUCP30T-rpoN Gene KO plasmid for interruption of rpoN  This study 
pUCP30T-rrpP Gene KO plasmid for interruption of rrpP  This study 
pUCP30T-spoT Gene KO plasmid for interruption of r1489  This study 
pUCP30T-0033 Gene KO plasmid for interruption of r0033  This study 
pUCP30T-0631 Gene KO plasmid for interruption of r0631  This study 
pUCP30T-1722 Gene KO plasmid for interruption of r1722  This study 
pUCP30T-3957 Gene KO plasmid for interruption of r3957  This study 
 
 
6.5.3 Fermentation for curdlan synthesis 
 The ATCC 31749 strains were grown from stock on solid LB media with 
appropriate antibiotics for plasmid-containing strains. After 1.5 days at 30°C, a single 
colony was inoculated into a test tube containing 4 mL of LB media (with antibiotics) 
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and grown overnight at 30°C with 250 rpm. The culture (100 µL) was used to inoculate a 
500 mL Erlenmeyer flask containing 150 mL of LB media (with antibiotics). After 17 
hours of growth, the cells were concentrated by centrifugation (3000 x g, 10 min, 4°C), 
reducing the liquid volume from 150 mL to 30 mL. The concentrated culture was added 
to 450 mL of the minimal fermentation media. The minimal fermentation media was 
described previously with 1.4 g/L of KH2PO4 [39]. NaOH and HCl (1 M) solutions were 
used for pH control. A Multifors fermenter system from Infors was employed for 
fermentation with four parallel 500 mL fermentation vessels. The agitation was set at 600 
rpm with 1 vvm for the air florwate, and the pH was controlled at pH 7 for growth. The 
ammonium level was measured using the Berthelot reaction as described by Bailey and 
coworkers [40]. Upon ammonium depletion, the pH was either maintained at pH 7 or 
shifted to pH 5.5. After the start of curdlan synthesis (i.e. nitrogen exhaustion), 10 mL 
samples were taken every 24 hours for 5 to 7 days.  
 From each sample, 1 mL was used for measuring curdlan. An appropriate amount 
of 3 M NaOH (15-25 mL) was added to dissolve the water-insoluble curdlan 
polysaccharide. After waiting 30 min for dissolution, cells were removed from the 
solublized curdlan solution by centrifugation at 5,000 x g for 20 min. Curdlan was then 
precipitated from the solution by neutralization using 3 M HCl. The precipitated curdlan 
was collected by centrifugation (5000 x g, 20 min) and washed 3 times with DI water. 
The washed curdlan pellet was dried at 80°C until a constant weight was obtained. 
 To measure the dry cell weight, 5 mL of the culture sample was used. An 
appropriate amount of 0.5 M NaOH (15-40 mL) was added to dissolve the water-
insoluble curdlan. The cells were collected by centrifugation at 5,000 x g and 4°C for 20 
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min. The cell pellet was washed twice with DI water, and the resulting cell pellet was 
dried at 80°C until a constant weight was obtained. 
6.5.4 RNA isolation and DNA microarray processing 
 The samples for microarray analysis were collected at 22 h and 100 h of the 
curdlan synthesis fermentations. The RNA was immediately stabilized using Qiagen’s 
RNAprotect Bacteria Reagent and stored at -80°C for no longer than 2 weeks prior to 
RNA isolation. RNA was isolated using Qiagen’s RNeasy mini kit with on-column 
DNase digestion using the RNase-free DNase set. For efficient cell lysis, the 
concentration of the lysozyme solution was increased to 15 mg/mL, and the incubation 
time was increased to 15 min. For the 100 h samples containing high levels of curdlan, 
the volumes of the lysozyme solution, RLT buffer, and ethanol were doubled, and a 
centrifugation step (5,000 x g for 5 min at 10°C) was added after the addition of RLT 
buffer to remove curdlan before RNA precipitation. After RNA isolation, contaminating 
genomic DNA was removed using Ambion’s DNA-free kit. RNA quality was determined 
using Agilent’s 2100 bioanalyzer with the RNA 6000 Nano kit. RNA concentration was 
calculated from the OD260 readings measured using the SpectraMax M5 microplate 
reader with Corning’s UV-transparent 96-well microplates. Purified RNA samples were 
stored at -80°C until analysis. 
  The additional RNA processing and the subsequent microarray processing 
described in this paragraph were performed by Gene Logic Inc. To prepare the RNA 
samples for microarray analysis, the RNA was converted to cDNA and labeled with 
either Cy-3 or Cy-5 using the Fairplay III Microarray Labeling kit from Agilent. The 
microarray is an 8 x 15k custom DNA microarray from Agilent with probes designed 
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using Agilent’s eArray program. The eArray program was able to design probes for 5,580 
of the 5,585 predicted genes in the ATCC 31749 genome. The 5 genes with no probes 
were all hypothetical and were less than 108 bp in length, with 4 of the 5 having less than 
60 bp. Due to their small size and no matches to other known sequences, it is possible 
that these sequences are not real genes and were therefore excluded from the DNA 
microarray. For the 5,580 genes on the DNA microarray, there is one probe sequence 
with two technical replicates for each gene. Fifteen putative housekeeping genes had 10 
replicate spots across the array for quality control analysis. (Putative housekeeping genes: 
glk, rpoD, atpA, cscA, cisY, edd, pgl, zwf, rplB, rpsC, tkt, pykA, gapA, rpoB, and kdgA). 
For each condition analyzed by the microarray, there are 4 biological replicates with dye 
swap so that two replicates were labeled with Cy-3 and two replicates with Cy-5. A 
microarray scanner model G2505B from Agilent Technologies was employed for 
imaging the microarray, and Agilent's Feature Extraction 10.5 Image Analysis Software 
was used to measure the signal intensities from the image of the microarray scan. 
6.5.5 Microarray data analysis 
 Using the Agilent feature extraction software, the mean local background signal 
intensity was subtracted from the mean signal intensity for each individual spot on the 
microarray. The background-subtracted signals were then normalized using a lowess 
normalization to account for any dye-labeling bias. The lowess-normalized data was 
uploaded into GeneSpring GX 10 for additional processing. For the nitrogen-dependent 
comparison microarrays, a scaling normalization was applied to the lowess-normalized 
data, and for the pH comparison microarrays, a quantile normalization was used. The 
normalized data was then analyzed for statistically significant changes in gene expression 
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using a paired T-test with a p-value cutoff of 0.05. Plots of the microarray data before and 
after normalization and statistical analysis are shown in Figures 6.11 and 6.12. 
Statistically significant genes with more than a 2-fold change in gene expression were 




Figure 6.11 Microarray data for the pH-dependent DNA microarray with gene expression 
for pH 7 on the x-axis and gene expression for pH 5.5 on the y-axis. (A) Signal intensity 
after background subtraction and baseline transformation to the median; (B) Signal 
intensity after lowess normalization; (C) Signal intensity after quantile normalization; (D) 
Signal intensity for statistically significant changes in gene expression as predicted by the 








Figure 6.12 Microarray data for the nitrogen-dependent DNA microarray with gene 
expression for the 22h sample on the x-axis and gene expression for the 100h sample on 
the y-axis. (A) Signal intensity after background subtraction and baseline transformation 
to the median; (B) Signal intensity after lowess normalization; (C) Signal intensity after 
75th percentile normalization; (D) Signal intensity for statistically significant changes in 
gene expression as predicted by the paired T-test. The green lines indicate genes with 2-
fold changes in gene expression. 
 
6.5.6 Gene knockouts 
 A gene KO method used previously with A. tumefaciens was followed for gene 
knockout in ATCC 31749 [38]. A small, internal fragment of the target gene (200-500bp) 
was cloned and inserted into the SacI and HindII sites of the suicide vector, pUCP30T. 





restriction enzyme sites underlined. The resulting KO plasmids (1 µL) were transformed 
into electrocompetent ATCC 31749 (20 µL) via electroporation using the Biorad 
micropulser Agr program with an ice-chilled 0.1 cm cuvette. Following electroporation, 1 
mL of sterile LB media was added, and the culture was transferred to an eppendorf tube 
(1.5 mL). The culture was then incubated for 4 hours at 30°C with 250 rpm. After 
incubation, the culture was concentrated using centrifugation for 5 min at 5,000 rpm and 
resuspended in 100 µL of supernant. The concentrated culture was spread on LB agar 
plates containing 50 µg/mL of gentamicin for selection of the gene KO candidates. 
Successful gene KO was confirmed with PCR using primers that span the junction 
between the chromosome and inserted KO plasmid. For each gene, the primer 
homologous to the gentamicin resistance gene (GMR) was used along with a primer 
homologous to the sequence upstream of the target gene. The primer sequences are listed 
in Table 6.6. 
Table 6.6 Primers used for gene KO plasmid construction and gene KO confirmation 
 
Target Gene Forward/ Primer Sequence    
  Reverse 
 
Internal gene fragment 
   exoN      F  5’- CTAAGCTTCGGCTGCAGGATATAACGGC-3’ 
      R  5’- GAGAGCTCAAGACCGCCATCGAGGACT-3’ 
   nifR      F  5’- GCAAGCTTCCCAATCCGCCCGTCCCTC-3’ 
      R  5’- CAGAGCTCGAAATGGTCGCCAGCCGC-3’ 
  r2763 (ppx1)     F  5’- CTAAGCTTGCAGCGAGGTCCAGTGGGTG-3’ 
      R  5’- CAGAGCTCCAGTTCCGGGTCGTCGATG-3’ 
   ppx (ppx2)     F  5’- CTAAGCTTGCTCCAATCCGCCAGTTCGC-3’ 
      R  5’- CAGAGCTCGGTCGGTGGTACATGGCGAA-3’ 
    
 195
Table 6.6 Continued 
 
Target Gene Forward/ Primer Sequence    
  Reverse 
 
rpoN      F  5’-GCAAGCTTCATCGAATCGTAACCCGCG-3’ 
      R  5’- GCGAGCTCAGCGACCACCTCAATCAG -3’ 
   rrpP      F  5’- GTAAGCTTGATCAGCGCCGTCACGACAAG-3’ 
      R  5’- CAGAGCTCCCGCGCAACCCTGCTACCAT-3’ 
  r1489 (spoT)     F  5’- GTAAGCTTGTATGCTCCAGGAACTCTTC-3’ 
      R  5’- GAGAGCTCCGTCAAGGGACGTCAGAAAA-3’ 
   r0033     F  5’- CGTGACAAGCTTTTCATAGATGCAGGCAACGTC-3’ 
      R  5’- GAACGTGAGCTCCTGGTGGGCGGATGATTGT-3’ 
   r0631     F  5’- CCTAGAAAGCTTCACAATAGTCGCTGCCAAGT-3’ 
      R  5’- CCTAGAGAGCTCGCTTGTCTCGTGACGCTCATT-3’ 
   r1722     F  5’- CGTGACAAGCTTCGGGATGGC AATGGTCTCGT-3’ 
      R  5’- CTTGTAGAGCTCCTGGCGTTGATACCCATGCT-3’ 
   r3957     F  5’- GAGTGTAAGCTTTCCAGCACATAATAGGGCGA-3’ 
      R  5’- CTTGGAGAGCTCGACACTTGCGGTTGTCATCG-3’ 
Gene KO confirmation 
   GMR      F  5’- GATGCCCATACTTGAGCCACCTAAC -3’ 
   exoN      R  5’- GAACTGTCAGAAAAGCCGTCATTCC -3’ 
   nifR      R  5’-AAGATCATCATTTGCCTCTTCCGGAG -3’ 
   r2763 (ppx1)    R  5’- GCGAAGCGATCCCGTCGTGGCAAGA -3’ 
   ppx (ppx2)       R  5’- GACTCGATCAGAAGCACAGGGGC -3’ 
   rpoN      R  5’- ATGACGCATTTCGAGCTGACGCAGTT-3’ 
   rrpP      R  5’- ATGCGGTGTCCTGTCCGTGGTTTA -3’ 
   r1489 (spoT)    R  5’- CGCTTTCTTTTTGTGGAATATCGCA -3’ 
   r0033     R  5’- GTCGTGTTTCAAGTTTCAGGGTCCG -3’ 
   r0631     R  5’- GATGTTGGGTCTTTGGAAAAAACCG -3’ 
   r1722     R  5’- ATGAATGGTGAAAAGCGGGGGAGC -3’ 
   r3957     R  5’-GGTGAATCGCAGATGATGGAATTGAT -3’ 
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6.5.6.1 ATCC 31749 electrocompetent cell preparation 
 For electrocompetent cell preparation, all glassware used for cell culture was 
rinsed repeatedly with purified water (resistivity = 18 MΩ/cm), and the same high purity 
water was used for all media and solution preparation. ATCC 31749 was inoculated in a 
test tube containing 4 mL of LB media and grown overnight at 30°C with 250 rpm. This 
culture was diluted 1000 times into 150 mL of LB media and grown at 30°C with 250 
rpm until an OD600 of 0.5 was reached. After a 30 min rest on ice, the cells were 
transferred to chilled 50 mL centrifuge tubes and centrifuged for 10 min at 2,000 x g and 
4°C. The cell pellet was washed repeatedly with 10 mL of sterile 10% glycerol. 
Following 3 wash cycles, the cell pellet was resuspended in 0.5 mL of sterile 10% 
glycerol, separated into 50 µL aliquots, and stored at -80°C until use.   
6.5.7 Growth and cell viability studies of gene KO mutants 
 To determine if the gene KO has any effect on cell growth, the growth profiles of 
each gene KO mutant were obtained. For each mutant, a single colony was inoculated 
into 4 mL of LB media and grown overnight at 30°C with 250 rpm. The seed culture was 
diluted 100 times into 150 mL of LB media. Growth was monitored measuring the 
optical density of the cell culture using a Beckman Coulter DU530 spectrophotometer. 
Samples were taken every 1.5 hr. 
 A reduction or elimination of curdlan synthesis in a mutant strain may be due to a 
direct effect of the target gene on curdlan production or due to cell death of the mutant 
strain. To determine if the curdlan-deficiency is merely a result of cell death, the cell 
viability of curdlan-deficient mutants was assayed. At time periods of 0 hr, 48 hr, and 120 
hr during the curdlan synthesis reaction, the cell culture was diluted and spread on LB 
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agar plates. After incubation at 30°C, the number of colony forming units was counted 
for each mutant to serve as a measure of cell viability. 
6.5.8 Shake-flask curdlan synthesis for analysis of KO mutants 
 Due to the large number of gene KO mutants generated in this study, shake-flask 
cultivation was employed to analyze curdlan synthesis in the mutant strains. For each 
mutant, a single colony was inoculated into 4 mL of LB media and incubated overnight at 
30°C and 250 rpm. The seed culture was diluted 100 times into two flasks containing 150 
mL LB media. The cultures were grown at 30°C and 250 rpm until stationary phase was 
reached (approximately 12 hours for mutants with growth similar to the wild-type) or 
prior to stationary phase (OD600 = 1.4). The cells were collected by centrifugation at 
3,000 x g and 4°C for 10 min. After one wash step with 10% glycerol, the cell pellets 
were resuspended in nitrogen-free minimal media. The nitrogen-free minimal media 
contains 40 g/L sucrose, 0.5 g/L KH2PO4, 0.5 g/L MgSO4•7H2O, and 10 mL/L of trace 
element solution, with the pH adjusted to 7 prior to autoclaving using 6N NaOH. 
Concentrated solutions of sucrose, MgSO4•7H2O, and trace element solution were 
autoclaved separately and added to the nitrogen-free media prior to the addition of cells. 
The trace element solution is comprised of 5 g/L FeSO4•7H2O, 2 g/L MnSO4•H2O, 1 g/L 
CoCl2•6H2O, 1 g/L ZnCl2 in 0.1 M HCl. For curdlan synthesis, the cells, resuspended in 
the nitrogen-free media, were incubated at 30°C and 250 rpm. Samples were taken at 24 
hr intervals to analyze the curdlan concentration. The procedure for measuring curdlan is 
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CONCLUSIONS AND RECOMMENDATIONS  
FOR FUTURE WORK 
 
7.1 Conclusions 
 The experimental results and analysis presented in this dissertation accomplish the 
two main objectives outlined in the introduction (Chapter 1): 1) biocatalysts were 
developed for oligosaccharide synthesis utilizing ATCC 31749 as host and 2) the factors 
influencing curdlan production in ATCC 31749 were determined. 
7.1.1 Biocatalyst construction for oligosaccharide production 
 Two biocatalysts were successfully constructed for the production of medically-
relevant oligosaccharides through the metabolic engineering of Agrobacterium sp. ATCC 
31749. The engineered Agrobacterium strain, ATCC 31749/pKEL, synthesized over 7 
g/L of N-acetyllactosamine (LacNAc), an oligosaccharide moiety involved in the process 
of inflammation and a potential target for cancer treatments. The second biocatalyst, 
ATCC 31749/pBQET, produced an α-Gal epitope, Gal-α1,3-Lac, an essential component 
of vaccines under development for the treatment of flu, HIV, and cancer. 
 Additional metabolic engineering efforts improved the production capacity of the 
α-Gal-producing biocatalyst. Heterologous expression of a lactose transporter, lacY, 
increased uptake of the acceptor sugar, lactose, resulting in increased production of the α-
Gal epitope. α-Gal epitope synthesis was further improved by increasing the supply of the 
sugar nucleotide precursor, UDP-glucose. Gene knockout of the curdlan synthase gene, 
crdS, eliminated the competitive consumption of UDP-glucose for curdlan synthesis. The 
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crdS mutant strain, ATCC 31749∆crdS/pBQETY, synthesized nearly 1 g/L of Gal-α1,3-
Lac. These results illustrate the benefit of applying metabolic engineering for biocatalyst 
improvement. 
 The synthesis of gram-scale quantities of oligosaccharides using the engineered 
Agrobacterium biocatalysts demonstrates the potential application for large-scale 
synthesis. Additionally, these biocatalysts offer advantages over other available methods 
for oligosaccharide synthesis. Unlike chemical synthesis and the bacterial coupling 
technique which require multiple steps for oligosaccharide synthesis [1-2], the engineered 
Agrobacterium synthesizes the glycosidic bond in only one step. This is ideal for 
industrial production where multiple reactors or fermenters can drive up both capital and 
production expenses. Furthermore, the Agrobacterium biocatalysts require limited and 
fairly inexpensive nutrients (sucrose, acceptor sugar, phosphate, buffer, and trace 
amounts of co-factors Mg2+ and Mn2+), again reducing production cost in relation to other 
methods such as enzymatic and bacterial coupling which often require expensive, high 
energy compounds and co-factors [1, 3-5]. Other one-step, whole-cell biocatalysts for 
oligosaccharide synthesis employ traditional microbial hosts such as Escherichia coli. In 
this work, we show Agrobacterium sp. ATCC 31749 to be a superior host, synthesizing 
up to 11-fold more LacNAc compared to a similarly engineered E. coli strain. While the 
development of two biocatalysts for the production of LacNAc and Gal-α1,3-Lac is 
significant in and of itself, this dissertation also demonstrates the potential for ATCC 
31749 to serve as host for the production of many other UDP-glucose derived 
oligosaccharides. 
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7.1.2 Multiple factors influence curdlan and oligosaccharide synthesis in ATCC 
31749 
 Agrobacterium sp. ATCC 31749 is a beneficial host for oligosaccharide synthesis 
due to its natural production of curdlan polysaccharide. The large amount of curdlan 
synthesized by ATCC 31749 implies efficient production of the sugar nucleotide 
precursor, UDP-glucose. Through metabolic engineering efforts, the efficient UDP-
glucose production pathway of ATCC 31749 was hijacked for production of the 
oligosaccharides LacNAc and Gal-α1,3-Lac. Thus, oligosaccharide production in the 
biocatalysts is dependent upon the same metabolic pathways for curdlan synthesis. At the 
start of this project, however, only limited information was available regarding curdlan 
synthesis. Previous work had identified several extracellular factors important for high 
curdlan production: nitrogen-limitation, a high level of dissolved oxygen, a pH shift from 
7.0 to 5.5 after nitrogen exhaustion, and a low phosphate concentration [6-9]. In addition, 
four genes were identified as necessary for curdlan production: crdA, crdS, crdC, and 
crdR, with only crdS having a determined function and reported nucleotide sequence [10-
11]. With this limited amount of information on curdlan synthesis, further improvement 
of the Agrobacterium biocatalysts was not feasible. To identify metabolic engineering 
targets for biocatalyst development, additional extracellular, intracellular, and regulatory 
factors affecting oligosaccharide and curdlan production in ATCC 31749 were 
investigated. 
 Several extracellular factors were found to enhance oligosaccharide synthesis in 
the Agrobacterium biocatalysts. Various carbon sources were investigated to optimize 
LacNAc synthesis in ATCC 31749/pKEL, including glucose, sucrose, fructose, glycerol, 
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and GlcNAc. Sucrose was found to be the preferred carbon source for efficient 
oligosaccharide synthesis. Presumably, ATCC 31749 can transport and metabolize 
sucrose more efficiently than other carbon sources, as sucrose was also shown to lead to 
higher amounts of curdlan production [12]. Another extracellular factor found to 
influence oligosaccharide synthesis was the addition of citrate to the synthesis medium, 
which resulted in up to a 10-fold improvement in LacNAc production. Further 
investigation revealed that ATCC 31749 can simultaneously metabolize both sucrose and 
citrate as sources of carbon and energy. Citrate, a weak acid, also acted as a buffer to help 
maintain the pH at a level optimal for oligosaccharide synthesis. Both the addition of 
citrate and the identification of a preferred carbon source led to improved oligosaccharide 
production in the Agrobacterium biocatalysts. 
 With the successful determination of extracellular factors influencing 
oligosaccharide and curdlan synthesis, intracellular and regulatory factors became the 
focus of further investigation. With very little genetic information available for ATCC 
31749, the first step in identifying intracellular factors for curdlan synthesis was to 
sequence the genome of this microorganism. Through genome sequencing, the metabolic 
pathways relevant to curdlan production were determined, including the pathway for 
UDP-glucose synthesis, the Entner-Doudoroff pathway for glycolysis, and the TCA cycle 
for energy production. The genome sequence also revealed regulatory processes and 
genes with possible influence over curdlan synthesis. Regulatory genes involved in 
nitrogen, oxygen, phosphate, pH, and exopolysaccharide regulation in other organisms 
were identified in ATCC 31749 and may be responsible for regulating curdlan synthesis 
in response to various environmental signals. While genome sequencing revealed the 
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genes present in ATCC 31749 and also provided the nucleotide sequences needed for 
metabolic engineering, additional information was required to pinpoint the genes relevant 
to curdlan production. For this purpose, the transcriptome profile of ATCC 31749 was 
studied before and after the start of curdlan production, and genes with significant 
changes in gene expression level were selected for further experimental investigation.  
 Using gene knockout, several intracellular and regulatory factors were found to 
influence curdlan production. As expected, the nitrogen signaling cascade was found to 
be important for curdlan synthesis. However, this nitrogen-limited regulation was shown 
to be RpoN-independent, indicating a unique mechanism of NtrC-mediated regulation. 
Another important factor for curdlan synthesis is polyP. Gene knockout of two 
exopolyphosphatases was found to have opposing effects on curdlan production as well 
as cell growth and cell viability. The exopolyphosphatase mutant ∆ppx1 was found to 
have slow cell growth but was able to produce curdlan at levels similar to the wild-type. 
Additionally, ∆ppx1 was shown to produce more than 5 times the amount of curdlan 
compared to the wild-type when transferred to nitrogen-free media before reaching the 
stationary phase. On the other hand, the ppx2 mutant showed normal growth but failed to 
produce curdlan and had reduced cell viability in the nitrogen-free media. I propose that 
these results indicate two subcellular locations of polyP accumulation and degradation 
via exopolyphosphatase: the acidocalcisome and the cytoplasm. PolyP has been shown to 
accumulate in acidocalcisomes, possibly serving as energy and phosphate storage [13-
15]. PolyP has also been shown to accumulate during the stationary phase and regulate 
gene transcription [16]. Thus, polyP may serve as a source of energy or phosphate during 
curdlan synthesis, or polyP may act as a transcriptional regulator. The GTP-derived 
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second messengers, (p)ppGpp and c-di-GMP, were also found to affect curdlan synthesis. 
Gene knockout of a spoT homolog eliminated curdlan synthesis in ATCC 31749. SpoT 
synthesizes the GTP-derived second messenger, (p)ppGpp. In many microorganisms, 
(p)ppGpp is found to accumulate at the start of the stationary phase and has been shown 
to be involved in regulating transcription, translation, and replication [17]. It is therefore 
plausible that (p)ppGpp is required for transcription or translation of the curdlan synthesis 
operon crdASC. Evidence suggests that c-di-GMP, another GTP-derived second 
messenger, also influences curdlan production. C-di-GMP may be an allosteric regulator 
of the curdlan synthesis proteins. 
 Interestingly, the two intracellular factors, (p)ppGpp and polyP, may not act 
independently to influence curdlan synthesis. Previous data has shown that (p)ppGpp is 
required for polyP accumulation. (p)ppGpp inhibits the exopolyphosphatase to allow for 
cytoplasmic polyP accumulation in the stationary phase [18]. Therefore, (p)ppGpp may 
regulate curdlan production via polyP accumulation. Additional evidence implies a 
possible connection between polyP and nitrogen regulation; a study on polyP 
accumulation in E. coli showed that polyP failed to accumulate in ntrC- mutants while 
polyP accumulation occurred in rpoN- mutants [19]. This suggests a similar mechanism 
of regulation for polyP and curdlan synthesis. Moreover, NtrC may regulate curdlan 
production indirectly by influencing polyP accumulation. While the exact mechanism for 
the regulation of curdlan synthesis remains to elucidated, this work identified four 
important factors for curdlan production in ATCC 31749: the nifR/ntrB/ntrC operon, 
polyP, (p)ppGpp, and c-di-GMP. 
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7.2 Significanct Contributions 
  The research presented in this dissertation makes significant contributions to the 
fields of oligosaccharide synthesis and microbial exopolysaccharide synthesis and 
regulation. The Agrobacterium whole-cell biocatalysts developed in this dissertation 
(Chapters 2 and 3) are the first examples of engineering a polysaccharide-producing 
microorganism for oligosaccharide synthesis. This metabolic engineering strategy takes 
advantage of the natural capability of the microorganism to produce the sugar nucleotide 
precursor for oligosaccharide synthesis. The expression of lacY, a lactose permease, 
constitutes a new strategy for increased acceptor uptake in whole-cell oligosaccharide 
synthesis: selective uptake of the acceptor sugar via transport protein. This strategy was 
shown to be successful for enhancing oligosaccharide synthesis in the engineered 
Agrobacterium and can be applied to other hosts for improved oligosaccharide 
production. These contributions are important advances in the field of oligosaccharide 
synthesis. 
 The knowledge and understanding of microbial ecopolysaccharide synthesis and 
regulation are also advanced through the results presented in this dissertation. The 
transcriptome analysis reveals the first evidence that the curdlan synthesis operon is 
transcriptionally regulated. This information contributes to the understanding of the 
regulation of curdlan production in ATCC 31749 and will help direct future efforts to 
elucidate the regulatory mechanism. The general understanding of microbial 
exopolysaccharide synthesis and regulation is advanced by the identification of important 
regulatory factors for curdlan synthesis: polyP, (p)ppGpp, and c-di-GMP. C-di-GMP was 
previously identified to influence synthesis of several exopolysaccharides [20-23], but 
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polyP and (p)ppGpp are factors first identified through this dissertation. These factors are 
known to accumulate during stress conditions in many microorganisms and may be 
components of a conserved regulatory mechanism for exopolysaccharide synthesis. 
Furthermore, this is the first evidence linking curdlan synthesis to the stress response of 
the cell, providing additional insight into the understanding of why this biopolymer is 
produced. This dissertation presents evidence to suggest two subcellular locations for 
polyP accumulation: the acidocalcisome and the cytoplasm. While this must still be 
confirmed experimentally, it may be a key component in understanding the regulation of 
curdlan synthesis. Lastly, the results of this research indicate a unique mechanism for 
nitrogen-limited regulation of curdlan synthesis. Some components of the nitrogen 
signaling cascade are shown to be important for curdlan synthesis, but this regulation is 
shown to be RpoN-independent. This is likely to be a key factor in elucidating the 
mechanism for transcriptional regulation of curdlan synthesis. The results of this 
dissertation provide important contributions to the understanding of microbial 
exopolysaccharide synthesis and will likely guide future research endeavors in the field. 
 
7.3 Recommendations for Future Work 
 The two main objectives of this dissertation were achieved: biocatalysts were 
successfully developed to produce medically-relevant oligosaccharides in just one step 
and requiring inexpensive co-factors and substrates, and several extracellular and 
intracellular factors influencing curdlan synthesis were determined. With the 
identification of genes affecting curdlan synthesis and regulation, future research efforts 
will focus on two areas: 1) additional metabolic engineering to improve oligosaccharide 
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synthesis in the Agrobacterium biocatalysts and 2) investigation of the mechanism(s) 
regulating curdlan synthesis in ATCC 31749. 
7.3.1 Biocatalyst development for improved oligosaccharide production 
7.3.1.1 Large-scale oligosaccharide synthesis 
 The Agrobacterium biocatalysts developed for oligosaccharide synthesis offer 
several advantages over other synthesis techniques, namely inexpensive co-factor and 
substrate requirements and a one-step synthesis process. These features are important for 
large-scale oligosaccharide production. Despite these beneficial attributes, initial attempts 
at large-scale oligosaccharide synthesis were unsuccessful using the engineered 
Agrobacterium biocatalysts.  
 The main factor preventing large-scale synthesis is insufficient recombinant 
protein expression. In small-scale synthesis, this problem is overcome by using a two-
step process. In the first step, the engineered Agrobacterium is grown in rich media, and 
recombinant protein expression is induced. After successful protein expression, the cells 
are collected, washed, and transferred to the minimal, nitrogen-free media for 
oligosaccharide synthesis. As this two-step process is undesirable for large-scale 
synthesis, the conditions established for large-scale curdlan production were employed 
for one-step oligosaccharide synthesis. Unfortunately, the minimal media used for large-
scale synthesis did not support recombinant protein expression, as indicated by the 
negligible activity measured after induction. To overcome this problem, I suggest that the 
fusion enzyme (galE:lgtB or galE:α1,3galT) be placed under the control of the promoter 
for the curdlan synthesis operon, crdASC. The genes for curdlan synthesis are adequately 
expressed in the minimal media following nitrogen-limitation, with a 75-fold increase in 
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gene expression detected for crdS in the nitrogen-dependent microarray comparison. The 
nucleotide sequence for cloning the promoter of the crdASC operon is available from the 
genome sequence. If gene expression of the fusion enzyme remains limited under the crd 
promoter, the nucleotide sequence of the amino acid codons for the fusion enzyme should 
be optimized for expression in ATCC 31749. These two steps, crd promoter expression 
of the fusion enzyme and codon optimization, should allow for a one-step process for 
large-scale oligosaccharide synthesis using the Agrobacterium biocatalysts. Moreover, 
oligosaccharide synthesis in the bioreactor should improve oligosaccharide yields, as the 
conditions promoting high curdlan production such as high dissolved oxygen 
concentration and pH maintenance are well controlled in the bioreactor. 
7.3.1.2 Targets for metabolic engineering  
 In this dissertation, several intracellular factors were found to be important for 
curdlan synthesis, including (p)ppGpp and polyP. Gene knockout of the GTP 
pyrophosphohydrolase /synthetase (spoT) and the exopolyphosphatase (ppx2) eliminated 
curdlan production. Presumably, the reverse may also be true: overexpression of spoT 
and ppx2 may enhance curdlan production. The two genes should be cloned and 
overexpressed in ATCC 31749 to determine their effect on curdlan synthesis. If this does 
in fact improve curdlan synthesis, it may also benefit oligosaccharide synthesis in the 
Agrobacterium biocatalysts. The fusion enzyme for oligosaccharide synthesis and the two 
genes (spoT and ppx2) can be simultaneously expressed using the pBQ expression vector 
to determine the influence of (p)ppGpp and polyP on oligosaccharide production. 
 Gene knockout of the other exopolyphosphatase (ppx1) led to a significant 
improvement in curdlan production when cells in the growth phase were transferred to 
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the nitrogen-free media. The same mutant may also be able to produce higher levels of 
oligosaccharide when engineered with a plasmid containing the requisite fusion enzyme. 
The plasmids required for LacNAc- and Gal-α1,3-Lac production can be directly 
transformed into ATCC 31749∆ppx1 to test this hypothesis. If successful, a double 
knockout mutant with gene deletions in both ppx1 and crdS can be constructed to 
determine if the elimination of curdlan production along with increased polyP will further 
improve oligosaccharide synthesis.  
 The development of biocatalysts with both spoT and ppx2 overexpression and 
ppx1 gene deletion may further improve oligosaccharide synthesis in the engineered 
Agrobacterium sp. ATCC 31749. These biocatalysts will also determine if (p)ppGpp and 
polyP regulate only the curdlan synthesis operon or if they also affect UDP-glucose 
synthesis. If (p)ppGpp and polyP only regulate the genes for curdlan synthesis, the 
biocatalysts with spoT and ppx2 overexpression and the ppx1 gene deletion will not show 
improvement in oligosaccharide synthesis. So in addition to the potential for improving 
oligosaccharide production, these results will also provide insight into the genes and 
pathways affected by (p)ppGpp and polyP. 
7.3.2 Determination of the mechanisms regulating curdlan synthesis in ATCC 31749 
 The gene knockout experiments detailed in this dissertation identified several 
important factors influencing curdlan synthesis in ATCC 31749; however, additional 
work is required to elucidate the details of the mechanism(s) involved in regulating 
curdlan production. The gene knockout results indicate that polyP, (p)ppGpp, and c-di-
GMP effect curdlan production in ATCC 31749. To confirm this hypothesis, the levels of 
polyP, (p)ppGpp, and c-di-GMP during both growth and curdlan synthesis should be 
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measured for the wild-type strain and the ∆nifR, ∆ppx1, ∆ppx2, ∆spoT, and ∆3957  
mutants. (p)ppGpp and polyP levels in the ∆nifR mutant should help to determine if the 
nitrogen signaling cascade directly regulates curdlan production or if it acts through the 
regulation of either (p)ppGpp or polyP. PolyP levels in the ∆ppx1 mutant should be 
enhanced compared to the wild-type while (p)ppGpp and polyP levels should be 
negligible in the ∆spoT mutant. Furthermore, a decrease in polyP during the course of 
curdlan synthesis may indicate that polyP is utilized as an energy source for curdlan 
synthesis as opposed to simply acting as a transcriptional or translational regulator. 
Alternatively, if polyP increases along with curdlan production, it will suggest a 
regulatory role for polyP.  
 Determining the role of polyP in the regulation curdlan production is an 
interesting challenge, as the two exopolyphosphatase knockouts showed very different 
effects on growth and curdlan production. To test the hypothesis that acidocalcisome-
associated polyP and cytoplasmic polyP play different roles in regulating growth and 
curdlan synthesis, a reporter protein such as green fluorescent protein (gfp) should be 
linked to the two exopolyphosphatases and the two polyphosphate kinases. Visualization 
of cells expressing the gfp-modified genes will determine if the polyP synthesizing and 
degrading proteins are localized in distinct subcellular regions. This may be the first step 
in unraveling the mechanism of polyP regulation with regard to both curdlan synthesis 
and other stress-induced processes influenced by polyP. 
 To determine if the four factors identified through gene knockout, the 
nifR/ntrB/ntrC operon, polyP, (p)ppGpp, and c-di-GMP, effect curdlan production 
through transcriptional regulation, gene expression levels of the crd operon should be 
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measured in the wild-type and the ∆nifR, ∆ppx1, ∆ppx2, ∆spoT, and ∆3957 mutants. The 
operon expression level can be measured by fusing the crd promoter region to a reporter 
gene, either gfp or lacZ (β-galactosidase). The estimated gene expression from 
measurement of the reporter gene in the background of the wild-type and mutant strains 
should reveal if transcription of the crd operon is influenced by any of the gene 
knockouts. 
 The knowledge gained through investigation of the mechanisms regulating 
curdlan synthesis may suggest additional genes that influence curdlan production. These 
genes can serve as targets for another round of metabolic engineering to further improve 
the Agrobacterium biocatalysts for oligosaccharide production. The work described in 
this dissertation establishes the foundation for using engineered Agrobacterium 
biocatalysts for oligosaccharide synthesis and also identifies extracellular and 
intracellular factors influencing the natural production of curdlan in ATCC 31749. By 
building upon this work with the recommend experiments detailed in this section, the 
resulting biocatalysts should enable large-scale and economical production of 
oligosaccharides for medical applications. 
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METABOLIC FLUX ANALYSIS 
 
A.1 Reactions included in the metabolic network of ATCC 31749/pKEL 
 
(1) Sucrose à Glc + Fru 
(2) Glc à Glc (extracellular) 
(3) Fru à Fru (extracellular) 
(4) Glc + ATP à G6P + ADP 
(5) Fru + ATP à F6P + ADP  
(6) F6P à G6P 
(7) G6P à G1P 
(8) G1P + ATP à UDP-Glc + ADP 
(9) UDP-Glc à Crd  
(10) UDP-Glc à UDP-Gal 
(11) UDP-Gal + Glc à Lactose   
(12) UDP-Gal + GlcNAc à LacNAc 
(13) UDP-Gal + F6P à P3  
(14) G6P à 6PG  
(15) 6PG à GAP + PYR  
(16) Glycerol-3-P + NAD à GAP + NADH 
(17) Glycerol + ATP à Glycerol-3-P + ADP 
(18) GAP + 2 ADP + NAD à PYR + 2 ATP + NADH 
(19) PYR + NAD à ACoA + NADH 
(20) ACoA + ADP à Acetate + ATP 
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(21) ACoA + OAA à CIT  
(22) CIT (extracellular) à CIT 
(23) CIT à ICT 
(24) ICT + NAD à aKG + NADH 
(25) aKG + NAD à SUCC-CoA + NADH 
(26) SUCC-CoA + ADP à SUCC + ATP  
(27) SUCC + FAD à MAL + FADH2 
(28) MAL + NAD à OAA + NADH 
(29) ICT + ACoA à SUCC + MAL  
(30) NADH + 3 ADP à NAD + 3 ATP 
(31) FADH2 + 2 ADP à FAD + 2 ATP 
(32) ATP à ADP 
A.2  MATLAB code for metabolic flux analysis 
 
% This m-file contains the stoichiometric matrix C for ATCC31749/pKEL.  
% 0 = C(transpose)v 
% There are 32 total fluxes and 25 metabolites, giving 7 degrees of 
freedom. 
  
% Since most values in the matrix are zero, start by identifying a  
% matrix of zeros with rows = number of unmeasured fluxes, and columns  
% = number of metabolites. 
  
% With: ED, TCA, Glyoxylate, curdlan, ATP, NAD/NADH, FAD/FADH 
% No: PPP, EMP, PEP carboxylase, PYR carboxylase 
  
% Sucrose is used as the carbon source. 
C = zeros(22,25); 
  
% Now specify stoichiometric coefficients for each flux. Reactants are 
% negative and products are positive. 
  
%(1) Glycerol-3-P + NAD -> GAP + NADH 
C(1,1)= -1; C(1,2)= -1; C(1,3)= 1; C(1,4)= 1; 
  
%(2) Fru + ATP -> F6P + ADP 
C(2,5)= -1; C(2,6)= -1; C(2,7)= 1; C(2,8)= 1; 
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%(3) Glc + ATP -> G6P + ADP 
C(3,9)= -1; C(3,6)= -1; C(3,10)= 1; C(3,8)= 1; 
  
%(4) F6P -> G6P 
C(4,7)= -1; C(4,10)= 1; 
  
%(5) GAP + 2 ADP + NAD -> PYR + 2 ATP + NADH 
C(5,3)= -1; C(5,8)= -2; C(5,2)= -1; C(5,11)= 1; C(5,6)= 2; C(5,4)= 1; 
  
%(6) PYR + NAD -> ACoA + NADH 
C(6,11)= -1; C(6,2)= -1; C(6,12)= 1; C(6,4)= 1; 
  
%(7) ACoA + OAA -> CIT  
C(7,12)= -1; C(7,13)= -1; C(7,14)= 1; 
  
%(8) CIT -> ICT 
C(8,14)= -1; C(8,15)= 1; 
  
%(9) ICT + NAD -> aKG + NADH 
C(9,15)= -1; C(9,2)= -1; C(9,16)= 1; C(9,4)= 1; 
  
%(10) aKG + NAD -> SUCC-CoA + NADH 
C(10,16)= -1; C(10,2)= -1; C(10,17)= 1; C(10,4)= 1; 
  
%(11) SUCC-CoA + ADP -> SUCC + ATP 
C(11,17)= -1; C(11,8)= -1; C(11,18)= 1; C(11,6)= 1; 
  
%(12) SUCC + FAD -> MAL + FADH2 
C(12,18)= -1; C(12,19)= -1; C(12,20)= 1; C(12,21)= 1; 
  
%(13) ICT + ACoA -> SUCC + MAL 
C(13,15)= -1; C(13,12)= -1; C(13,18)= 1; C(13,20)= 1;  
  
%(14) MAL + NAD -> OAA + NADH 
C(14,20)= -1; C(14,2)= -1; C(14,13)= 1; C(14,4)= 1; 
  
%(15) G6P -> 6PG 
C(15,10)= -1; C(15,22)= 1; 
  
%(16) 6PG -> GAP + PYR 
C(16,22)= -1; C(16,3)= 1; C(16,11)= 1; 
  
%(17) G6P -> G1P 
C(17,10)= -1; C(17,23)= 1; 
  
%(18) G1P + ATP -> UDP-Glc + ADP 
C(18,23)= -1; C(18,6)= -1; C(18,24)= 1; C(18,8)= 1; 
  
%(19) UDP-Glc -> UDP-Gal 
C(19,24)= -1; C(19,25)= 1; 
  
%(20) NADH + 3 ADP -> NAD + 3 ATP 
C(20,4)= -1; C(20,8)= -3; C(20,2)= 1; C(20,6)= 3; 
  
%(21) FADH2 + 2 ADP -> FAD + 2 ATP 
C(21,21)= -1; C(21,8)= -2; C(21,19)= 1; C(21,6)= 2; 
 220
  
%(22) ATP -> ADP 
C(22,6)= -1; C(22,8)= 1; 
 
% This m-file contains the stoichiometric matrix M for ATCC31749/pKEL.  
% There are 32 fluxes and 25 metabolites, giving 7 degrees of freedom. 
  
% Since most values in the matrix are zero, start by identifying a  
% matrix of zeros with rows = number of measured fluxes and columns =  
% number of metabolites. 
 
% no sucrose phosphorylase, overdetermined 
  
% Sucrose is used as the carbon source. 
M = zeros(10,25); 
  
% Now specify stoichiometric coefficients for each flux. Reactants are 
% negative and products are positive. 
  
%(1) Sucrose -> Glc + Fru 
M(1,9)= 1; M(1,5)= 1; 
  
%(2) Glc -> Glc(ex) 
M(2,9)= -1; 
  
%(3) Fru -> Fru(ex) 
M(3,5)= -1; 
  
%(4) Glycerol + ATP -> Glycerol-3-P + ADP 
M(4,6)= -1; M(4,1)= 1; M(4,8)= 1; 
  
%(5) ACoA + ADP -> Acetate + ATP 
M(5,12)= -1; M(5,8)= -1; M(5,6)= 1; 
  
%(6) CIT(ex) -> CIT 
M(6,14)= 1; 
  
%(7) UDP-Glc -> crd + UDP 
M(7,24)= -1; 
  
%(8) UDP-Gal + Glc -> Lactose + UDP 
M(8,25)= -1; M(8,9)= -1;  
  
%(9) UDP-Gal + GlcNAc -> LacNAc + UDP 
M(9,25)= -1; 
  
%(10) UDP-Gal + F6P -> LacN + UDP 
M(10,25)= -1; M(10,7)= -1; 
  
 
% Measured values for 5g/L citrate (mM/h) 
  
% Sucrose consumption 
V(1,1)= 2.737826; 
  




% Fructose accumulation 
V(3,1)= 0.239839; 
  
% Glycerol consumption 
V(4,1) = 0.649883; 
  
% Acetate production 
V(5,1)= 0.679199; 
  
% Citrate consumption 
V(6,1)= 0.077918; 
  
% Curdlan formation 
V(7,1)= 0.012129; 
  
% Lactose formation 
V(8,1)= 0.099341; 
  
% LacNAc formation 
V(9,1)= 0.089897; 
  




% Measured values for 0g/L citrate (mM/h) 
  
% Sucrose consumption 
V(1,1)= 0.520147; 
  
% Glucose accumulation 
V(2,1)= 0.091229; 
  
% Fructose accumulation 
V(3,1)= 0.11749; 
  
% Glycerol consumption 
V(4,1)= -0.09471; 
  
% Acetate production 
V(5,1)= 0.460595; 
  
% Citrate consumption 
V(6,1)= 0; 
  
% Curdlan formation 
V(7,1)= 0.010739; 
  
% Lactose formation 
V(8,1)= -0.00619; 
  
% LacNAc formation 
V(9,1)= -0.00473; 
  








# Purpose: To extract blast information from the generated XML file 
 




# Declare and initialize variables 
my $file_blast = 'Pangenome_S_meliloti1021.out'; 
my @XML = ( ); 
my @query = ( ); 
my @qlength = ( ); 
my @number = ( ); 
my @id = ( ); 
my @definition = ( ); 
my @hlength = ( ); 
my @score = ( ); 
my @evalue = ( ); 
my @identity = ( ); 
my @positive = ( ); 
my $count = -1; 
my $hit_query = ''; 
my $hit_qlen = ''; 
my $hit_num = ''; 
my $hit_id = ''; 
my $hit_def = ''; 
my $hit_hlen = ''; 
my $hit_score = ''; 
my $hit_evalue = ''; 
my $hit_identity = ''; 
my $hit_pos = ''; 
 
# Open blast XML file and store as array 
open(XML_BLAST, $file_blast); 





foreach my$line (@XML) { 
 
 # Find query and store in query array 
 if ($line =~ /^ {6}<Iteration_query-def>/) { 
   
  # Add one to count 
  $count++; 
 
  # Remove XML notation from line 
  $line =~ s/^ {6}<Iteration_query-def>//; 
  $line =~ s/<\/Iteration_query-def>//; 
 
  # Store in query array 
  $hit_query = $line; 
  $query[$count] = $hit_query; 
 
 # Find query length and store in qlength array 
 }elsif ($line =~ /^ {6}<Iteration_query-len>/) { 
 
  # Remove XML notation from line 
  $line =~ s/^ {6}<Iteration_query-len>//; 
  $line =~ s/<\/Iteration_query-len>//; 
 
  # Store in qlength array 
  $hit_qlen = $line; 
  $qlength[$count] = $hit_qlen; 
 
 # If there are no hits, store no hits message in definition array 
 }elsif ($line =~ /^ {6}<Iteration_message>/) { 
 
  # Remove XML notation from line 
  $line =~ s/^ {6}<Iteration_message>//; 
  $line =~ s/<\/Iteration_message>//; 
 
  # Store line in definition array 
  $hit_def = $line; 
  $definition[$count] = $hit_def; 
 
  # All other arrays should add a newline \n, with number set to 1. 
  $number[$count] = "1\n"; 
  $id[$count] = "\n"; 
  $hlength[$count] = "\n"; 
  $score[$count] = "\n"; 
  $evalue[$count] = "\n"; 
  $identity[$count] = "\n"; 




 # Find hit number and store in number array 
 }elsif ($line =~ /^ {10}<Hit_num>/) { 
   
  # Remove XML notation from line 
  $line =~ s/^ {10}<Hit_num>//; 
  $line =~ s/<\/Hit_num>//; 
 
  # Store in number array 
  $hit_num = $line; 
 
  # if hit number is greater than 1, add one to count and add another line to 
query  
# and query length 
  if ($hit_num > 1) { 
   $count++; 
   $query[$count] = $hit_query; 
   $qlength[$count] = $hit_qlen; 
  } 
 
  $number[$count] = $hit_num; 
 
 # Find hit id and store in id array 
 }elsif ($line =~ /^ {10}<Hit_id>/) { 
 
  # Remove XML notation from line 
  $line =~ s/^ {10}<Hit_id>//; 
  $line =~ s/<\/Hit_id>//; 
 
  # Store in id array 
  $hit_id = $line; 
  $id[$count] = $hit_id; 
 
 # Find hit definition and store in definition array 
 }elsif ($line =~ /^ {10}<Hit_def>/) { 
   
  # Remove XML notation from line 
  $line =~ s/^ {10}<Hit_def>//; 
  $line =~ s/<\/Hit_def>//; 
 
  # Store in definition array 
  $hit_def = $line; 
  $definition[$count] = $hit_def; 
  
 # Find length and store in length array 
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 }elsif ($line =~ /^ {10}<Hit_len>/) { 
 
  # Remove XML notation from line 
  $line =~ s/^ {10}<Hit_len>//; 
  $line =~ s/<\/Hit_len>//; 
 
  # Store in length array 
  $hit_hlen = $line; 
  $hlength[$count] = $hit_hlen; 
 
 # Find score and store in score array 
 }elsif ($line =~ /^ {14}<Hsp_score>/) { 
 
  # Remove XML notation from line 
  $line =~ s/^ {14}<Hsp_score>//; 
  $line =~ s/<\/Hsp_score>//; 
 
  # Store in score array 
  $hit_score = $line; 
  $score[$count] = $hit_score; 
 
 # Find e-value and store in evalue array 
 }elsif ($line =~ /^ {14}<Hsp_evalue>/) { 
 
  # Remove XML notation from line 
  $line =~ s/^ {14}<Hsp_evalue>//; 
  $line =~ s/<\/Hsp_evalue>//; 
 
  # Store in evalue array 
  $hit_evalue = $line; 
  $evalue[$count] = $hit_evalue; 
 
 # Find identities and store in idenitity array 
 }elsif ($line =~ /^ {14}<Hsp_identity>/) { 
 
  # Remove XML notation from line 
  $line =~ s/^ {14}<Hsp_identity>//; 
  $line =~ s/<\/Hsp_identity>//; 
 
  # Store in identity array 
  $hit_identity = $line; 
  $identity[$count] = $hit_identity; 
 
 # Find positives and store in positive array 
 }elsif ($line =~ /^ {14}<Hsp_positive>/) { 
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  # Remove XML notation from line 
  $line =~ s/^ {14}<Hsp_positive>//; 
  $line =~ s/<\/Hsp_positive>//; 
 
  # Store in positive array 
  $hit_pos = $line; 




# Print arrays to files 
 
my$outputfile1 = "S_meliloti1021_query.txt"; 
unless(open(blast_nr_query, ">>$outputfile1")) { 
 print "Cannot open file \"$outputfile1\" to write to!!\n\n"; 
 exit; 
} 
print blast_nr_query @query; 
close (blast_nr_query); 
 
my$outputfile5 = "S_meliloti1021_qlength.txt"; 
unless(open(blast_nr_qlength, ">>$outputfile5")) { 
 print "Cannot open file \"$outputfile5\" to write to!!\n\n"; 
 exit; 
} 




my$outputfile2 = "S_meliloti1021_number.txt"; 
unless(open(blast_nr_number, ">>$outputfile2")) { 
 print "Cannot open file \"$outputfile2\" to write to!!\n\n"; 
 exit; 
} 
print blast_nr_number @number; 
close (blast_nr_number); 
 
my$outputfile3 = "S_meliloti1021_id.txt"; 
unless(open(blast_nr_id, ">>$outputfile3")) { 
 print "Cannot open file \"$outputfile3\" to write to!!\n\n"; 
 exit; 
} 
print blast_nr_id @id; 
close (blast_nr_id); 
 
my$outputfile4 = "S_meliloti1021_definition.txt"; 
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unless(open(blast_nr_definition, ">>$outputfile4")) { 
 print "Cannot open file \"$outputfile4\" to write to!!\n\n"; 
 exit; 
} 
print blast_nr_definition @definition; 
close (blast_nr_definition); 
 
my$outputfile6 = "S_meliloti1021_hlength.txt"; 
unless(open(blast_nr_hlength, ">>$outputfile6")) { 
 print "Cannot open file \"$outputfile6\" to write to!!\n\n"; 
 exit; 
} 
print blast_nr_hlength @hlength; 
close (blast_nr_hlength); 
 
my$outputfile7 = "S_meliloti1021_score.txt"; 
unless(open(blast_nr_score, ">>$outputfile7")) { 
 print "Cannot open file \"$outputfile7\" to write to!!\n\n"; 
 exit; 
} 
print blast_nr_score @score; 
close (blast_nr_score); 
 
my$outputfile8 = "S_meliloti1021_evalue.txt"; 
unless(open(blast_nr_evalue, ">>$outputfile8")) { 
 print "Cannot open file \"$outputfile8\" to write to!!\n\n"; 
 exit; 
} 
print blast_nr_evalue @evalue; 
close (blast_nr_evalue); 
 
my$outputfile9 = "S_meliloti1021_identity.txt"; 
unless(open(blast_nr_identity, ">>$outputfile9")) { 
 print "Cannot open file \"$outputfile9\" to write to!!\n\n"; 
 exit; 
} 
print blast_nr_identity @identity; 
close (blast_nr_identity); 
 
my$outputfile10 = "S_meliloti1021_positive.txt"; 
unless(open(blast_nr_positive, ">>$outputfile10")) { 
 print "Cannot open file \"$outputfile10\" to write to!!\n\n"; 
 exit; 
} 







# Purpose: To format the ATCC 31749 annotation into PathoLogic format for upload into 
Pathway Tools 
 




# Declare and initialize variables 
my $file_ORF = 'Pathologic_ORFs.txt'; 
my $file_gene = 'Pathologic_gene.txt'; 
my $file_startb = 'Pathologic_startbase.txt'; 
my $file_endb = 'Pathologic_endbase.txt'; 
my $file_function = 'Pathologic_function.txt'; 
my $file_comment = 'Pathologic_comment.txt'; 
my @orf = ( ); 
my @gene = ( ); 
my @startbase = ( ); 
my @endbase = ( ); 
my @function = ( ); 
my @genecomment = ( ); 
my $count = 0; 
my $id_line = ''; 
my $name_line = ''; 
my $startbase_line = ''; 
my $endbase_line = ''; 
my $function_line = ''; 
my $genecomment_line = ''; 
my $id = "ID\t"; 
my $name = "NAME\t"; 
my $sbase = "STARTBASE\t"; 
my $ebase = "ENDBASE\t"; 
my $func = "FUNCTION\t"; 
my $dblink_line = "DBLINK PID:\t\n"; 
my $producttype_line = "PRODUCT-TYPE\tP\n"; 
my $comment = "GENE-COMMENT\t"; 
my $divider = "//\n"; 
my $gene1 = ''; 
my $startbase1 = ''; 
my $endbase1 = ''; 
my $function1 = ''; 
my $comment1 = ''; 
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# Open input files and store as arrays 
open(ORF_file, $file_ORF); 




















@genecomment = <COMMENT>; 
close COMMENT; 
 
# Remove tabs from comment lines 
foreach my$line1 (@genecomment) { 
  
 $line1 =~ s/\t//g; 
} 
 
# Remove spaces from function file 
foreach my$line2 (@function) { 
 $line2 =~ s/^  //; 
} 
 
# Format each ORF and write to Pathologic file 
foreach my$line (@orf) { 
 
 $gene1 = $gene[$count]; 
 $startbase1 = $startbase[$count]; 
 $endbase1 = $endbase[$count]; 
 $function1 = $function[$count]; 
 $comment1 = $genecomment[$count]; 
 
 $id_line = "$id$line"; 
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 $name_line = "$name$gene1"; 
 $startbase_line = "$sbase$startbase1"; 
 $endbase_line = "$ebase$endbase1"; 
 $function_line = "$func$function1"; 
 $genecomment_line = "$comment$comment1"; 
 
 # Open output file and print lines 
 my$outputfile1 = "Pathologic_ATCC31749.txt"; 
 unless (open(pathologic_ATCC31749, ">>$outputfile1")) { 
  print "Cannot open file \"$outputfile1\" to write to!!\n\n"; 
  exit; 
 } 
 print pathologic_ATCC31749 "$id_line"; 
 print pathologic_ATCC31749 "$name_line"; 
 print pathologic_ATCC31749 "$startbase_line"; 
 print pathologic_ATCC31749 "$endbase_line"; 
 print pathologic_ATCC31749 "$function_line"; 
 print pathologic_ATCC31749 "$dblink_line"; 
 print pathologic_ATCC31749 "$producttype_line"; 
 print pathologic_ATCC31749 "$genecomment_line"; 
 print pathologic_ATCC31749 "$divider"; 
 close(pathologic_ATCC31749); 
 









# Purpose: To compare hits from comparative genomics and form a core genome and 
differences list of genes. 
 




# Declare and initialize variables 
my $file_vitis = '31749_vitis_AA_match.txt'; 
my $file_orf = '31749_ORF_query.txt'; 
my $file_radio = '31749_radiobacter_AA_match.txt'; 
my $file_tume = '31749_tumefaciens_AA_match.txt'; 
my @que = ( ); 
my @vgene = ( ); 
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my @rgene = ( ); 
my @tgene = ( ); 
my @corgene = ( ); 
my @vdiff = ( ); 
my @rdiff = ( ); 
my @tdiff = ( ); 
my @qdiff = ( ); 
my $count1 = 0; 
my $count2 = 0; 
my $count3 = 0; 
my $count4 = 0; 
my $que1 = ''; 
my $rgene1 = ''; 
my $vgene1 = ''; 
my $tgene1 = ''; 
 
# open each file and store as array 
 
open(NR_VITIS, $file_vitis); 












@tgene = <NR_TUM>; 
close NR_TUM; 
 
# for each line of gene array, if it equals the query, store in newque array.  
# if not, add line to newque array and compare query to next gene. 
 
foreach my$line (@que) { 
 
 $rgene1 = $rgene[$count1]; 
 $tgene1 = $tgene[$count1]; 
 $vgene1 = $vgene[$count1]; 
 
 $count4 = $count2; 
 
 if ($line eq $rgene1) { 
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  if ($line eq $tgene1) { 
   if ($line eq $vgene1) { 
    $corgene[$count2] = $line; 
    $count2 ++; 
   } 
  } 
 } 
 if ($count2 == $count4) { 
  $qdiff[$count3] = $line; 
  $rdiff[$count3] = $rgene1; 
  $tdiff[$count3] = $tgene1; 
  $vdiff[$count3] = $vgene1; 
  $count3 ++; 
 } 
 $count1 ++; 
} 
   
# Print array to new files 
 




















my$outputfile5 = "vitis_differences.txt"; 
open(VIT_DIF, ">>$outputfile5"); 
print VIT_DIF"@vdiff"; 
close (VIT_DIF); 
 
exit; 
